MyHealth@Eu Imaging Diagnostic Report
0.0.1 - ci-build
150
MyHealth@Eu Imaging Diagnostic Report
0.0.1 - ci-build
150
MyHealth@Eu Imaging Diagnostic Report - Local Development build (v0.0.1) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
| Page standards status: Draft | Maturity Level: 1 |
<ValueSet xmlns="http://hl7.org/fhir">
<id value="eHDSIOncologyDisease"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: ValueSet eHDSIOncologyDisease</b></p><a name="eHDSIOncologyDisease"> </a><a name="hceHDSIOncologyDisease"> </a><a name="eHDSIOncologyDisease-en-US"> </a><ul><li>Include these codes as defined in <a href="https://build.fhir.org/ig/HL7/UTG/CodeSystem-icd-o-3.html"><code>http://terminology.hl7.org/CodeSystem/icd-o-3</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>8000/0</td><td>Neoplasm, benign</td></tr><tr><td>8000/1</td><td>Neoplasm, uncertain whether benign or malignant</td></tr><tr><td>8000/3</td><td>Neoplasm, malignant</td></tr><tr><td>8000/6</td><td>Neoplasm, metastatic</td></tr><tr><td>8000/9</td><td>Neoplasm, malignant, uncertain whether primary or metastatic</td></tr><tr><td>8001/0</td><td>Tumour cells, benign</td></tr><tr><td>8001/1</td><td>Tumour cells, uncertain whether benign or malignant</td></tr><tr><td>8001/3</td><td>Tumour cells, malignant</td></tr><tr><td>8002/3</td><td>Malignant tumour, small cell type</td></tr><tr><td>8003/3</td><td>Malignant tumour, giant cell type</td></tr><tr><td>8004/3</td><td>Malignant tumour, spindle cell type</td></tr><tr><td>8005/0</td><td>Clear cell tumour, NOS</td></tr><tr><td>8005/3</td><td>Malignant tumour, clear cell type</td></tr><tr><td>8010/0</td><td>Epithelial tumour, benign</td></tr><tr><td>8010/2</td><td>Carcinoma in situ, NOS</td></tr><tr><td>8010/3</td><td>Carcinoma, NOS</td></tr><tr><td>8010/6</td><td>Carcinoma, metastatic, NOS</td></tr><tr><td>8010/9</td><td>Carcinomatosis</td></tr><tr><td>8011/0</td><td>Epithelioma, benign</td></tr><tr><td>8011/3</td><td>Epithelioma, malignant</td></tr><tr><td>8012/3</td><td>Large cell carcinoma, NOS</td></tr><tr><td>8013/3</td><td>Large cell neuroendocrine carcinoma</td></tr><tr><td>8014/3</td><td>Large cell carcinoma with rhabdoid phenotype</td></tr><tr><td>8015/3</td><td>Glassy cell carcinoma</td></tr><tr><td>8020/3</td><td>Carcinoma, undifferentiated, NOS</td></tr><tr><td>8021/3</td><td>Carcinoma, anaplastic, NOS</td></tr><tr><td>8022/3</td><td>Pleomorphic carcinoma</td></tr><tr><td>8023/3</td><td>Nuclear protein in testis (NUT) associated carcinoma</td></tr><tr><td>8030/3</td><td>Giant cell and spindle cell carcinoma</td></tr><tr><td>8031/3</td><td>Giant cell carcinoma</td></tr><tr><td>8032/3</td><td>Spindle cell carcinoma, NOS</td></tr><tr><td>8033/3</td><td>Pseudosarcomatous carcinoma</td></tr><tr><td>8034/3</td><td>Polygonal cell carcinoma</td></tr><tr><td>8035/3</td><td>Carcinoma with osteoclast-like giant cells</td></tr><tr><td>8040/0</td><td>Tumourlet, benign</td></tr><tr><td>8040/1</td><td>Tumourlet, NOS</td></tr><tr><td>8041/3</td><td>Small cell carcinoma, NOS</td></tr><tr><td>8042/3</td><td>Oat cell carcinoma</td></tr><tr><td>8043/3</td><td>Small cell carcinoma, fusiform cell</td></tr><tr><td>8044/3</td><td>Small cell carcinoma, intermediate cell</td></tr><tr><td>8045/3</td><td>Combined small cell carcinoma</td></tr><tr><td>8046/3</td><td>Non-small cell carcinoma</td></tr><tr><td>8050/0</td><td>Papilloma, NOS</td></tr><tr><td>8050/2</td><td>Papillary carcinoma in situ</td></tr><tr><td>8050/3</td><td>Papillary carcinoma, NOS</td></tr><tr><td>8051/0</td><td>Verrucous papilloma</td></tr><tr><td>8051/3</td><td>Verrucous carcinoma, NOS</td></tr><tr><td>8052/0</td><td>Squamous cell papilloma, NOS</td></tr><tr><td>8052/2</td><td>Papillary squamous cell carcinoma, non-invasive</td></tr><tr><td>8052/3</td><td>Papillary squamous cell carcinoma</td></tr><tr><td>8053/0</td><td>Squamous cell papilloma, inverted</td></tr><tr><td>8054/0</td><td>Warty dyskeratoma</td></tr><tr><td>8054/3</td><td>Warty carcinoma</td></tr><tr><td>8060/0</td><td>Squamous papillomatosis</td></tr><tr><td>8070/0</td><td>Actinic keratosis</td></tr><tr><td>8070/2</td><td>Squamous cell carcinoma in situ, NOS</td></tr><tr><td>8070/3</td><td>Squamous cell carcinoma, NOS</td></tr><tr><td>8070/6</td><td>Squamous cell carcinoma, metastatic, NOS</td></tr><tr><td>8071/2</td><td>Differentiated intraepithelial neoplasia</td></tr><tr><td>8071/3</td><td>Squamous cell carcinoma, keratinizing, NOS</td></tr><tr><td>8072/0</td><td>Large cell acanthoma</td></tr><tr><td>8072/3</td><td>Squamous cell carcinoma, large cell, nonkeratinizing, NOS</td></tr><tr><td>8073/3</td><td>Squamous cell carcinoma, small cell, nonkeratinizing</td></tr><tr><td>8074/3</td><td>Squamous cell carcinoma, spindle cell</td></tr><tr><td>8075/3</td><td>Squamous cell carcinoma, adenoid</td></tr><tr><td>8076/2</td><td>Squamous cell carcinoma in situ with questionable stromal invasion</td></tr><tr><td>8076/3</td><td>Squamous cell carcinoma, microinvasive</td></tr><tr><td>8077/0</td><td>Squamous intraepithelial neoplasia, low grade</td></tr><tr><td>8077/2</td><td>Squamous intraepithelial neoplasia, high grade</td></tr><tr><td>8078/3</td><td>Squamous cell carcinoma with horn formation</td></tr><tr><td>8080/2</td><td>Queyrat erythroplasia</td></tr><tr><td>8081/2</td><td>Bowen disease</td></tr><tr><td>8082/3</td><td>Lymphoepithelial carcinoma</td></tr><tr><td>8083/3</td><td>Basaloid squamous cell carcinoma</td></tr><tr><td>8084/0</td><td>Clear cell acanthoma</td></tr><tr><td>8084/3</td><td>Squamous cell carcinoma, clear cell type</td></tr><tr><td>8085/3</td><td>Squamous cell carcinoma, HPV-positive</td></tr><tr><td>8086/3</td><td>Squamous cell carcinoma, HPV-negative</td></tr><tr><td>8090/1</td><td>Basal cell tumour</td></tr><tr><td>8090/3</td><td>Basal cell carcinoma, NOS</td></tr><tr><td>8091/3</td><td>Superficial basal cell carcinoma</td></tr><tr><td>8092/3</td><td>Infiltrating basal cell carcinoma, NOS</td></tr><tr><td>8093/3</td><td>Basal cell carcinoma, fibroepithelial</td></tr><tr><td>8094/3</td><td>Basosquamous carcinoma</td></tr><tr><td>8095/3</td><td>Metatypical carcinoma</td></tr><tr><td>8096/0</td><td>Intraepidermal epithelioma of Jadassohn</td></tr><tr><td>8097/3</td><td>Basal cell carcinoma, nodular</td></tr><tr><td>8098/3</td><td>Adenoid basal carcinoma</td></tr><tr><td>8100/0</td><td>Trichoepithelioma</td></tr><tr><td>8100/3</td><td>Trichoblastic carcinoma</td></tr><tr><td>8101/0</td><td>Trichofolliculoma</td></tr><tr><td>8102/0</td><td>Trichilemmoma</td></tr><tr><td>8102/3</td><td>Trichilemmocarcinoma</td></tr><tr><td>8103/0</td><td>Pilar tumour</td></tr><tr><td>8103/1</td><td>Proliferating trichilemmal cyst</td></tr><tr><td>8104/0</td><td>Pilar sheath acanthoma</td></tr><tr><td>8110/0</td><td>Pilomatricoma, NOS</td></tr><tr><td>8110/3</td><td>Pilomatrical carcinoma</td></tr><tr><td>8120/0</td><td>Urothelial papilloma, NOS</td></tr><tr><td>8120/2</td><td>Urothelial carcinoma in situ</td></tr><tr><td>8120/3</td><td>Transitional cell carcinoma, NOS</td></tr><tr><td>8121/0</td><td>Sinonasal papilloma, exophytic</td></tr><tr><td>8121/1</td><td>Sinonasal papilloma, inverted</td></tr><tr><td>8121/3</td><td>Schneiderian carcinoma</td></tr><tr><td>8122/3</td><td>Urothelial carcinoma, sarcomatoid</td></tr><tr><td>8123/3</td><td>Basaloid carcinoma</td></tr><tr><td>8124/3</td><td>Cloacogenic carcinoma</td></tr><tr><td>8130/1</td><td>Papillary urothelial neoplasm of low malignant potential</td></tr><tr><td>8130/2</td><td>Papillary urothelial carcinoma, non-invasive</td></tr><tr><td>8130/3</td><td>Papillary urothelial carcinoma</td></tr><tr><td>8131/3</td><td>Urothelial carcinoma, micropapillary</td></tr><tr><td>8140/0</td><td>Adenoma, NOS</td></tr><tr><td>8140/1</td><td>Atypical adenoma</td></tr><tr><td>8140/2</td><td>Adenocarcinoma in situ, NOS</td></tr><tr><td>8140/3</td><td>Adenocarcinoma, NOS</td></tr><tr><td>8140/6</td><td>Adenocarcinoma, metastatic, NOS</td></tr><tr><td>8141/3</td><td>Scirrhous adenocarcinoma</td></tr><tr><td>8142/3</td><td>Linitis plastica</td></tr><tr><td>8143/3</td><td>Superficial spreading adenocarcinoma</td></tr><tr><td>8144/0</td><td>Adenoma, intestinal type</td></tr><tr><td>8144/3</td><td>Adenocarcinoma, intestinal type</td></tr><tr><td>8145/3</td><td>Carcinoma, diffuse type</td></tr><tr><td>8146/0</td><td>Monomorphic adenoma</td></tr><tr><td>8147/0</td><td>Basal cell adenoma</td></tr><tr><td>8147/3</td><td>Basal cell adenocarcinoma</td></tr><tr><td>8148/0</td><td>Glandular intraepithelial neoplasia, low grade</td></tr><tr><td>8148/2</td><td>Glandular intraepithelial neoplasia, high grade</td></tr><tr><td>8149/0</td><td>Canalicular adenoma</td></tr><tr><td>8150/0</td><td>Pancreatic neuroendocrine microadenoma</td></tr><tr><td>8150/3</td><td>Pancreatic neuroendocrine tumour, nonfunctioning</td></tr><tr><td>8151/3</td><td>Insulinoma, NOS</td></tr><tr><td>8152/3</td><td>Glucagonoma</td></tr><tr><td>8153/3</td><td>Gastrinoma</td></tr><tr><td>8154/3</td><td>Mixed neuroendocrine non-neuroendocrine neoplasm (MiNEN)</td></tr><tr><td>8155/3</td><td>Vipoma</td></tr><tr><td>8156/3</td><td>Somatostatinoma</td></tr><tr><td>8158/3</td><td>ACTH-producing tumour</td></tr><tr><td>8160/0</td><td>Bile duct adenoma</td></tr><tr><td>8160/3</td><td>Cholangiocarcinoma</td></tr><tr><td>8161/0</td><td>Bile duct cystadenoma</td></tr><tr><td>8161/3</td><td>Bile duct cystadenocarcinoma</td></tr><tr><td>8162/3</td><td>Perihilar cholangiocarcinoma</td></tr><tr><td>8163/0</td><td>Pancreatobiliary neoplasm, non-invasive</td></tr><tr><td>8163/2</td><td>Papillary neoplasm, pancreatobiliary-type, with high grade intraepithelial neoplasia</td></tr><tr><td>8163/3</td><td>Pancreatobiliary-type carcinoma</td></tr><tr><td>8170/0</td><td>Liver cell adenoma</td></tr><tr><td>8170/3</td><td>Hepatocellular carcinoma, NOS</td></tr><tr><td>8171/3</td><td>Hepatocellular carcinoma, fibrolamellar</td></tr><tr><td>8172/3</td><td>Hepatocellular carcinoma, scirrhous</td></tr><tr><td>8173/3</td><td>Hepatocellular carcinoma, spindle cell variant</td></tr><tr><td>8174/3</td><td>Hepatocellular carcinoma, clear cell type</td></tr><tr><td>8175/3</td><td>Hepatocellular carcinoma, pleomorphic type</td></tr><tr><td>8180/3</td><td>Combined hepatocellular carcinoma and cholangiocarcinoma</td></tr><tr><td>8190/0</td><td>Trabecular adenoma</td></tr><tr><td>8190/3</td><td>Trabecular adenocarcinoma</td></tr><tr><td>8191/0</td><td>Embryonal adenoma</td></tr><tr><td>8200/0</td><td>Eccrine dermal cylindroma</td></tr><tr><td>8200/3</td><td>Adenoid cystic carcinoma</td></tr><tr><td>8201/2</td><td>Cribriform carcinoma in situ</td></tr><tr><td>8201/3</td><td>Cribriform carcinoma, NOS</td></tr><tr><td>8202/0</td><td>Microcystic adenoma</td></tr><tr><td>8204/0</td><td>Lactating adenoma</td></tr><tr><td>8210/0</td><td>Adenomatous polyp, NOS</td></tr><tr><td>8210/2</td><td>Adenocarcinoma in situ in adenomatous polyp</td></tr><tr><td>8210/3</td><td>Adenocarcinoma in adenomatous polyp</td></tr><tr><td>8211/0</td><td>Tubular adenoma, NOS</td></tr><tr><td>8211/3</td><td>Tubular adenocarcinoma</td></tr><tr><td>8212/0</td><td>Flat adenoma</td></tr><tr><td>8213/0</td><td>Serrated adenoma</td></tr><tr><td>8213/3</td><td>Serrated adenocarcinoma</td></tr><tr><td>8214/3</td><td>Parietal cell carcinoma</td></tr><tr><td>8215/3</td><td>Adenocarcinoma of anal glands</td></tr><tr><td>8220/0</td><td>Adenomatous polyposis coli</td></tr><tr><td>8220/3</td><td>Adenocarcinoma in adenomatous polyposis coli</td></tr><tr><td>8221/0</td><td>Multiple adenomatous polyps</td></tr><tr><td>8221/3</td><td>Adenocarcinoma in multiple adenomatous polyps</td></tr><tr><td>8230/2</td><td>Ductal carcinoma in situ, solid type</td></tr><tr><td>8230/3</td><td>Solid carcinoma, NOS</td></tr><tr><td>8231/3</td><td>Carcinoma simplex</td></tr><tr><td>8240/3</td><td>Neuroendocrine tumour, NOS</td></tr><tr><td>8241/3</td><td>Enterochromaffin cell carcinoid</td></tr><tr><td>8242/3</td><td>Enterochromaffin-like cell tumour</td></tr><tr><td>8243/3</td><td>Goblet cell carcinoid</td></tr><tr><td>8244/3</td><td>Mixed adenoneuroendocrine carcinoma</td></tr><tr><td>8245/1</td><td>Tubular carcinoid</td></tr><tr><td>8245/3</td><td>Adenocarcinoid tumour</td></tr><tr><td>8246/3</td><td>Neuroendocrine carcinoma, NOS</td></tr><tr><td>8247/3</td><td>Merkel cell carcinoma</td></tr><tr><td>8248/1</td><td>Apudoma</td></tr><tr><td>8249/3</td><td>Neuroendocrine tumour, grade 2</td></tr><tr><td>8250/0</td><td>Atypical adenomatous hyperplasia</td></tr><tr><td>8250/1</td><td>Pulmonary adenomatosis</td></tr><tr><td>8250/2</td><td>Adenocarcinoma in situ of lung, non-mucinous</td></tr><tr><td>8250/3</td><td>Lepidic adenocarcinoma</td></tr><tr><td>8251/0</td><td>Alveolar adenoma</td></tr><tr><td>8251/3</td><td>Alveolar adenocarcinoma</td></tr><tr><td>8252/3</td><td>Bronchiolo-alveolar carcinoma, non-mucinous</td></tr><tr><td>8253/2</td><td>Adenocarcinoma in situ of lung, mucinous</td></tr><tr><td>8253/3</td><td>Adenocarcinoma of lung, mucinous</td></tr><tr><td>8254/3</td><td>Adenocarcinoma of lung, mixed mucinous and non-mucinous</td></tr><tr><td>8255/3</td><td>Adenocarcinoma with mixed subtypes</td></tr><tr><td>8256/3</td><td>Minimally invasive adenocarcinoma, Non-mucinous</td></tr><tr><td>8257/3</td><td>Minimally invasive adenocarcinoma, Mucinous</td></tr><tr><td>8260/0</td><td>Papillary adenoma, NOS</td></tr><tr><td>8260/1</td><td>Aggressive papillary tumour</td></tr><tr><td>8260/3</td><td>Papillary adenocarcinoma, NOS</td></tr><tr><td>8261/0</td><td>Villous adenoma, NOS</td></tr><tr><td>8261/2</td><td>Adenocarcinoma in situ in villous adenoma</td></tr><tr><td>8261/3</td><td>Adenocarcinoma in villous adenoma</td></tr><tr><td>8262/3</td><td>Villous adenocarcinoma</td></tr><tr><td>8263/0</td><td>Tubulovillous adenoma, NOS</td></tr><tr><td>8263/2</td><td>Adenocarcinoma in situ in tubulovillous adenoma</td></tr><tr><td>8263/3</td><td>Adenocarcinoma in tubulovillous adenoma</td></tr><tr><td>8264/0</td><td>Papillomatosis, glandular</td></tr><tr><td>8265/3</td><td>Micropapillary carcinoma, NOS</td></tr><tr><td>8270/0</td><td>Chromophobe adenoma</td></tr><tr><td>8270/3</td><td>Chromophobe carcinoma</td></tr><tr><td>8271/0</td><td>Lactotroph adenoma</td></tr><tr><td>8272/0</td><td>Pituitary adenoma, NOS</td></tr><tr><td>8272/3</td><td>Pituitary carcinoma, NOS</td></tr><tr><td>8273/3</td><td>Pituitary blastoma</td></tr><tr><td>8280/0</td><td>Acidophil adenoma</td></tr><tr><td>8280/3</td><td>Acidophil carcinoma</td></tr><tr><td>8281/0</td><td>Mixed acidophil-basophil adenoma</td></tr><tr><td>8281/3</td><td>Mixed acidophil-basophil carcinoma</td></tr><tr><td>8290/0</td><td>Oxyphilic adenoma</td></tr><tr><td>8290/3</td><td>Oxyphilic adenocarcinoma</td></tr><tr><td>8300/0</td><td>Basophil adenoma</td></tr><tr><td>8300/3</td><td>Basophil carcinoma</td></tr><tr><td>8310/0</td><td>Clear cell adenoma</td></tr><tr><td>8310/3</td><td>Clear cell adenocarcinoma, NOS</td></tr><tr><td>8311/1</td><td>Hypernephroid tumour</td></tr><tr><td>8311/3</td><td>Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome-associated renal cell carcinoma</td></tr><tr><td>8312/3</td><td>Renal cell carcinoma, NOS</td></tr><tr><td>8313/0</td><td>Clear cell adenofibroma</td></tr><tr><td>8313/1</td><td>Clear cell borderline tumour</td></tr><tr><td>8313/3</td><td>Clear cell adenocarcinofibroma</td></tr><tr><td>8314/3</td><td>Lipid-rich carcinoma</td></tr><tr><td>8315/3</td><td>Glycogen-rich carcinoma</td></tr><tr><td>8316/1</td><td>Multilocular cystic renal neoplasm of low malignant potential</td></tr><tr><td>8316/3</td><td>Cyst-associated renal cell carcinoma</td></tr><tr><td>8317/3</td><td>Renal cell carcinoma, chromophobe type</td></tr><tr><td>8318/3</td><td>Renal cell carcinoma, sarcomatoid</td></tr><tr><td>8319/3</td><td>Collecting duct carcinoma</td></tr><tr><td>8320/3</td><td>Granular cell carcinoma</td></tr><tr><td>8321/0</td><td>Chief cell adenoma</td></tr><tr><td>8322/0</td><td>Water-clear cell adenoma</td></tr><tr><td>8322/3</td><td>Water-clear cell adenocarcinoma</td></tr><tr><td>8323/0</td><td>Mixed cell adenoma</td></tr><tr><td>8323/1</td><td>Clear cell papillary renal cell carcinoma</td></tr><tr><td>8323/3</td><td>Mixed cell adenocarcinoma</td></tr><tr><td>8324/0</td><td>Lipoadenoma</td></tr><tr><td>8325/0</td><td>Metanephric adenoma</td></tr><tr><td>8330/0</td><td>Follicular adenoma</td></tr><tr><td>8330/1</td><td>Atypical follicular adenoma</td></tr><tr><td>8330/3</td><td>Follicular carcinoma, NOS</td></tr><tr><td>8331/3</td><td>Follicular adenocarcinoma, well differentiated</td></tr><tr><td>8332/3</td><td>Follicular adenocarcinoma, trabecular</td></tr><tr><td>8333/0</td><td>Microfollicular adenoma, NOS</td></tr><tr><td>8333/3</td><td>Fetal adenocarcinoma</td></tr><tr><td>8334/0</td><td>Macrofollicular adenoma</td></tr><tr><td>8335/1</td><td>Follicular tumour of uncertain malignant potential</td></tr><tr><td>8335/3</td><td>Follicular carcinoma, minimally invasive</td></tr><tr><td>8336/1</td><td>Hyalinizing trabecular tumour</td></tr><tr><td>8337/3</td><td>Poorly differentiated thyroid carcinoma</td></tr><tr><td>8339/3</td><td>Follicular carcinoma, encapsulated, angioinvasive</td></tr><tr><td>8340/3</td><td>Papillary carcinoma, follicular variant</td></tr><tr><td>8341/3</td><td>Papillary microcarcinoma</td></tr><tr><td>8342/3</td><td>Papillary carcinoma, oncocytic variant</td></tr><tr><td>8343/3</td><td>Papillary carcinoma, encapsulated, of thyroid</td></tr><tr><td>8344/3</td><td>Papillary carcinoma, columnar cell</td></tr><tr><td>8345/3</td><td>Medullary thyroid carcinoma</td></tr><tr><td>8346/3</td><td>Mixed medullary-follicular carcinoma</td></tr><tr><td>8347/3</td><td>Mixed medullary-papillary carcinoma</td></tr><tr><td>8348/1</td><td>Well differentiated tumour of uncertain malignant potential</td></tr><tr><td>8349/1</td><td>Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)</td></tr><tr><td>8350/3</td><td>Nonencapsulated sclerosing carcinoma</td></tr><tr><td>8360/1</td><td>Multiple endocrine adenomas</td></tr><tr><td>8361/0</td><td>Juxtaglomerular tumour</td></tr><tr><td>8370/0</td><td>Adrenal cortical adenoma, NOS</td></tr><tr><td>8370/3</td><td>Adrenal cortical carcinoma</td></tr><tr><td>8371/0</td><td>Adrenal cortical adenoma, compact cell</td></tr><tr><td>8372/0</td><td>Adrenal cortical adenoma, pigmented</td></tr><tr><td>8373/0</td><td>Adrenal cortical adenoma, clear cell</td></tr><tr><td>8374/0</td><td>Adrenal cortical adenoma, glomerulosa cell</td></tr><tr><td>8375/0</td><td>Adrenal cortical adenoma, mixed cell</td></tr><tr><td>8380/0</td><td>Endometrioid adenoma, NOS</td></tr><tr><td>8380/1</td><td>Endometrioid adenoma, borderline malignancy</td></tr><tr><td>8380/2</td><td>Endometrioid intraepithelial neoplasia</td></tr><tr><td>8380/3</td><td>Endometrioid adenocarcinoma, NOS</td></tr><tr><td>8381/0</td><td>Endometrioid adenofibroma, NOS</td></tr><tr><td>8381/1</td><td>Endometrioid adenofibroma, borderline malignancy</td></tr><tr><td>8381/3</td><td>Endometrioid adenofibroma, malignant</td></tr><tr><td>8382/3</td><td>Endometrioid adenocarcinoma, secretory variant</td></tr><tr><td>8383/3</td><td>Endometrioid adenocarcinoma, ciliated cell variant</td></tr><tr><td>8384/3</td><td>Adenocarcinoma, endocervical type</td></tr><tr><td>8390/0</td><td>Skin appendage adenoma</td></tr><tr><td>8390/3</td><td>Adnexal adenocarcinoma, NOS</td></tr><tr><td>8391/0</td><td>Follicular fibroma</td></tr><tr><td>8392/0</td><td>Syringofibroadenoma</td></tr><tr><td>8400/0</td><td>Sweat gland adenoma</td></tr><tr><td>8400/1</td><td>Sweat gland tumour, NOS</td></tr><tr><td>8400/3</td><td>Sweat gland adenocarcinoma</td></tr><tr><td>8401/0</td><td>Apocrine adenoma</td></tr><tr><td>8401/3</td><td>Apocrine adenocarcinoma</td></tr><tr><td>8402/0</td><td>Hidradenoma, NOS</td></tr><tr><td>8402/3</td><td>Hidradenocarcinoma</td></tr><tr><td>8403/0</td><td>Spiradenoma, NOS</td></tr><tr><td>8403/3</td><td>Malignant eccrine spiradenoma</td></tr><tr><td>8404/0</td><td>Hidrocystoma</td></tr><tr><td>8405/0</td><td>Papillary hidradenoma</td></tr><tr><td>8406/0</td><td>Syringocystadenoma papilliferum</td></tr><tr><td>8406/3</td><td>Syringocystadenocarcinoma papilliferum</td></tr><tr><td>8407/0</td><td>Syringoma, NOS</td></tr><tr><td>8407/3</td><td>Microcystic adnexal carcinoma</td></tr><tr><td>8408/0</td><td>Eccrine papillary adenoma</td></tr><tr><td>8409/0</td><td>Poroma, NOS</td></tr><tr><td>8409/2</td><td>Porocarcinoma in situ</td></tr><tr><td>8409/3</td><td>Porocarcinoma, NOS</td></tr><tr><td>8410/0</td><td>Sebaceoma</td></tr><tr><td>8410/3</td><td>Sebaceous carcinoma</td></tr><tr><td>8413/3</td><td>Eccrine adenocarcinoma</td></tr><tr><td>8420/0</td><td>Ceruminous adenoma</td></tr><tr><td>8420/3</td><td>Ceruminous adenocarcinoma</td></tr><tr><td>8430/1</td><td>Mucoepidermoid tumour</td></tr><tr><td>8430/3</td><td>Mucoepidermoid carcinoma</td></tr><tr><td>8440/0</td><td>Cystadenoma, NOS</td></tr><tr><td>8440/3</td><td>Cystadenocarcinoma, NOS</td></tr><tr><td>8441/0</td><td>Serous cystadenoma, NOS</td></tr><tr><td>8441/2</td><td>Serous intraepithelial carcinoma</td></tr><tr><td>8441/3</td><td>Serous carcinoma, NOS</td></tr><tr><td>8443/0</td><td>Clear cell cystadenoma</td></tr><tr><td>8450/0</td><td>Papillary cystadenoma, NOS</td></tr><tr><td>8450/3</td><td>Papillary cystadenocarcinoma, NOS</td></tr><tr><td>8451/1</td><td>Papillary cystadenoma, borderline malignancy</td></tr><tr><td>8452/1</td><td>Solid pseudopapillary tumour of ovary</td></tr><tr><td>8452/3</td><td>Solid pseudopapillary neoplasm of pancreas</td></tr><tr><td>8453/0</td><td>Intraductal papillary-mucinous adenoma</td></tr><tr><td>8453/2</td><td>Intraductal papillary mucinous neoplasm with high grade dysplasia</td></tr><tr><td>8453/3</td><td>Intraductal papillary mucinous neoplasm with an associated invasive carcinoma</td></tr><tr><td>8454/0</td><td>Cystic tumour of atrio-ventricular node</td></tr><tr><td>8460/2</td><td>Serous borderline tumour, micropapillary variant</td></tr><tr><td>8460/3</td><td>Low grade serous carcinoma</td></tr><tr><td>8461/0</td><td>Serous surface papilloma</td></tr><tr><td>8461/3</td><td>High grade serous carcinoma</td></tr><tr><td>8470/0</td><td>Mucinous cystadenoma, NOS</td></tr><tr><td>8470/2</td><td>Mucinous cystic neoplasm with high-grade dysplasia</td></tr><tr><td>8470/3</td><td>Mucinous cystadenocarcinoma, NOS</td></tr><tr><td>8472/1</td><td>Mucinous cystic tumour of borderline malignancy</td></tr><tr><td>8474/0</td><td>Seromucinous cystadenoma</td></tr><tr><td>8474/1</td><td>Seromucinous borderline tumour</td></tr><tr><td>8474/3</td><td>Seromucinous carcinoma</td></tr><tr><td>8480/0</td><td>Mucinous adenoma</td></tr><tr><td>8480/1</td><td>Low grade appendiceal mucinous neoplasm</td></tr><tr><td>8480/3</td><td>Mucinous adenocarcinoma</td></tr><tr><td>8480/6</td><td>Pseudomyxoma peritonei</td></tr><tr><td>8481/3</td><td>Mucin-producing adenocarcinoma</td></tr><tr><td>8482/3</td><td>Mucinous carcinoma, gastric type</td></tr><tr><td>8490/3</td><td>Signet ring cell carcinoma</td></tr><tr><td>8490/6</td><td>Metastatic signet ring cell carcinoma</td></tr><tr><td>8500/2</td><td>Intraductal carcinoma, noninfiltrating, NOS</td></tr><tr><td>8500/3</td><td>Infiltrating duct carcinoma, NOS</td></tr><tr><td>8501/2</td><td>Comedocarcinoma, noninfiltrating</td></tr><tr><td>8501/3</td><td>Comedocarcinoma, NOS</td></tr><tr><td>8502/3</td><td>Secretory carcinoma</td></tr><tr><td>8503/0</td><td>Intraductal papilloma</td></tr><tr><td>8503/2</td><td>Noninfiltrating intraductal papillary adenocarcinoma</td></tr><tr><td>8503/3</td><td>Intraductal papillary adenocarcinoma with invasion</td></tr><tr><td>8504/0</td><td>Intracystic papillary adenoma</td></tr><tr><td>8504/2</td><td>Noninfiltrating intracystic carcinoma</td></tr><tr><td>8504/3</td><td>Encapsulated papillary carcinoma with invasion</td></tr><tr><td>8505/0</td><td>Intraductal papillomatosis, NOS</td></tr><tr><td>8506/0</td><td>Adenoma of nipple</td></tr><tr><td>8507/2</td><td>Intraductal micropapillary carcinoma</td></tr><tr><td>8507/3</td><td>Invasive micropapillary carcinoma of breast</td></tr><tr><td>8508/3</td><td>Cystic hypersecretory carcinoma</td></tr><tr><td>8509/2</td><td>Solid papillary carcinoma in situ</td></tr><tr><td>8509/3</td><td>Solid papillary carcinoma with invasion</td></tr><tr><td>8510/3</td><td>Medullary carcinoma, NOS</td></tr><tr><td>8512/3</td><td>Medullary carcinoma with lymphoid stroma</td></tr><tr><td>8513/3</td><td>Atypical medullary carcinoma</td></tr><tr><td>8514/3</td><td>Duct carcinoma, desmoplastic type</td></tr><tr><td>8519/2</td><td>Lobular carcinoma in situ, pleomorphic</td></tr><tr><td>8520/2</td><td>Lobular carcinoma in situ, NOS</td></tr><tr><td>8520/3</td><td>Lobular carcinoma, NOS</td></tr><tr><td>8521/3</td><td>Infiltrating ductular carcinoma</td></tr><tr><td>8522/2</td><td>Intraductal carcinoma and lobular carcinoma in situ</td></tr><tr><td>8522/3</td><td>Infiltrating duct and lobular carcinoma</td></tr><tr><td>8523/3</td><td>Infiltrating duct mixed with other types of carcinoma</td></tr><tr><td>8524/3</td><td>Infiltrating lobular mixed with other types of carcinoma</td></tr><tr><td>8525/3</td><td>Polymorphous adenocarcinoma</td></tr><tr><td>8530/3</td><td>Inflammatory carcinoma</td></tr><tr><td>8540/3</td><td>Paget disease, mammary</td></tr><tr><td>8541/3</td><td>Paget disease and infiltrating duct carcinoma of breast</td></tr><tr><td>8542/3</td><td>Paget disease, extramammary</td></tr><tr><td>8543/3</td><td>Paget disease and intraductal carcinoma of breast</td></tr><tr><td>8550/0</td><td>Acinar cell adenoma</td></tr><tr><td>8550/1</td><td>Acinar cell tumour</td></tr><tr><td>8550/3</td><td>Acinar cell carcinoma</td></tr><tr><td>8551/3</td><td>Acinar cell cystadenocarcinoma</td></tr><tr><td>8552/3</td><td>Mixed acinar-ductal carcinoma</td></tr><tr><td>8560/0</td><td>Mixed squamous cell and glandular papilloma</td></tr><tr><td>8560/3</td><td>Adenosquamous carcinoma</td></tr><tr><td>8561/0</td><td>Adenolymphoma</td></tr><tr><td>8562/3</td><td>Epithelial-myoepithelial carcinoma</td></tr><tr><td>8563/0</td><td>Lymphadenoma</td></tr><tr><td>8570/3</td><td>Adenocarcinoma with squamous metaplasia</td></tr><tr><td>8571/3</td><td>Adenocarcinoma with cartilaginous and osseous metaplasia</td></tr><tr><td>8572/3</td><td>Adenocarcinoma with spindle cell metaplasia</td></tr><tr><td>8573/3</td><td>Adenocarcinoma with apocrine metaplasia</td></tr><tr><td>8574/3</td><td>Adenocarcinoma with neuroendocrine differentiation</td></tr><tr><td>8575/3</td><td>Metaplastic carcinoma, NOS</td></tr><tr><td>8576/3</td><td>Hepatoid adenocarcinoma</td></tr><tr><td>8580/0</td><td>Microscopic thymoma</td></tr><tr><td>8580/1</td><td>Micronodular thymoma with lymphoid stroma</td></tr><tr><td>8580/3</td><td>Thymoma, NOS</td></tr><tr><td>8581/3</td><td>Thymoma, type A</td></tr><tr><td>8582/3</td><td>Thymoma, type AB</td></tr><tr><td>8583/3</td><td>Thymoma, type B1</td></tr><tr><td>8584/3</td><td>Thymoma, type B2</td></tr><tr><td>8585/3</td><td>Thymoma, type B3</td></tr><tr><td>8586/3</td><td>Thymic carcinoma, NOS</td></tr><tr><td>8587/0</td><td>Ectopic hamartomatous thymoma</td></tr><tr><td>8588/3</td><td>Spindle epithelial tumour with thymus-like element</td></tr><tr><td>8589/3</td><td>Intrathyroid thymic carcinoma</td></tr><tr><td>8590/0</td><td>Sex cord-stromal tumour, benign</td></tr><tr><td>8590/1</td><td>Sex cord-gonadal stromal tumour, NOS</td></tr><tr><td>8591/1</td><td>Sex cord-gonadal stromal tumour, incompletely differentiated</td></tr><tr><td>8592/1</td><td>Sex cord-gonadal stromal tumour, mixed forms</td></tr><tr><td>8593/1</td><td>Stromal tumour with minor sex cord elements</td></tr><tr><td>8594/1</td><td>Mixed germ cell-sex cord-stromal tumour, NOS</td></tr><tr><td>8600/0</td><td>Thecoma, NOS</td></tr><tr><td>8600/3</td><td>Thecoma, malignant</td></tr><tr><td>8601/0</td><td>Thecoma, luteinized</td></tr><tr><td>8602/0</td><td>Sclerosing stromal tumour</td></tr><tr><td>8610/0</td><td>Luteoma, NOS</td></tr><tr><td>8620/1</td><td>Adult granulosa cell tumour of testis</td></tr><tr><td>8620/3</td><td>Adult granulosa cell tumour of ovary</td></tr><tr><td>8621/1</td><td>Granulosa cell-theca cell tumour</td></tr><tr><td>8622/0</td><td>Granulosa cell tumour of the testis, juvenile</td></tr><tr><td>8622/1</td><td>Granulosa cell tumour, juvenile</td></tr><tr><td>8623/1</td><td>Sex cord tumour with annular tubules</td></tr><tr><td>8630/0</td><td>Androblastoma, benign</td></tr><tr><td>8630/1</td><td>Androblastoma, NOS</td></tr><tr><td>8630/3</td><td>Androblastoma, malignant</td></tr><tr><td>8631/0</td><td>Sertoli-Leydig cell tumour, well differentiated</td></tr><tr><td>8631/1</td><td>Sertoli-Leydig cell tumour of intermediate differentiation</td></tr><tr><td>8631/3</td><td>Sertoli-Leydig cell tumour, poorly differentiated</td></tr><tr><td>8632/1</td><td>Gynandroblastoma</td></tr><tr><td>8633/1</td><td>Sertoli-Leydig cell tumour, retiform</td></tr><tr><td>8634/1</td><td>Sertoli-Leydig cell tumour, intermediate differentiation, with heterologous elements</td></tr><tr><td>8634/3</td><td>Sertoli-Leydig cell tumour, poorly differentiated, with heterologous elements</td></tr><tr><td>8640/1</td><td>Sertoli cell tumour, NOS</td></tr><tr><td>8640/3</td><td>Sertoli cell carcinoma</td></tr><tr><td>8641/0</td><td>Sertoli cell tumour with lipid storage</td></tr><tr><td>8642/1</td><td>Large cell calcifying Sertoli cell tumour</td></tr><tr><td>8643/1</td><td>Intratubular large cell hyalinizing Sertoli cell neoplasia</td></tr><tr><td>8650/0</td><td>Leydig cell tumour of the ovary, NOS</td></tr><tr><td>8650/1</td><td>Leydig cell tumour of the testis, NOS</td></tr><tr><td>8650/3</td><td>Leydig cell tumour, malignant</td></tr><tr><td>8660/0</td><td>Hilus cell tumour</td></tr><tr><td>8670/0</td><td>Lipid cell tumour of ovary</td></tr><tr><td>8670/3</td><td>Steroid cell tumour, malignant</td></tr><tr><td>8671/0</td><td>Adrenal rest tumour</td></tr><tr><td>8680/3</td><td>Paraganglioma, NOS</td></tr><tr><td>8681/3</td><td>Sympathetic paraganglioma</td></tr><tr><td>8682/3</td><td>Parasympathetic paraganglioma</td></tr><tr><td>8683/0</td><td>Gangliocytic paraganglioma</td></tr><tr><td>8690/3</td><td>Middle ear paraganglioma</td></tr><tr><td>8691/3</td><td>Aortic body tumour</td></tr><tr><td>8692/3</td><td>Carotid body paraganglioma</td></tr><tr><td>8693/3</td><td>Extra-adrenal paraganglioma</td></tr><tr><td>8700/3</td><td>Pheochromocytoma, NOS</td></tr><tr><td>8710/3</td><td>Glomangiosarcoma</td></tr><tr><td>8711/0</td><td>Glomus tumour, NOS</td></tr><tr><td>8711/1</td><td>Glomangiomatosis</td></tr><tr><td>8711/3</td><td>Glomus tumour, malignant</td></tr><tr><td>8712/0</td><td>Glomangioma</td></tr><tr><td>8713/0</td><td>Glomangiomyoma</td></tr><tr><td>8714/0</td><td>Perivascular epithelioid tumour, benign</td></tr><tr><td>8714/3</td><td>Perivascular epithelioid tumour, malignant</td></tr><tr><td>8720/0</td><td>Pigmented naevus, NOS</td></tr><tr><td>8720/2</td><td>Melanoma in situ</td></tr><tr><td>8720/3</td><td>Malignant melanoma, NOS</td></tr><tr><td>8721/3</td><td>Nodular melanoma</td></tr><tr><td>8722/0</td><td>Balloon cell naevus</td></tr><tr><td>8722/3</td><td>Balloon cell melanoma</td></tr><tr><td>8723/0</td><td>Halo naevus</td></tr><tr><td>8723/3</td><td>Malignant melanoma, regressing</td></tr><tr><td>8725/0</td><td>Neuronevus</td></tr><tr><td>8726/0</td><td>Magnocellular naevus</td></tr><tr><td>8727/0</td><td>Dysplastic naevus</td></tr><tr><td>8728/0</td><td>Meningeal melanocytosis</td></tr><tr><td>8728/1</td><td>Meningeal melanocytoma</td></tr><tr><td>8728/3</td><td>Meningeal melanomatosis</td></tr><tr><td>8730/0</td><td>Nonpigmented naevus</td></tr><tr><td>8730/3</td><td>Amelanotic melanoma</td></tr><tr><td>8740/0</td><td>Junctional naevus, NOS</td></tr><tr><td>8740/3</td><td>Malignant melanoma in junctional naevus</td></tr><tr><td>8741/2</td><td>Precancerous melanosis, NOS</td></tr><tr><td>8741/3</td><td>Malignant melanoma in precancerous melanosis</td></tr><tr><td>8742/0</td><td>Lentiginous melanocytic naevus</td></tr><tr><td>8742/2</td><td>Lentigo maligna</td></tr><tr><td>8742/3</td><td>Lentigo maligna melanoma</td></tr><tr><td>8743/3</td><td>Low cumulative sun damage melanoma</td></tr><tr><td>8744/0</td><td>Acral naevus</td></tr><tr><td>8744/3</td><td>Acral melanoma</td></tr><tr><td>8745/3</td><td>Desmoplastic melanoma, NOS</td></tr><tr><td>8746/3</td><td>Mucosal lentiginous melanoma</td></tr><tr><td>8750/0</td><td>Dermal naevus</td></tr><tr><td>8760/0</td><td>Compound naevus</td></tr><tr><td>8761/0</td><td>Congenital melanocytic naevus, NOS</td></tr><tr><td>8761/1</td><td>Giant pigmented naevus, NOS</td></tr><tr><td>8761/3</td><td>Malignant melanoma arising in giant congenital naevus</td></tr><tr><td>8762/1</td><td>Proliferative dermal lesion in congenital naevus</td></tr><tr><td>8770/0</td><td>Epithelioid and spindle cell naevus</td></tr><tr><td>8770/3</td><td>Malignant Spitz tumour</td></tr><tr><td>8771/0</td><td>Epithelioid cell naevus</td></tr><tr><td>8771/3</td><td>Epithelioid cell melanoma</td></tr><tr><td>8772/0</td><td>Spindle cell naevus, NOS</td></tr><tr><td>8772/3</td><td>Spindle cell melanoma, NOS</td></tr><tr><td>8773/3</td><td>Spindle cell melanoma, type A</td></tr><tr><td>8774/3</td><td>Spindle cell melanoma, type B</td></tr><tr><td>8780/0</td><td>Blue nevus, NOS</td></tr><tr><td>8780/1</td><td>Pigmented epithelioid melanocytoma</td></tr><tr><td>8780/3</td><td>Blue naevus, malignant</td></tr><tr><td>8790/0</td><td>Cellular blue naevus</td></tr><tr><td>8800/0</td><td>Soft tissue tumour, benign</td></tr><tr><td>8800/3</td><td>Sarcoma, NOS</td></tr><tr><td>8800/9</td><td>Sarcomatosis, NOS</td></tr><tr><td>8801/3</td><td>Spindle cell sarcoma</td></tr><tr><td>8802/1</td><td>Pleomorphic hyalinizing angiectatic tumour</td></tr><tr><td>8802/3</td><td>Giant cell sarcoma</td></tr><tr><td>8803/3</td><td>Small cell sarcoma</td></tr><tr><td>8804/3</td><td>Epithelioid sarcoma</td></tr><tr><td>8805/3</td><td>Undifferentiated sarcoma</td></tr><tr><td>8806/3</td><td>Desmoplastic small round cell tumour</td></tr><tr><td>8810/0</td><td>Fibroma, NOS</td></tr><tr><td>8810/1</td><td>Cellular fibroma</td></tr><tr><td>8810/3</td><td>Fibrosarcoma, NOS</td></tr><tr><td>8811/0</td><td>Fibromyxoma</td></tr><tr><td>8811/1</td><td>Myxoinflammatory fibroblastic sarcoma</td></tr><tr><td>8811/3</td><td>Myxofibrosarcoma</td></tr><tr><td>8812/0</td><td>Periosteal fibroma</td></tr><tr><td>8812/3</td><td>Periosteal fibrosarcoma</td></tr><tr><td>8813/0</td><td>Fibroma of tendon sheath</td></tr><tr><td>8813/1</td><td>Palmar/plantar type fibromatosis</td></tr><tr><td>8813/3</td><td>Fascial fibrosarcoma</td></tr><tr><td>8814/3</td><td>Infantile fibrosarcoma</td></tr><tr><td>8815/0</td><td>Solitary fibrous tumour/Haemangiopericytoma, grade 1</td></tr><tr><td>8815/1</td><td>Solitary fibrous tumour, NOS</td></tr><tr><td>8815/3</td><td>Solitary fibrous tumour, malignant</td></tr><tr><td>8816/0</td><td>Calcifying aponeurotic fibroma</td></tr><tr><td>8817/0</td><td>Calcifying fibrous tumour</td></tr><tr><td>8818/0</td><td>Fibrous dysplasia</td></tr><tr><td>8820/0</td><td>Elastofibroma</td></tr><tr><td>8821/1</td><td>Aggressive fibromatosis</td></tr><tr><td>8822/1</td><td>Abdominal fibromatosis</td></tr><tr><td>8823/0</td><td>Sclerotic fibroma</td></tr><tr><td>8823/1</td><td>Desmoplastic fibroma</td></tr><tr><td>8824/0</td><td>Myofibroma</td></tr><tr><td>8824/1</td><td>Myofibromatosis</td></tr><tr><td>8825/0</td><td>Myofibroblastoma</td></tr><tr><td>8825/1</td><td>Myofibroblastic tumour, NOS</td></tr><tr><td>8825/3</td><td>Myofibroblastic sarcoma</td></tr><tr><td>8826/0</td><td>Angiomyofibroblastoma</td></tr><tr><td>8827/1</td><td>Myofibroblastic tumour, peribronchial</td></tr><tr><td>8828/0</td><td>Nodular fasciitis</td></tr><tr><td>8830/0</td><td>Benign fibrous histiocytoma</td></tr><tr><td>8830/1</td><td>Atypical fibrous histiocytoma</td></tr><tr><td>8830/3</td><td>Malignant fibrous histiocytoma</td></tr><tr><td>8831/0</td><td>Histiocytoma, NOS</td></tr><tr><td>8832/0</td><td>Dermatofibroma, NOS</td></tr><tr><td>8832/1</td><td>Dermatofibrosarcoma protuberans, NOS</td></tr><tr><td>8832/3</td><td>Dermatofibrosarcoma protuberans, fibrosarcomatous</td></tr><tr><td>8833/1</td><td>Pigmented dermatofibrosarcoma protuberans</td></tr><tr><td>8834/1</td><td>Giant cell fibroblastoma</td></tr><tr><td>8835/1</td><td>Plexiform fibrohistiocytic tumour</td></tr><tr><td>8836/1</td><td>Angiomatoid fibrous histiocytoma</td></tr><tr><td>8840/0</td><td>Myxoma, NOS</td></tr><tr><td>8840/3</td><td>Myxosarcoma</td></tr><tr><td>8841/0</td><td>Angiomyxoma</td></tr><tr><td>8842/0</td><td>Ossifying fibromyxoid tumour</td></tr><tr><td>8842/3</td><td>Ossifying fibromyxoid tumour, malignant</td></tr><tr><td>8850/0</td><td>Lipoma, NOS</td></tr><tr><td>8850/1</td><td>Atypical lipomatous tumour</td></tr><tr><td>8850/3</td><td>Liposarcoma, NOS</td></tr><tr><td>8851/0</td><td>Fibrolipoma</td></tr><tr><td>8851/1</td><td>Lipofibromatosis</td></tr><tr><td>8851/3</td><td>Liposarcoma, well differentiated</td></tr><tr><td>8852/0</td><td>Fibromyxolipoma</td></tr><tr><td>8852/3</td><td>Myxoid liposarcoma</td></tr><tr><td>8854/0</td><td>Pleomorphic lipoma</td></tr><tr><td>8854/3</td><td>Pleomorphic liposarcoma</td></tr><tr><td>8855/3</td><td>Mixed liposarcoma</td></tr><tr><td>8856/0</td><td>Intramuscular lipoma</td></tr><tr><td>8857/0</td><td>Spindle cell lipoma</td></tr><tr><td>8857/3</td><td>Fibroblastic liposarcoma</td></tr><tr><td>8858/3</td><td>Dedifferentiated liposarcoma</td></tr><tr><td>8860/0</td><td>Angiomyolipoma</td></tr><tr><td>8860/1</td><td>Angiomyolipoma, Epithelioid</td></tr><tr><td>8861/0</td><td>Angiolipoma, NOS</td></tr><tr><td>8862/0</td><td>Chondroid lipoma</td></tr><tr><td>8870/0</td><td>Myelolipoma</td></tr><tr><td>8880/0</td><td>Hibernoma</td></tr><tr><td>8881/0</td><td>Lipoblastomatosis</td></tr><tr><td>8890/0</td><td>Leiomyoma, NOS</td></tr><tr><td>8890/1</td><td>Leiomyomatosis, NOS</td></tr><tr><td>8890/3</td><td>Leiomyosarcoma, NOS</td></tr><tr><td>8891/0</td><td>Epithelioid leiomyoma</td></tr><tr><td>8891/3</td><td>Epithelioid leiomyosarcoma</td></tr><tr><td>8892/0</td><td>Cellular leiomyoma</td></tr><tr><td>8893/0</td><td>Bizarre leiomyoma</td></tr><tr><td>8894/0</td><td>Angiomyoma</td></tr><tr><td>8894/3</td><td>Angiomyosarcoma</td></tr><tr><td>8895/0</td><td>Myoma</td></tr><tr><td>8895/3</td><td>Myosarcoma</td></tr><tr><td>8896/0</td><td>Myxoid leiomyoma</td></tr><tr><td>8896/3</td><td>Myxoid leiomyosarcoma</td></tr><tr><td>8897/1</td><td>Smooth muscle tumour of uncertain malignant potential</td></tr><tr><td>8898/1</td><td>Metastasizing leiomyoma</td></tr><tr><td>8900/0</td><td>Rhabdomyoma, NOS</td></tr><tr><td>8900/3</td><td>Rhabdomyosarcoma, NOS</td></tr><tr><td>8901/3</td><td>Pleomorphic rhabdomyosarcoma, adult type</td></tr><tr><td>8902/3</td><td>Mixed type rhabdomyosarcoma</td></tr><tr><td>8903/0</td><td>Fetal rhabdomyoma</td></tr><tr><td>8904/0</td><td>Adult cellular rhabdomyoma</td></tr><tr><td>8905/0</td><td>Genital rhabdomyoma</td></tr><tr><td>8910/3</td><td>Embryonal rhabdomyosarcoma, NOS</td></tr><tr><td>8912/3</td><td>Spindle cell rhabdomyosarcoma</td></tr><tr><td>8920/3</td><td>Alveolar rhabdomyosarcoma</td></tr><tr><td>8921/3</td><td>Ectomesenchymoma</td></tr><tr><td>8930/0</td><td>Endometrial stromal nodule</td></tr><tr><td>8930/3</td><td>Endometrial stromal sarcoma, NOS</td></tr><tr><td>8931/3</td><td>Endometrial stromal sarcoma, low grade</td></tr><tr><td>8932/0</td><td>Adenomyoma</td></tr><tr><td>8933/3</td><td>Adenosarcoma</td></tr><tr><td>8934/3</td><td>Carcinofibroma</td></tr><tr><td>8935/0</td><td>Stromal tumour, benign</td></tr><tr><td>8935/1</td><td>Stromal tumour, NOS</td></tr><tr><td>8935/3</td><td>Stromal sarcoma, NOS</td></tr><tr><td>8936/3</td><td>Gastrointestinal stromal tumour</td></tr><tr><td>8940/0</td><td>Pleomorphic adenoma</td></tr><tr><td>8940/3</td><td>Mixed tumour, malignant, NOS</td></tr><tr><td>8941/3</td><td>Carcinoma ex pleomorphic adenoma</td></tr><tr><td>8950/3</td><td>Mullerian mixed tumour</td></tr><tr><td>8951/3</td><td>Mesodermal mixed tumour</td></tr><tr><td>8959/0</td><td>Benign cystic nephroma</td></tr><tr><td>8959/1</td><td>Cystic partially differentiated nephroblastoma</td></tr><tr><td>8959/3</td><td>Malignant cystic nephroma</td></tr><tr><td>8960/1</td><td>Mesoblastic nephroma</td></tr><tr><td>8960/3</td><td>Nephroblastoma, NOS</td></tr><tr><td>8963/3</td><td>Rhabdoid tumour, NOS</td></tr><tr><td>8964/3</td><td>Clear cell sarcoma of kidney</td></tr><tr><td>8966/0</td><td>Renomedullary interstitial cell tumour</td></tr><tr><td>8967/0</td><td>Ossifying renal tumour</td></tr><tr><td>8970/3</td><td>Hepatoblastoma</td></tr><tr><td>8971/3</td><td>Pancreatoblastoma</td></tr><tr><td>8972/3</td><td>Pulmonary blastoma</td></tr><tr><td>8973/3</td><td>Pleuropulmonary blastoma</td></tr><tr><td>8974/1</td><td>Sialoblastoma</td></tr><tr><td>8975/1</td><td>Calcifying nested stromal-epithelial tumour</td></tr><tr><td>8980/3</td><td>Carcinosarcoma, NOS</td></tr><tr><td>8981/3</td><td>Carcinosarcoma, embryonal</td></tr><tr><td>8982/0</td><td>Myoepithelioma</td></tr><tr><td>8982/3</td><td>Myoepithelial carcinoma</td></tr><tr><td>8983/0</td><td>Adenomyoepithelioma, NOS</td></tr><tr><td>8983/3</td><td>Adenomyoepithelioma with carcinoma</td></tr><tr><td>8990/0</td><td>Mesenchymoma, benign</td></tr><tr><td>8990/1</td><td>Mesenchymoma, NOS</td></tr><tr><td>8990/3</td><td>Mesenchymoma, malignant</td></tr><tr><td>8991/3</td><td>Embryonal sarcoma</td></tr><tr><td>8992/0</td><td>Pulmonary hamartoma</td></tr><tr><td>9000/0</td><td>Brenner tumour, NOS</td></tr><tr><td>9000/1</td><td>Brenner tumour, borderline malignancy</td></tr><tr><td>9000/3</td><td>Brenner tumour, malignant</td></tr><tr><td>9010/0</td><td>Fibroadenoma, NOS</td></tr><tr><td>9011/0</td><td>Intracanalicular fibroadenoma</td></tr><tr><td>9012/0</td><td>Pericanalicular fibroadenoma</td></tr><tr><td>9013/0</td><td>Adenofibroma, NOS</td></tr><tr><td>9014/0</td><td>Serous adenofibroma, NOS</td></tr><tr><td>9014/1</td><td>Serous adenofibroma of borderline malignancy</td></tr><tr><td>9014/3</td><td>Serous adenocarcinofibroma</td></tr><tr><td>9015/0</td><td>Mucinous adenofibroma, NOS</td></tr><tr><td>9015/1</td><td>Mucinous adenofibroma of borderline malignancy</td></tr><tr><td>9015/3</td><td>Mucinous adenocarcinofibroma</td></tr><tr><td>9016/0</td><td>Giant fibroadenoma</td></tr><tr><td>9020/0</td><td>Phyllodes tumour, benign</td></tr><tr><td>9020/1</td><td>Phyllodes tumour, borderline</td></tr><tr><td>9020/3</td><td>Phyllodes tumour, malignant</td></tr><tr><td>9030/0</td><td>Juvenile fibroadenoma</td></tr><tr><td>9040/0</td><td>Synovioma, benign</td></tr><tr><td>9040/3</td><td>Synovial sarcoma, NOS</td></tr><tr><td>9041/3</td><td>Synovial sarcoma, spindle cell</td></tr><tr><td>9042/3</td><td>Synovial sarcoma, epithelioid cell</td></tr><tr><td>9043/3</td><td>Synovial sarcoma, biphasic</td></tr><tr><td>9044/3</td><td>Clear cell sarcoma, NOS</td></tr><tr><td>9045/3</td><td>Biphenotypic sinonasal sarcoma</td></tr><tr><td>9050/0</td><td>Mesothelioma, benign</td></tr><tr><td>9050/3</td><td>Mesothelioma, malignant</td></tr><tr><td>9051/0</td><td>Fibrous mesothelioma, benign</td></tr><tr><td>9051/3</td><td>Fibrous mesothelioma, malignant</td></tr><tr><td>9052/0</td><td>Epithelioid mesothelioma, benign</td></tr><tr><td>9052/1</td><td>Well differentiated papillary mesothelioma of the pleura</td></tr><tr><td>9052/3</td><td>Epithelioid mesothelioma, malignant</td></tr><tr><td>9053/3</td><td>Mesothelioma, biphasic, malignant</td></tr><tr><td>9054/0</td><td>Adenomatoid tumour, NOS</td></tr><tr><td>9055/0</td><td>Peritoneal inclusion cysts</td></tr><tr><td>9060/3</td><td>Dysgerminoma</td></tr><tr><td>9061/3</td><td>Seminoma, NOS</td></tr><tr><td>9062/3</td><td>Seminoma, anaplastic</td></tr><tr><td>9063/3</td><td>Spermatocytic seminoma</td></tr><tr><td>9064/2</td><td>Intratubular malignant germ cells</td></tr><tr><td>9064/3</td><td>Germinoma</td></tr><tr><td>9065/3</td><td>Germ cell tumour, nonseminomatous</td></tr><tr><td>9070/3</td><td>Embryonal carcinoma, NOS</td></tr><tr><td>9071/3</td><td>Yolk sac tumour</td></tr><tr><td>9072/3</td><td>Polyembryoma</td></tr><tr><td>9073/1</td><td>Gonadoblastoma</td></tr><tr><td>9080/0</td><td>Teratoma, benign</td></tr><tr><td>9080/1</td><td>Teratoma, NOS</td></tr><tr><td>9080/3</td><td>Teratoma, malignant, NOS</td></tr><tr><td>9081/3</td><td>Teratocarcinoma</td></tr><tr><td>9082/3</td><td>Malignant teratoma, undifferentiated</td></tr><tr><td>9083/3</td><td>Malignant teratoma, intermediate</td></tr><tr><td>9084/0</td><td>Dermoid cyst, NOS</td></tr><tr><td>9084/3</td><td>Teratoma with malignant transformation</td></tr><tr><td>9085/3</td><td>Mixed germ cell tumour</td></tr><tr><td>9086/3</td><td>Germ cell tumour with associated haematological malignancy</td></tr><tr><td>9090/0</td><td>Struma ovarii, NOS</td></tr><tr><td>9090/3</td><td>Struma ovarii, malignant</td></tr><tr><td>9091/1</td><td>Strumal carcinoid</td></tr><tr><td>9100/0</td><td>Hydatidiform mole, NOS</td></tr><tr><td>9100/1</td><td>Invasive hydatidiform mole</td></tr><tr><td>9100/3</td><td>Choriocarcinoma, NOS</td></tr><tr><td>9101/3</td><td>Choriocarcinoma combined with other germ cell elements</td></tr><tr><td>9102/3</td><td>Malignant teratoma, trophoblastic</td></tr><tr><td>9103/0</td><td>Partial hydatidiform mole</td></tr><tr><td>9104/1</td><td>Placental site trophoblastic tumour</td></tr><tr><td>9105/3</td><td>Trophoblastic tumour, epithelioid</td></tr><tr><td>9110/0</td><td>Adenoma of rete ovarii</td></tr><tr><td>9110/1</td><td>Wolffian tumour</td></tr><tr><td>9110/3</td><td>Mesonephroma, malignant</td></tr><tr><td>9120/0</td><td>Haemangioma, NOS</td></tr><tr><td>9120/3</td><td>Hemangiosarcoma</td></tr><tr><td>9121/0</td><td>Cavernous haemangioma</td></tr><tr><td>9122/0</td><td>Venous haemangioma</td></tr><tr><td>9123/0</td><td>Racemose haemangioma</td></tr><tr><td>9124/3</td><td>Kupffer cell sarcoma</td></tr><tr><td>9125/0</td><td>Epithelioid haemangioma</td></tr><tr><td>9126/0</td><td>Atypical vascular lesion</td></tr><tr><td>9130/0</td><td>Haemangioendothelioma, benign</td></tr><tr><td>9130/1</td><td>Haemangioendothelioma, NOS</td></tr><tr><td>9130/3</td><td>Haemangioendothelioma, malignant</td></tr><tr><td>9131/0</td><td>Capillary haemangioma</td></tr><tr><td>9132/0</td><td>Intramuscular haemangioma</td></tr><tr><td>9133/3</td><td>Epithelioid haemangioendothelioma, NOS</td></tr><tr><td>9135/1</td><td>Papillary intralymphatic angioendothelioma</td></tr><tr><td>9136/1</td><td>Spindle cell haemangioendothelioma</td></tr><tr><td>9137/0</td><td>Myointimoma</td></tr><tr><td>9137/3</td><td>Intimal sarcoma</td></tr><tr><td>9138/1</td><td>Pseudomyogenic (epithelioid sarcoma-like) haemangioendothelioma</td></tr><tr><td>9140/3</td><td>Kaposi sarcoma</td></tr><tr><td>9141/0</td><td>Angiokeratoma</td></tr><tr><td>9142/0</td><td>Verrucous keratotic haemangioma</td></tr><tr><td>9160/0</td><td>Angiofibroma, NOS</td></tr><tr><td>9161/0</td><td>Acquired tufted haemangioma</td></tr><tr><td>9161/1</td><td>Haemangioblastoma</td></tr><tr><td>9170/0</td><td>Lymphangioma, NOS</td></tr><tr><td>9170/3</td><td>Lymphangiosarcoma</td></tr><tr><td>9171/0</td><td>Capillary lymphangioma</td></tr><tr><td>9172/0</td><td>Cavernous lymphangioma</td></tr><tr><td>9173/0</td><td>Cystic lymphangioma</td></tr><tr><td>9174/0</td><td>Lymphangiomyoma</td></tr><tr><td>9174/1</td><td>Lymphangiomyomatosis</td></tr><tr><td>9175/0</td><td>Haemolymphangioma</td></tr><tr><td>9180/0</td><td>Osteoma, NOS</td></tr><tr><td>9180/3</td><td>Osteosarcoma, NOS</td></tr><tr><td>9181/3</td><td>Chondroblastic osteosarcoma</td></tr><tr><td>9182/3</td><td>Fibroblastic osteosarcoma</td></tr><tr><td>9183/3</td><td>Telangiectatic osteosarcoma</td></tr><tr><td>9184/3</td><td>Osteosarcoma in Paget disease of bone</td></tr><tr><td>9185/3</td><td>Small cell osteosarcoma</td></tr><tr><td>9186/3</td><td>Central osteosarcoma</td></tr><tr><td>9187/3</td><td>Low grade central osteosarcoma</td></tr><tr><td>9191/0</td><td>Osteoid osteoma, NOS</td></tr><tr><td>9192/3</td><td>Parosteal osteosarcoma</td></tr><tr><td>9193/3</td><td>Periosteal osteosarcoma</td></tr><tr><td>9194/3</td><td>High grade surface osteosarcoma</td></tr><tr><td>9195/3</td><td>Intracortical osteosarcoma</td></tr><tr><td>9200/0</td><td>Osteoblastoma, NOS</td></tr><tr><td>9200/1</td><td>Aggressive osteoblastoma</td></tr><tr><td>9210/0</td><td>Osteochondroma</td></tr><tr><td>9210/1</td><td>Osteochondromatosis, NOS</td></tr><tr><td>9211/0</td><td>Osteochondromyxoma</td></tr><tr><td>9212/0</td><td>Bizarre parosteal osteochondromatous proliferation</td></tr><tr><td>9213/0</td><td>Subungual exostosis</td></tr><tr><td>9220/0</td><td>Chondroma, NOS</td></tr><tr><td>9220/1</td><td>Chondromatosis, NOS</td></tr><tr><td>9220/3</td><td>Chondrosarcoma, NOS</td></tr><tr><td>9221/0</td><td>Periosteal chondroma</td></tr><tr><td>9221/3</td><td>Periosteal chondrosarcoma</td></tr><tr><td>9222/1</td><td>Atypical cartilaginous tumour</td></tr><tr><td>9230/1</td><td>Chondroblastoma, NOS</td></tr><tr><td>9230/3</td><td>Chondroblastoma, malignant</td></tr><tr><td>9231/3</td><td>Myxoid chondrosarcoma</td></tr><tr><td>9240/3</td><td>Mesenchymal chondrosarcoma</td></tr><tr><td>9241/0</td><td>Chondromyxoid fibroma</td></tr><tr><td>9242/3</td><td>Clear cell chondrosarcoma</td></tr><tr><td>9243/3</td><td>Dedifferentiated chondrosarcoma</td></tr><tr><td>9250/1</td><td>Giant cell tumour of bone, NOS</td></tr><tr><td>9250/3</td><td>Giant cell tumour of bone, malignant</td></tr><tr><td>9251/1</td><td>Giant cell tumour of soft parts, NOS</td></tr><tr><td>9251/3</td><td>Malignant giant cell tumour of soft parts</td></tr><tr><td>9252/0</td><td>Tenosynovial giant cell tumour, NOS</td></tr><tr><td>9252/1</td><td>Tenosynovial giant cell tumour, diffuse</td></tr><tr><td>9252/3</td><td>Malignant tenosynovial giant cell tumour</td></tr><tr><td>9260/0</td><td>Aneurysmal bone cyst</td></tr><tr><td>9261/3</td><td>Adamantinoma of long bones</td></tr><tr><td>9262/0</td><td>Ossifying fibroma</td></tr><tr><td>9270/0</td><td>Odontogenic tumour, benign</td></tr><tr><td>9270/1</td><td>Odontogenic tumour, NOS</td></tr><tr><td>9270/3</td><td>Odontogenic tumour, malignant</td></tr><tr><td>9271/0</td><td>Ameloblastic fibrodentinoma</td></tr><tr><td>9272/0</td><td>Cementoma, NOS</td></tr><tr><td>9273/0</td><td>Cementoblastoma, benign</td></tr><tr><td>9274/0</td><td>Cemento-ossifying fibroma</td></tr><tr><td>9275/0</td><td>Gigantiform cementoma</td></tr><tr><td>9280/0</td><td>Odontoma, NOS</td></tr><tr><td>9281/0</td><td>Compound odontoma</td></tr><tr><td>9282/0</td><td>Complex odontoma</td></tr><tr><td>9290/0</td><td>Ameloblastic fibro-odontoma</td></tr><tr><td>9290/3</td><td>Ameloblastic odontosarcoma</td></tr><tr><td>9300/0</td><td>Adenomatoid odontogenic tumour</td></tr><tr><td>9301/0</td><td>Calcifying odontogenic cyst</td></tr><tr><td>9302/0</td><td>Dentinogenic ghost cell tumour</td></tr><tr><td>9302/3</td><td>Ghost cell odontogenic carcinoma</td></tr><tr><td>9310/0</td><td>Ameloblastoma, NOS</td></tr><tr><td>9310/3</td><td>Ameloblastoma, metastasizing</td></tr><tr><td>9311/0</td><td>Odontoameloblastoma</td></tr><tr><td>9312/0</td><td>Squamous odontogenic tumour</td></tr><tr><td>9320/0</td><td>Odontogenic myxoma</td></tr><tr><td>9321/0</td><td>Odontogenic fibroma, NOS</td></tr><tr><td>9322/0</td><td>Peripheral odontogenic fibroma</td></tr><tr><td>9330/0</td><td>Ameloblastic fibroma</td></tr><tr><td>9330/3</td><td>Ameloblastic fibrosarcoma</td></tr><tr><td>9340/0</td><td>Calcifying epithelial odontogenic tumour</td></tr><tr><td>9341/3</td><td>Clear cell odontogenic carcinoma</td></tr><tr><td>9342/3</td><td>Odontogenic carcinosarcoma</td></tr><tr><td>9350/1</td><td>Craniopharyngioma</td></tr><tr><td>9351/1</td><td>Craniopharyngioma, adamantinomatous</td></tr><tr><td>9352/1</td><td>Craniopharyngioma, papillary</td></tr><tr><td>9360/1</td><td>Pinealoma</td></tr><tr><td>9361/1</td><td>Pineocytoma</td></tr><tr><td>9362/3</td><td>Pineoblastoma</td></tr><tr><td>9363/0</td><td>Melanotic neuroectodermal tumour</td></tr><tr><td>9364/3</td><td>Ewing sarcoma</td></tr><tr><td>9365/3</td><td>Askin tumour</td></tr><tr><td>9370/0</td><td>Benign notochordal cell tumour</td></tr><tr><td>9370/3</td><td>Chordoma, NOS</td></tr><tr><td>9371/3</td><td>Chondroid chordoma</td></tr><tr><td>9372/3</td><td>Dedifferentiated chordoma</td></tr><tr><td>9373/0</td><td>Parachordoma</td></tr><tr><td>9380/3</td><td>Glioma, malignant</td></tr><tr><td>9381/3</td><td>Gliomatosis cerebri</td></tr><tr><td>9382/3</td><td>Oligoastrocytoma, NOS</td></tr><tr><td>9383/1</td><td>Subependymoma</td></tr><tr><td>9384/1</td><td>Subependymal giant cell astrocytoma</td></tr><tr><td>9385/3</td><td>Diffuse midline glioma, H3 K27M-mutant</td></tr><tr><td>9390/0</td><td>Choroid plexus papilloma, NOS</td></tr><tr><td>9390/1</td><td>Atypical choroid plexus papilloma</td></tr><tr><td>9390/3</td><td>Choroid plexus carcinoma</td></tr><tr><td>9391/1</td><td>Sellar ependymoma</td></tr><tr><td>9391/3</td><td>Ependymoma, NOS</td></tr><tr><td>9392/3</td><td>Ependymoma, anaplastic</td></tr><tr><td>9393/3</td><td>Papillary ependymoma</td></tr><tr><td>9394/1</td><td>Myxopapillary ependymoma</td></tr><tr><td>9395/3</td><td>Papillary tumour of the pineal region</td></tr><tr><td>9396/3</td><td>Ependymoma, RELA fusion-positive</td></tr><tr><td>9400/3</td><td>Astrocytoma, NOS</td></tr><tr><td>9401/3</td><td>Astrocytoma, anaplastic</td></tr><tr><td>9410/3</td><td>Protoplasmic astrocytoma</td></tr><tr><td>9411/3</td><td>Gemistocytic astrocytoma</td></tr><tr><td>9412/1</td><td>Desmoplastic infantile astrocytoma</td></tr><tr><td>9413/0</td><td>Dysembryoplastic neuroepithelial tumour</td></tr><tr><td>9420/3</td><td>Fibrillary astrocytoma</td></tr><tr><td>9421/1</td><td>Pilocytic astrocytoma</td></tr><tr><td>9423/3</td><td>Polar spongioblastoma</td></tr><tr><td>9424/3</td><td>Pleomorphic xanthoastrocytoma</td></tr><tr><td>9425/3</td><td>Pilomyxoid astrocytoma</td></tr><tr><td>9430/3</td><td>Astroblastoma</td></tr><tr><td>9431/1</td><td>Angiocentric glioma</td></tr><tr><td>9432/1</td><td>Pituicytoma</td></tr><tr><td>9440/3</td><td>Glioblastoma, NOS</td></tr><tr><td>9441/3</td><td>Giant cell glioblastoma</td></tr><tr><td>9442/1</td><td>Gliofibroma</td></tr><tr><td>9442/3</td><td>Gliosarcoma</td></tr><tr><td>9444/1</td><td>Chordoid glioma</td></tr><tr><td>9445/3</td><td>Glioblastoma, IDH mutant</td></tr><tr><td>9450/3</td><td>Oligodendroglioma, NOS</td></tr><tr><td>9451/3</td><td>Oligodendroglioma, anaplastic</td></tr><tr><td>9460/3</td><td>Oligodendroblastoma</td></tr><tr><td>9470/3</td><td>Medulloblastoma, NOS</td></tr><tr><td>9471/3</td><td>Desmoplastic nodular medulloblastoma</td></tr><tr><td>9472/3</td><td>Medullomyoblastoma</td></tr><tr><td>9473/3</td><td>CNS embryonal tumour, NOS</td></tr><tr><td>9474/3</td><td>Large cell medulloblastoma</td></tr><tr><td>9475/3</td><td>Medulloblastoma, WNT-activated, NOS</td></tr><tr><td>9476/3</td><td>Medulloblastoma, SHH-activated and TP53-mutant</td></tr><tr><td>9477/3</td><td>Medulloblastoma, non-WNT/non-SHH</td></tr><tr><td>9478/3</td><td>Embryonal tumours with multilayered rosettes with C19MC alteration</td></tr><tr><td>9480/3</td><td>Cerebellar sarcoma, NOS</td></tr><tr><td>9490/0</td><td>Ganglioneuroma</td></tr><tr><td>9490/3</td><td>Ganglioneuroblastoma</td></tr><tr><td>9491/0</td><td>Ganglioneuromatosis</td></tr><tr><td>9492/0</td><td>Gangliocytoma</td></tr><tr><td>9493/0</td><td>Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos)</td></tr><tr><td>9500/3</td><td>Neuroblastoma, NOS</td></tr><tr><td>9501/0</td><td>Medulloepithelioma, benign</td></tr><tr><td>9501/3</td><td>Medulloepithelioma, NOS</td></tr><tr><td>9502/0</td><td>Teratoid medulloepithelioma, benign</td></tr><tr><td>9502/3</td><td>Teratoid medulloepithelioma</td></tr><tr><td>9503/3</td><td>Neuroepithelioma, NOS</td></tr><tr><td>9504/3</td><td>Spongioneuroblastoma</td></tr><tr><td>9505/1</td><td>Ganglioglioma, NOS</td></tr><tr><td>9505/3</td><td>Ganglioglioma, anaplastic</td></tr><tr><td>9506/1</td><td>Central neurocytoma</td></tr><tr><td>9507/0</td><td>Pacinian tumour</td></tr><tr><td>9508/3</td><td>Atypical teratoid/rhabdoid tumour</td></tr><tr><td>9509/1</td><td>Papillary glioneuronal tumour</td></tr><tr><td>9510/0</td><td>Retinocytoma</td></tr><tr><td>9510/3</td><td>Retinoblastoma, NOS</td></tr><tr><td>9511/3</td><td>Retinoblastoma, differentiated</td></tr><tr><td>9512/3</td><td>Retinoblastoma, undifferentiated</td></tr><tr><td>9513/3</td><td>Retinoblastoma, diffuse</td></tr><tr><td>9514/1</td><td>Retinoblastoma, spontaneously regressed</td></tr><tr><td>9520/3</td><td>Olfactory neurogenic tumour</td></tr><tr><td>9521/3</td><td>Olfactory neurocytoma</td></tr><tr><td>9522/3</td><td>Olfactory neuroblastoma</td></tr><tr><td>9523/3</td><td>Olfactory neuroepithelioma</td></tr><tr><td>9530/0</td><td>Meningioma, NOS</td></tr><tr><td>9530/3</td><td>Meningioma, malignant</td></tr><tr><td>9531/0</td><td>Meningothelial meningioma</td></tr><tr><td>9532/0</td><td>Fibrous meningioma</td></tr><tr><td>9533/0</td><td>Psammomatous meningioma</td></tr><tr><td>9534/0</td><td>Angiomatous meningioma</td></tr><tr><td>9535/0</td><td>Haemangioblastic meningioma</td></tr><tr><td>9537/0</td><td>Transitional meningioma</td></tr><tr><td>9538/1</td><td>Clear cell meningioma</td></tr><tr><td>9538/3</td><td>Papillary meningioma</td></tr><tr><td>9539/1</td><td>Atypical meningioma</td></tr><tr><td>9539/3</td><td>Meningeal sarcomatosis</td></tr><tr><td>9540/0</td><td>Neurofibroma, NOS</td></tr><tr><td>9540/3</td><td>Malignant peripheral nerve sheath tumour</td></tr><tr><td>9541/0</td><td>Melanotic neurofibroma</td></tr><tr><td>9542/3</td><td>Malignant peripheral nerve sheath tumour, epithelioid</td></tr><tr><td>9550/0</td><td>Plexiform neurofibroma</td></tr><tr><td>9560/0</td><td>Schwannoma, NOS</td></tr><tr><td>9560/1</td><td>Melanotic schwannoma</td></tr><tr><td>9560/3</td><td>Neurilemoma, malignant</td></tr><tr><td>9561/3</td><td>Malignant peripheral nerve sheath tumour with rhabdomyoblastic differentiation</td></tr><tr><td>9562/0</td><td>Nerve sheath myxoma</td></tr><tr><td>9563/0</td><td>Nerve sheath tumour, NOS</td></tr><tr><td>9570/0</td><td>Neuroma, NOS</td></tr><tr><td>9571/0</td><td>Perineurioma, NOS</td></tr><tr><td>9571/3</td><td>Perineurioma, malignant</td></tr><tr><td>9580/0</td><td>Granular cell tumour, NOS</td></tr><tr><td>9580/3</td><td>Granular cell tumour, malignant</td></tr><tr><td>9581/3</td><td>Alveolar soft part sarcoma</td></tr><tr><td>9582/0</td><td>Granular cell tumour of the sellar region</td></tr><tr><td>9590/3</td><td>Malignant lymphoma, NOS</td></tr><tr><td>9591/1</td><td>Monoclonal B-cell lymphocytosis, NOS</td></tr><tr><td>9591/3</td><td>Malignant lymphoma, non-Hodgkin, NOS</td></tr><tr><td>9596/3</td><td>Composite Hodgkin and non-Hodgkin lymphoma</td></tr><tr><td>9597/3</td><td>Primary cutaneous follicle centre lymphoma</td></tr><tr><td>9650/3</td><td>Hodgkin lymphoma, NOS</td></tr><tr><td>9651/3</td><td>Hodgkin lymphoma, lymphocyte-rich</td></tr><tr><td>9652/3</td><td>Hodgkin lymphoma, mixed cellularity, NOS</td></tr><tr><td>9653/3</td><td>Hodgkin lymphoma, lymphocyte depletion, NOS</td></tr><tr><td>9654/3</td><td>Hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis</td></tr><tr><td>9655/3</td><td>Hodgkin lymphoma, lymphocyte depletion, reticular</td></tr><tr><td>9659/3</td><td>Hodgkin lymphoma, nodular lymphocyte predominant</td></tr><tr><td>9661/3</td><td>Hodgkin granuloma</td></tr><tr><td>9662/3</td><td>Hodgkin sarcoma</td></tr><tr><td>9663/3</td><td>Hodgkin lymphoma, nodular sclerosis, NOS</td></tr><tr><td>9664/3</td><td>Hodgkin lymphoma, nodular sclerosis, cellular phase</td></tr><tr><td>9665/3</td><td>Hodgkin lymphoma, nodular sclerosis, grade 1</td></tr><tr><td>9667/3</td><td>Hodgkin lymphoma, nodular sclerosis, grade 2</td></tr><tr><td>9671/3</td><td>Lymphoplasmacytic lymphoma</td></tr><tr><td>9673/1</td><td>In situ mantle cell neoplasia</td></tr><tr><td>9673/3</td><td>Mantle cell lymphoma</td></tr><tr><td>9675/3</td><td>Malignant lymphoma, mixed small and large cell, diffuse</td></tr><tr><td>9678/3</td><td>Primary effusion lymphoma</td></tr><tr><td>9679/3</td><td>Mediastinal large B-cell lymphoma</td></tr><tr><td>9680/1</td><td>EBV positive mucocutaneous ulcer</td></tr><tr><td>9680/3</td><td>Diffuse large B-cell lymphoma, NOS</td></tr><tr><td>9684/3</td><td>Malignant lymphoma, large B-cell, diffuse, immunoblastic, NOS</td></tr><tr><td>9687/3</td><td>Burkitt lymphoma, NOS</td></tr><tr><td>9688/3</td><td>T-cell/histiocyte rich large B-cell lymphoma</td></tr><tr><td>9689/3</td><td>Splenic marginal zone B-cell lymphoma</td></tr><tr><td>9690/3</td><td>Follicular lymphoma, NOS</td></tr><tr><td>9691/3</td><td>Follicular lymphoma, grade 2</td></tr><tr><td>9695/1</td><td>In situ follicular neoplasia</td></tr><tr><td>9695/3</td><td>Follicular lymphoma, grade 1</td></tr><tr><td>9698/3</td><td>Follicular lymphoma, grade 3</td></tr><tr><td>9699/3</td><td>Marginal zone B-cell lymphoma, NOS</td></tr><tr><td>9700/3</td><td>Mycosis fungoides</td></tr><tr><td>9701/3</td><td>Sezary syndrome</td></tr><tr><td>9702/1</td><td>Indolent T-cell lymphoproliferative disorder of gastrointestinal tract</td></tr><tr><td>9702/3</td><td>Mature T-cell lymphoma, NOS</td></tr><tr><td>9705/3</td><td>Angioimmunoblastic T-cell lymphoma</td></tr><tr><td>9708/3</td><td>Subcutaneous panniculitis-like T-cell lymphoma</td></tr><tr><td>9709/1</td><td>Primary cutaneous CD4 positive small/medium T-cell lymphoproliferative disorder</td></tr><tr><td>9709/3</td><td>Cutaneous T-cell lymphoma, NOS</td></tr><tr><td>9712/3</td><td>Intravascular large B-cell lymphoma</td></tr><tr><td>9714/3</td><td>Anaplastic large cell lymphoma, T cell and Null cell type</td></tr><tr><td>9715/3</td><td>Anaplastic large cell lymphoma, ALK negative</td></tr><tr><td>9716/3</td><td>Hepatosplenic T-cell lymphoma</td></tr><tr><td>9717/3</td><td>Intestinal T-cell lymphoma</td></tr><tr><td>9718/1</td><td>Primary cutaneous CD30+ T-cell lymphoproliferative disorder</td></tr><tr><td>9718/3</td><td>Primary cutaneous anaplastic large cell lymphoma</td></tr><tr><td>9719/3</td><td>NK/T-cell lymphoma, nasal and nasal-type</td></tr><tr><td>9724/3</td><td>Systemic EBV positive T-cell lymphoproliferative disease of childhood</td></tr><tr><td>9725/1</td><td>Hydroa vacciniforme-like lymphoproliferative disorder</td></tr><tr><td>9726/3</td><td>Primary cutaneous gamma/delta T-cell lymphoma</td></tr><tr><td>9727/3</td><td>Precursor cell lymphoblastic lymphoma, NOS</td></tr><tr><td>9731/3</td><td>Plasmacytoma, NOS</td></tr><tr><td>9732/3</td><td>Plasma cell myeloma</td></tr><tr><td>9733/3</td><td>Plasma cell leukaemia</td></tr><tr><td>9734/3</td><td>Plasmacytoma, extramedullary</td></tr><tr><td>9735/3</td><td>Plasmablastic lymphoma</td></tr><tr><td>9737/3</td><td>ALK positive large B-cell lymphoma</td></tr><tr><td>9738/3</td><td>Large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease</td></tr><tr><td>9740/1</td><td>Mastocytoma, NOS</td></tr><tr><td>9740/3</td><td>Mast cell sarcoma</td></tr><tr><td>9741/1</td><td>Indolent systemic mastocytosis</td></tr><tr><td>9741/3</td><td>Malignant mastocytosis</td></tr><tr><td>9742/3</td><td>Mast cell leukaemia</td></tr><tr><td>9749/3</td><td>Erdheim-Chester disease</td></tr><tr><td>9750/3</td><td>Malignant histiocytosis</td></tr><tr><td>9751/1</td><td>Langerhans cell histiocytosis</td></tr><tr><td>9751/3</td><td>Langerhans cell histiocytosis, disseminated</td></tr><tr><td>9755/3</td><td>Histiocytic sarcoma</td></tr><tr><td>9756/3</td><td>Langerhans cell sarcoma</td></tr><tr><td>9757/3</td><td>Interdigitating dendritic cell sarcoma</td></tr><tr><td>9758/3</td><td>Follicular dendritic cell sarcoma</td></tr><tr><td>9759/3</td><td>Fibroblastic reticular cell tumour</td></tr><tr><td>9760/3</td><td>Immunoproliferative disease, NOS</td></tr><tr><td>9761/1</td><td>IgM monoclonal gammopathy of undetermined significance</td></tr><tr><td>9761/3</td><td>Waldenstrom macroglobulinemia</td></tr><tr><td>9762/3</td><td>Heavy chain disease, NOS</td></tr><tr><td>9764/3</td><td>Immunoproliferative small intestinal disease</td></tr><tr><td>9765/1</td><td>Monoclonal gammopathy of undetermined significance</td></tr><tr><td>9766/1</td><td>Angiocentric immunoproliferative lesion</td></tr><tr><td>9766/3</td><td>Lymphomatoid granulomatosis, grade 3</td></tr><tr><td>9767/1</td><td>Angioimmunoblastic lymphadenopathy (AIL)</td></tr><tr><td>9768/1</td><td>T-gamma lymphoproliferative disease</td></tr><tr><td>9769/1</td><td>Immunoglobulin deposition disease</td></tr><tr><td>9800/3</td><td>Leukaemia, NOS</td></tr><tr><td>9801/3</td><td>Acute leukaemia, NOS</td></tr><tr><td>9805/3</td><td>Acute biphenotypic leukaemia</td></tr><tr><td>9806/3</td><td>Mixed phenotype acute leukaemia with t(9;22)(q34;q11.2); BCR-ABL1</td></tr><tr><td>9807/3</td><td>Mixed phenotype acute leukaemia with t(v;11q23); MLL rearranged</td></tr><tr><td>9808/3</td><td>Mixed phenotype acute leukaemia, B/myeloid, NOS</td></tr><tr><td>9809/3</td><td>Mixed phenotype acute leukaemia, T/myeloid, NOS</td></tr><tr><td>9811/3</td><td>B lymphoblastic leukaemia/lymphoma, NOS</td></tr><tr><td>9812/3</td><td>B lymphoblastic leukaemia/lymphoma with t(9;22)(q34;q11.2); BCR-ABL1</td></tr><tr><td>9813/3</td><td>B lymphoblastic leukaemia/lymphoma with t(v;11q23); MLL rearranged</td></tr><tr><td>9814/3</td><td>B lymphoblastic leukaemia/lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)</td></tr><tr><td>9815/3</td><td>B lymphoblastic leukaemia/lymphoma with hyperdiploidy</td></tr><tr><td>9816/3</td><td>B lymphoblastic leukaemia/lymphoma with hypodiploidy (Hypodiploid ALL)</td></tr><tr><td>9817/3</td><td>B lymphoblastic leukaemia/lymphoma with t(5;14)(q31;q32); IL3-IGH</td></tr><tr><td>9818/3</td><td>B lymphoblastic leukaemia/lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)</td></tr><tr><td>9819/3</td><td>B lymphoblastic leukemia/lymphoma, BCR-ABL1-like</td></tr><tr><td>9820/3</td><td>Lymphoid leukaemia, NOS</td></tr><tr><td>9823/1</td><td>Monoclonal B-cell lymphocytosis, CLL type</td></tr><tr><td>9823/3</td><td>B-cell chronic lymphocytic leukaemia/small lymphocytic lymphoma</td></tr><tr><td>9827/3</td><td>Adult T-cell leukaemia/lymphoma (HTLV-1 positive)</td></tr><tr><td>9831/3</td><td>T-cell large granular lymphocytic leukaemia</td></tr><tr><td>9832/3</td><td>Prolymphocytic leukaemia, NOS</td></tr><tr><td>9833/3</td><td>Prolymphocytic leukaemia, B-cell type</td></tr><tr><td>9834/3</td><td>Prolymphocytic leukaemia, T-cell type</td></tr><tr><td>9835/3</td><td>Precursor cell lymphoblastic leukaemia, NOS</td></tr><tr><td>9837/3</td><td>Precursor T-cell lymphoblastic leukaemia</td></tr><tr><td>9840/3</td><td>Acute erythroid leukemia</td></tr><tr><td>9860/3</td><td>Myeloid leukaemia, NOS</td></tr><tr><td>9861/3</td><td>Acute myeloid leukaemia, NOS</td></tr><tr><td>9863/3</td><td>Chronic myeloid leukaemia, NOS</td></tr><tr><td>9865/3</td><td>Acute myeloid leukaemia with t(6;9)(p23;q34); DEK-NUP214</td></tr><tr><td>9866/3</td><td>Acute promyelocytic leukaemia, t(15;17)(q22;q11-12)</td></tr><tr><td>9867/3</td><td>Acute myelomonocytic leukaemia</td></tr><tr><td>9869/3</td><td>Acute myeloid leukaemia with inv(3)(q21;q26.2) or t(3.3)(q21;q26.2); RPN1-EVI1</td></tr><tr><td>9870/3</td><td>Acute basophilic leukaemia</td></tr><tr><td>9871/3</td><td>Acute myeloid leukaemia with abnormal marrow eosinophils</td></tr><tr><td>9872/3</td><td>Acute myeloid leukaemia, minimal differentiation</td></tr><tr><td>9873/3</td><td>Acute myeloid leukaemia without maturation</td></tr><tr><td>9874/3</td><td>Acute myeloid leukaemia with maturation</td></tr><tr><td>9875/3</td><td>Chronic myelogenous leukaemia, BCR/ABL positive</td></tr><tr><td>9876/3</td><td>Atypical chronic myeloid leukaemia, BCR/ABL negative</td></tr><tr><td>9877/3</td><td>Acute myeloid leukaemia with mutated NPM1</td></tr><tr><td>9878/3</td><td>Acute myeloid leukemia with biallelic mutation of CEBPA</td></tr><tr><td>9879/3</td><td>Acute myeloid leukemia with mutated RUNX1</td></tr><tr><td>9891/3</td><td>Acute monocytic leukaemia</td></tr><tr><td>9895/3</td><td>Acute myeloid leukaemia with myelodysplasia-related changes</td></tr><tr><td>9896/3</td><td>Acute myeloid leukaemia, t(8;21)(q22;q22)</td></tr><tr><td>9897/3</td><td>Acute myeloid leukaemia, 11q23 abnormalities</td></tr><tr><td>9898/1</td><td>Transient abnormal myelopoiesis</td></tr><tr><td>9898/3</td><td>Myeloid leukaemia associated with Down Syndrome</td></tr><tr><td>9910/3</td><td>Acute megakaryoblastic leukaemia</td></tr><tr><td>9911/3</td><td>Acute myeloid leukaemia (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1</td></tr><tr><td>9912/3</td><td>Acute myeloid leukemia with BCR-ABL1</td></tr><tr><td>9920/3</td><td>Therapy related myeloid neoplasm</td></tr><tr><td>9930/3</td><td>Myeloid sarcoma</td></tr><tr><td>9931/3</td><td>Acute panmyelosis with myelofibrosis</td></tr><tr><td>9940/3</td><td>Hairy cell leukaemia</td></tr><tr><td>9945/3</td><td>Chronic myelomonocytic leukaemia, NOS</td></tr><tr><td>9946/3</td><td>Juvenile myelomonocytic leukaemia</td></tr><tr><td>9948/3</td><td>Aggressive NK-cell leukaemia</td></tr><tr><td>9950/3</td><td>Polycythaemia vera</td></tr><tr><td>9960/3</td><td>Myeloproliferative neoplasm, NOS</td></tr><tr><td>9961/3</td><td>Primary myelofibrosis</td></tr><tr><td>9962/3</td><td>Essential thrombocythemia</td></tr><tr><td>9963/3</td><td>Chronic neutrophilic leukaemia</td></tr><tr><td>9964/3</td><td>Chronic eosinophilic leukaemia</td></tr><tr><td>9965/3</td><td>Myeloid and lymphoid neoplasms with PDGFRA rearrangement</td></tr><tr><td>9966/3</td><td>Myeloid neoplasms with PDGFRB rearrangement</td></tr><tr><td>9967/3</td><td>Myeloid and lymphoid neoplasms with FGFR1 abnormalities</td></tr><tr><td>9968/3</td><td>Myeloid or lymphoid neoplasm with PCM1-JAK2</td></tr><tr><td>9970/1</td><td>Lymphoproliferative disorder, NOS</td></tr><tr><td>9971/1</td><td>Post transplant lymphoproliferative disorder, NOS</td></tr><tr><td>9975/3</td><td>Myeloproliferative neoplasm, unclassifiable</td></tr><tr><td>9982/3</td><td>Myelodysplastic syndrome with ring sideroblasts and single lineage dysplasia</td></tr><tr><td>9983/3</td><td>Myelodysplastic syndrome with excess blasts</td></tr><tr><td>9984/3</td><td>Refractory anaemia with excess blasts in transformation</td></tr><tr><td>9985/3</td><td>Myelodysplastic syndrome with multilineage dysplasia</td></tr><tr><td>9986/3</td><td>Myelodysplastic syndrome with isolated del (5q)</td></tr><tr><td>9987/3</td><td>Therapy-related myelodysplastic syndrome, NOS</td></tr><tr><td>9989/3</td><td>Myelodysplastic syndrome, NOS</td></tr><tr><td>9993/3</td><td>Myelodysplastic syndrome with ring sideroblasts and multilineage dysplasia</td></tr><tr><td>8408/3</td><td>Digital papillary adenocarcinoma</td></tr><tr><td>8442/1</td><td>Serous borderline tumour, NOS</td></tr><tr><td>9980/3</td><td>Myelodysplastic syndrome with single lineage dysplasia</td></tr></table></li></ul></div>
</text>
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm">
<valueInteger value="1"/>
</extension>
<extension
url="http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status">
<valueCode value="draft"/>
</extension>
<url value="http://terminology.ehdsi.eu/ValueSet/eHDSIOncologyDisease"/>
<identifier>
<system value="urn:ietf:rfc:3986"/>
<value value="urn:oid:1.3.6.1.4.1.12559.11.10.1.3.1.42.93"/>
</identifier>
<version value="0.0.1"/>
<name value="EHDSIOncologyDisease"/>
<title value="eHDSI Oncology Disease"/>
<status value="draft"/>
<experimental value="false"/>
<date value="2025-06-06T12:16:39+00:00"/>
<publisher value="MyHealth@Eu"/>
<contact>
<name value="MyHealth@Eu"/>
<telecom>
<system value="url"/>
<value
value="https://health.ec.europa.eu/other-pages/basic-page/myhealtheu-flyer-addressed-patients-and-health-professionals_en"/>
</telecom>
</contact>
<description
value="The Value Set is used for coding the site (topography) and the histology (morphology) of neoplasms"/>
<jurisdiction>
<coding>
<system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/>
<code value="150"/>
<display value="Europe"/>
</coding>
</jurisdiction>
<compose>
<include>
<system value="http://terminology.hl7.org/CodeSystem/icd-o-3"/>
<concept>
<code value="8000/0"/>
<display value="Neoplasm, benign"/>
</concept>
<concept>
<code value="8000/1"/>
<display value="Neoplasm, uncertain whether benign or malignant"/>
</concept>
<concept>
<code value="8000/3"/>
<display value="Neoplasm, malignant"/>
</concept>
<concept>
<code value="8000/6"/>
<display value="Neoplasm, metastatic"/>
</concept>
<concept>
<code value="8000/9"/>
<display
value="Neoplasm, malignant, uncertain whether primary or metastatic"/>
</concept>
<concept>
<code value="8001/0"/>
<display value="Tumour cells, benign"/>
</concept>
<concept>
<code value="8001/1"/>
<display value="Tumour cells, uncertain whether benign or malignant"/>
</concept>
<concept>
<code value="8001/3"/>
<display value="Tumour cells, malignant"/>
</concept>
<concept>
<code value="8002/3"/>
<display value="Malignant tumour, small cell type"/>
</concept>
<concept>
<code value="8003/3"/>
<display value="Malignant tumour, giant cell type"/>
</concept>
<concept>
<code value="8004/3"/>
<display value="Malignant tumour, spindle cell type"/>
</concept>
<concept>
<code value="8005/0"/>
<display value="Clear cell tumour, NOS"/>
</concept>
<concept>
<code value="8005/3"/>
<display value="Malignant tumour, clear cell type"/>
</concept>
<concept>
<code value="8010/0"/>
<display value="Epithelial tumour, benign"/>
</concept>
<concept>
<code value="8010/2"/>
<display value="Carcinoma in situ, NOS"/>
</concept>
<concept>
<code value="8010/3"/>
<display value="Carcinoma, NOS"/>
</concept>
<concept>
<code value="8010/6"/>
<display value="Carcinoma, metastatic, NOS"/>
</concept>
<concept>
<code value="8010/9"/>
<display value="Carcinomatosis"/>
</concept>
<concept>
<code value="8011/0"/>
<display value="Epithelioma, benign"/>
</concept>
<concept>
<code value="8011/3"/>
<display value="Epithelioma, malignant"/>
</concept>
<concept>
<code value="8012/3"/>
<display value="Large cell carcinoma, NOS"/>
</concept>
<concept>
<code value="8013/3"/>
<display value="Large cell neuroendocrine carcinoma"/>
</concept>
<concept>
<code value="8014/3"/>
<display value="Large cell carcinoma with rhabdoid phenotype"/>
</concept>
<concept>
<code value="8015/3"/>
<display value="Glassy cell carcinoma"/>
</concept>
<concept>
<code value="8020/3"/>
<display value="Carcinoma, undifferentiated, NOS"/>
</concept>
<concept>
<code value="8021/3"/>
<display value="Carcinoma, anaplastic, NOS"/>
</concept>
<concept>
<code value="8022/3"/>
<display value="Pleomorphic carcinoma"/>
</concept>
<concept>
<code value="8023/3"/>
<display
value="Nuclear protein in testis (NUT) associated carcinoma"/>
</concept>
<concept>
<code value="8030/3"/>
<display value="Giant cell and spindle cell carcinoma"/>
</concept>
<concept>
<code value="8031/3"/>
<display value="Giant cell carcinoma"/>
</concept>
<concept>
<code value="8032/3"/>
<display value="Spindle cell carcinoma, NOS"/>
</concept>
<concept>
<code value="8033/3"/>
<display value="Pseudosarcomatous carcinoma"/>
</concept>
<concept>
<code value="8034/3"/>
<display value="Polygonal cell carcinoma"/>
</concept>
<concept>
<code value="8035/3"/>
<display value="Carcinoma with osteoclast-like giant cells"/>
</concept>
<concept>
<code value="8040/0"/>
<display value="Tumourlet, benign"/>
</concept>
<concept>
<code value="8040/1"/>
<display value="Tumourlet, NOS"/>
</concept>
<concept>
<code value="8041/3"/>
<display value="Small cell carcinoma, NOS"/>
</concept>
<concept>
<code value="8042/3"/>
<display value="Oat cell carcinoma"/>
</concept>
<concept>
<code value="8043/3"/>
<display value="Small cell carcinoma, fusiform cell"/>
</concept>
<concept>
<code value="8044/3"/>
<display value="Small cell carcinoma, intermediate cell"/>
</concept>
<concept>
<code value="8045/3"/>
<display value="Combined small cell carcinoma"/>
</concept>
<concept>
<code value="8046/3"/>
<display value="Non-small cell carcinoma"/>
</concept>
<concept>
<code value="8050/0"/>
<display value="Papilloma, NOS"/>
</concept>
<concept>
<code value="8050/2"/>
<display value="Papillary carcinoma in situ"/>
</concept>
<concept>
<code value="8050/3"/>
<display value="Papillary carcinoma, NOS"/>
</concept>
<concept>
<code value="8051/0"/>
<display value="Verrucous papilloma"/>
</concept>
<concept>
<code value="8051/3"/>
<display value="Verrucous carcinoma, NOS"/>
</concept>
<concept>
<code value="8052/0"/>
<display value="Squamous cell papilloma, NOS"/>
</concept>
<concept>
<code value="8052/2"/>
<display value="Papillary squamous cell carcinoma, non-invasive"/>
</concept>
<concept>
<code value="8052/3"/>
<display value="Papillary squamous cell carcinoma"/>
</concept>
<concept>
<code value="8053/0"/>
<display value="Squamous cell papilloma, inverted"/>
</concept>
<concept>
<code value="8054/0"/>
<display value="Warty dyskeratoma"/>
</concept>
<concept>
<code value="8054/3"/>
<display value="Warty carcinoma"/>
</concept>
<concept>
<code value="8060/0"/>
<display value="Squamous papillomatosis"/>
</concept>
<concept>
<code value="8070/0"/>
<display value="Actinic keratosis"/>
</concept>
<concept>
<code value="8070/2"/>
<display value="Squamous cell carcinoma in situ, NOS"/>
</concept>
<concept>
<code value="8070/3"/>
<display value="Squamous cell carcinoma, NOS"/>
</concept>
<concept>
<code value="8070/6"/>
<display value="Squamous cell carcinoma, metastatic, NOS"/>
</concept>
<concept>
<code value="8071/2"/>
<display value="Differentiated intraepithelial neoplasia"/>
</concept>
<concept>
<code value="8071/3"/>
<display value="Squamous cell carcinoma, keratinizing, NOS"/>
</concept>
<concept>
<code value="8072/0"/>
<display value="Large cell acanthoma"/>
</concept>
<concept>
<code value="8072/3"/>
<display
value="Squamous cell carcinoma, large cell, nonkeratinizing, NOS"/>
</concept>
<concept>
<code value="8073/3"/>
<display
value="Squamous cell carcinoma, small cell, nonkeratinizing"/>
</concept>
<concept>
<code value="8074/3"/>
<display value="Squamous cell carcinoma, spindle cell"/>
</concept>
<concept>
<code value="8075/3"/>
<display value="Squamous cell carcinoma, adenoid"/>
</concept>
<concept>
<code value="8076/2"/>
<display
value="Squamous cell carcinoma in situ with questionable stromal invasion"/>
</concept>
<concept>
<code value="8076/3"/>
<display value="Squamous cell carcinoma, microinvasive"/>
</concept>
<concept>
<code value="8077/0"/>
<display value="Squamous intraepithelial neoplasia, low grade"/>
</concept>
<concept>
<code value="8077/2"/>
<display value="Squamous intraepithelial neoplasia, high grade"/>
</concept>
<concept>
<code value="8078/3"/>
<display value="Squamous cell carcinoma with horn formation"/>
</concept>
<concept>
<code value="8080/2"/>
<display value="Queyrat erythroplasia"/>
</concept>
<concept>
<code value="8081/2"/>
<display value="Bowen disease"/>
</concept>
<concept>
<code value="8082/3"/>
<display value="Lymphoepithelial carcinoma"/>
</concept>
<concept>
<code value="8083/3"/>
<display value="Basaloid squamous cell carcinoma"/>
</concept>
<concept>
<code value="8084/0"/>
<display value="Clear cell acanthoma"/>
</concept>
<concept>
<code value="8084/3"/>
<display value="Squamous cell carcinoma, clear cell type"/>
</concept>
<concept>
<code value="8085/3"/>
<display value="Squamous cell carcinoma, HPV-positive"/>
</concept>
<concept>
<code value="8086/3"/>
<display value="Squamous cell carcinoma, HPV-negative"/>
</concept>
<concept>
<code value="8090/1"/>
<display value="Basal cell tumour"/>
</concept>
<concept>
<code value="8090/3"/>
<display value="Basal cell carcinoma, NOS"/>
</concept>
<concept>
<code value="8091/3"/>
<display value="Superficial basal cell carcinoma"/>
</concept>
<concept>
<code value="8092/3"/>
<display value="Infiltrating basal cell carcinoma, NOS"/>
</concept>
<concept>
<code value="8093/3"/>
<display value="Basal cell carcinoma, fibroepithelial"/>
</concept>
<concept>
<code value="8094/3"/>
<display value="Basosquamous carcinoma"/>
</concept>
<concept>
<code value="8095/3"/>
<display value="Metatypical carcinoma"/>
</concept>
<concept>
<code value="8096/0"/>
<display value="Intraepidermal epithelioma of Jadassohn"/>
</concept>
<concept>
<code value="8097/3"/>
<display value="Basal cell carcinoma, nodular"/>
</concept>
<concept>
<code value="8098/3"/>
<display value="Adenoid basal carcinoma"/>
</concept>
<concept>
<code value="8100/0"/>
<display value="Trichoepithelioma"/>
</concept>
<concept>
<code value="8100/3"/>
<display value="Trichoblastic carcinoma"/>
</concept>
<concept>
<code value="8101/0"/>
<display value="Trichofolliculoma"/>
</concept>
<concept>
<code value="8102/0"/>
<display value="Trichilemmoma"/>
</concept>
<concept>
<code value="8102/3"/>
<display value="Trichilemmocarcinoma"/>
</concept>
<concept>
<code value="8103/0"/>
<display value="Pilar tumour"/>
</concept>
<concept>
<code value="8103/1"/>
<display value="Proliferating trichilemmal cyst"/>
</concept>
<concept>
<code value="8104/0"/>
<display value="Pilar sheath acanthoma"/>
</concept>
<concept>
<code value="8110/0"/>
<display value="Pilomatricoma, NOS"/>
</concept>
<concept>
<code value="8110/3"/>
<display value="Pilomatrical carcinoma"/>
</concept>
<concept>
<code value="8120/0"/>
<display value="Urothelial papilloma, NOS"/>
</concept>
<concept>
<code value="8120/2"/>
<display value="Urothelial carcinoma in situ"/>
</concept>
<concept>
<code value="8120/3"/>
<display value="Transitional cell carcinoma, NOS"/>
</concept>
<concept>
<code value="8121/0"/>
<display value="Sinonasal papilloma, exophytic"/>
</concept>
<concept>
<code value="8121/1"/>
<display value="Sinonasal papilloma, inverted"/>
</concept>
<concept>
<code value="8121/3"/>
<display value="Schneiderian carcinoma"/>
</concept>
<concept>
<code value="8122/3"/>
<display value="Urothelial carcinoma, sarcomatoid"/>
</concept>
<concept>
<code value="8123/3"/>
<display value="Basaloid carcinoma"/>
</concept>
<concept>
<code value="8124/3"/>
<display value="Cloacogenic carcinoma"/>
</concept>
<concept>
<code value="8130/1"/>
<display
value="Papillary urothelial neoplasm of low malignant potential"/>
</concept>
<concept>
<code value="8130/2"/>
<display value="Papillary urothelial carcinoma, non-invasive"/>
</concept>
<concept>
<code value="8130/3"/>
<display value="Papillary urothelial carcinoma"/>
</concept>
<concept>
<code value="8131/3"/>
<display value="Urothelial carcinoma, micropapillary"/>
</concept>
<concept>
<code value="8140/0"/>
<display value="Adenoma, NOS"/>
</concept>
<concept>
<code value="8140/1"/>
<display value="Atypical adenoma"/>
</concept>
<concept>
<code value="8140/2"/>
<display value="Adenocarcinoma in situ, NOS"/>
</concept>
<concept>
<code value="8140/3"/>
<display value="Adenocarcinoma, NOS"/>
</concept>
<concept>
<code value="8140/6"/>
<display value="Adenocarcinoma, metastatic, NOS"/>
</concept>
<concept>
<code value="8141/3"/>
<display value="Scirrhous adenocarcinoma"/>
</concept>
<concept>
<code value="8142/3"/>
<display value="Linitis plastica"/>
</concept>
<concept>
<code value="8143/3"/>
<display value="Superficial spreading adenocarcinoma"/>
</concept>
<concept>
<code value="8144/0"/>
<display value="Adenoma, intestinal type"/>
</concept>
<concept>
<code value="8144/3"/>
<display value="Adenocarcinoma, intestinal type"/>
</concept>
<concept>
<code value="8145/3"/>
<display value="Carcinoma, diffuse type"/>
</concept>
<concept>
<code value="8146/0"/>
<display value="Monomorphic adenoma"/>
</concept>
<concept>
<code value="8147/0"/>
<display value="Basal cell adenoma"/>
</concept>
<concept>
<code value="8147/3"/>
<display value="Basal cell adenocarcinoma"/>
</concept>
<concept>
<code value="8148/0"/>
<display value="Glandular intraepithelial neoplasia, low grade"/>
</concept>
<concept>
<code value="8148/2"/>
<display value="Glandular intraepithelial neoplasia, high grade"/>
</concept>
<concept>
<code value="8149/0"/>
<display value="Canalicular adenoma"/>
</concept>
<concept>
<code value="8150/0"/>
<display value="Pancreatic neuroendocrine microadenoma"/>
</concept>
<concept>
<code value="8150/3"/>
<display value="Pancreatic neuroendocrine tumour, nonfunctioning"/>
</concept>
<concept>
<code value="8151/3"/>
<display value="Insulinoma, NOS"/>
</concept>
<concept>
<code value="8152/3"/>
<display value="Glucagonoma"/>
</concept>
<concept>
<code value="8153/3"/>
<display value="Gastrinoma"/>
</concept>
<concept>
<code value="8154/3"/>
<display
value="Mixed neuroendocrine non-neuroendocrine neoplasm (MiNEN)"/>
</concept>
<concept>
<code value="8155/3"/>
<display value="Vipoma"/>
</concept>
<concept>
<code value="8156/3"/>
<display value="Somatostatinoma"/>
</concept>
<concept>
<code value="8158/3"/>
<display value="ACTH-producing tumour"/>
</concept>
<concept>
<code value="8160/0"/>
<display value="Bile duct adenoma"/>
</concept>
<concept>
<code value="8160/3"/>
<display value="Cholangiocarcinoma"/>
</concept>
<concept>
<code value="8161/0"/>
<display value="Bile duct cystadenoma"/>
</concept>
<concept>
<code value="8161/3"/>
<display value="Bile duct cystadenocarcinoma"/>
</concept>
<concept>
<code value="8162/3"/>
<display value="Perihilar cholangiocarcinoma"/>
</concept>
<concept>
<code value="8163/0"/>
<display value="Pancreatobiliary neoplasm, non-invasive"/>
</concept>
<concept>
<code value="8163/2"/>
<display
value="Papillary neoplasm, pancreatobiliary-type, with high grade intraepithelial neoplasia"/>
</concept>
<concept>
<code value="8163/3"/>
<display value="Pancreatobiliary-type carcinoma"/>
</concept>
<concept>
<code value="8170/0"/>
<display value="Liver cell adenoma"/>
</concept>
<concept>
<code value="8170/3"/>
<display value="Hepatocellular carcinoma, NOS"/>
</concept>
<concept>
<code value="8171/3"/>
<display value="Hepatocellular carcinoma, fibrolamellar"/>
</concept>
<concept>
<code value="8172/3"/>
<display value="Hepatocellular carcinoma, scirrhous"/>
</concept>
<concept>
<code value="8173/3"/>
<display value="Hepatocellular carcinoma, spindle cell variant"/>
</concept>
<concept>
<code value="8174/3"/>
<display value="Hepatocellular carcinoma, clear cell type"/>
</concept>
<concept>
<code value="8175/3"/>
<display value="Hepatocellular carcinoma, pleomorphic type"/>
</concept>
<concept>
<code value="8180/3"/>
<display
value="Combined hepatocellular carcinoma and cholangiocarcinoma"/>
</concept>
<concept>
<code value="8190/0"/>
<display value="Trabecular adenoma"/>
</concept>
<concept>
<code value="8190/3"/>
<display value="Trabecular adenocarcinoma"/>
</concept>
<concept>
<code value="8191/0"/>
<display value="Embryonal adenoma"/>
</concept>
<concept>
<code value="8200/0"/>
<display value="Eccrine dermal cylindroma"/>
</concept>
<concept>
<code value="8200/3"/>
<display value="Adenoid cystic carcinoma"/>
</concept>
<concept>
<code value="8201/2"/>
<display value="Cribriform carcinoma in situ"/>
</concept>
<concept>
<code value="8201/3"/>
<display value="Cribriform carcinoma, NOS"/>
</concept>
<concept>
<code value="8202/0"/>
<display value="Microcystic adenoma"/>
</concept>
<concept>
<code value="8204/0"/>
<display value="Lactating adenoma"/>
</concept>
<concept>
<code value="8210/0"/>
<display value="Adenomatous polyp, NOS"/>
</concept>
<concept>
<code value="8210/2"/>
<display value="Adenocarcinoma in situ in adenomatous polyp"/>
</concept>
<concept>
<code value="8210/3"/>
<display value="Adenocarcinoma in adenomatous polyp"/>
</concept>
<concept>
<code value="8211/0"/>
<display value="Tubular adenoma, NOS"/>
</concept>
<concept>
<code value="8211/3"/>
<display value="Tubular adenocarcinoma"/>
</concept>
<concept>
<code value="8212/0"/>
<display value="Flat adenoma"/>
</concept>
<concept>
<code value="8213/0"/>
<display value="Serrated adenoma"/>
</concept>
<concept>
<code value="8213/3"/>
<display value="Serrated adenocarcinoma"/>
</concept>
<concept>
<code value="8214/3"/>
<display value="Parietal cell carcinoma"/>
</concept>
<concept>
<code value="8215/3"/>
<display value="Adenocarcinoma of anal glands"/>
</concept>
<concept>
<code value="8220/0"/>
<display value="Adenomatous polyposis coli"/>
</concept>
<concept>
<code value="8220/3"/>
<display value="Adenocarcinoma in adenomatous polyposis coli"/>
</concept>
<concept>
<code value="8221/0"/>
<display value="Multiple adenomatous polyps"/>
</concept>
<concept>
<code value="8221/3"/>
<display value="Adenocarcinoma in multiple adenomatous polyps"/>
</concept>
<concept>
<code value="8230/2"/>
<display value="Ductal carcinoma in situ, solid type"/>
</concept>
<concept>
<code value="8230/3"/>
<display value="Solid carcinoma, NOS"/>
</concept>
<concept>
<code value="8231/3"/>
<display value="Carcinoma simplex"/>
</concept>
<concept>
<code value="8240/3"/>
<display value="Neuroendocrine tumour, NOS"/>
</concept>
<concept>
<code value="8241/3"/>
<display value="Enterochromaffin cell carcinoid"/>
</concept>
<concept>
<code value="8242/3"/>
<display value="Enterochromaffin-like cell tumour"/>
</concept>
<concept>
<code value="8243/3"/>
<display value="Goblet cell carcinoid"/>
</concept>
<concept>
<code value="8244/3"/>
<display value="Mixed adenoneuroendocrine carcinoma"/>
</concept>
<concept>
<code value="8245/1"/>
<display value="Tubular carcinoid"/>
</concept>
<concept>
<code value="8245/3"/>
<display value="Adenocarcinoid tumour"/>
</concept>
<concept>
<code value="8246/3"/>
<display value="Neuroendocrine carcinoma, NOS"/>
</concept>
<concept>
<code value="8247/3"/>
<display value="Merkel cell carcinoma"/>
</concept>
<concept>
<code value="8248/1"/>
<display value="Apudoma"/>
</concept>
<concept>
<code value="8249/3"/>
<display value="Neuroendocrine tumour, grade 2"/>
</concept>
<concept>
<code value="8250/0"/>
<display value="Atypical adenomatous hyperplasia"/>
</concept>
<concept>
<code value="8250/1"/>
<display value="Pulmonary adenomatosis"/>
</concept>
<concept>
<code value="8250/2"/>
<display value="Adenocarcinoma in situ of lung, non-mucinous"/>
</concept>
<concept>
<code value="8250/3"/>
<display value="Lepidic adenocarcinoma"/>
</concept>
<concept>
<code value="8251/0"/>
<display value="Alveolar adenoma"/>
</concept>
<concept>
<code value="8251/3"/>
<display value="Alveolar adenocarcinoma"/>
</concept>
<concept>
<code value="8252/3"/>
<display value="Bronchiolo-alveolar carcinoma, non-mucinous"/>
</concept>
<concept>
<code value="8253/2"/>
<display value="Adenocarcinoma in situ of lung, mucinous"/>
</concept>
<concept>
<code value="8253/3"/>
<display value="Adenocarcinoma of lung, mucinous"/>
</concept>
<concept>
<code value="8254/3"/>
<display
value="Adenocarcinoma of lung, mixed mucinous and non-mucinous"/>
</concept>
<concept>
<code value="8255/3"/>
<display value="Adenocarcinoma with mixed subtypes"/>
</concept>
<concept>
<code value="8256/3"/>
<display value="Minimally invasive adenocarcinoma, Non-mucinous"/>
</concept>
<concept>
<code value="8257/3"/>
<display value="Minimally invasive adenocarcinoma, Mucinous"/>
</concept>
<concept>
<code value="8260/0"/>
<display value="Papillary adenoma, NOS"/>
</concept>
<concept>
<code value="8260/1"/>
<display value="Aggressive papillary tumour"/>
</concept>
<concept>
<code value="8260/3"/>
<display value="Papillary adenocarcinoma, NOS"/>
</concept>
<concept>
<code value="8261/0"/>
<display value="Villous adenoma, NOS"/>
</concept>
<concept>
<code value="8261/2"/>
<display value="Adenocarcinoma in situ in villous adenoma"/>
</concept>
<concept>
<code value="8261/3"/>
<display value="Adenocarcinoma in villous adenoma"/>
</concept>
<concept>
<code value="8262/3"/>
<display value="Villous adenocarcinoma"/>
</concept>
<concept>
<code value="8263/0"/>
<display value="Tubulovillous adenoma, NOS"/>
</concept>
<concept>
<code value="8263/2"/>
<display value="Adenocarcinoma in situ in tubulovillous adenoma"/>
</concept>
<concept>
<code value="8263/3"/>
<display value="Adenocarcinoma in tubulovillous adenoma"/>
</concept>
<concept>
<code value="8264/0"/>
<display value="Papillomatosis, glandular"/>
</concept>
<concept>
<code value="8265/3"/>
<display value="Micropapillary carcinoma, NOS"/>
</concept>
<concept>
<code value="8270/0"/>
<display value="Chromophobe adenoma"/>
</concept>
<concept>
<code value="8270/3"/>
<display value="Chromophobe carcinoma"/>
</concept>
<concept>
<code value="8271/0"/>
<display value="Lactotroph adenoma"/>
</concept>
<concept>
<code value="8272/0"/>
<display value="Pituitary adenoma, NOS"/>
</concept>
<concept>
<code value="8272/3"/>
<display value="Pituitary carcinoma, NOS"/>
</concept>
<concept>
<code value="8273/3"/>
<display value="Pituitary blastoma"/>
</concept>
<concept>
<code value="8280/0"/>
<display value="Acidophil adenoma"/>
</concept>
<concept>
<code value="8280/3"/>
<display value="Acidophil carcinoma"/>
</concept>
<concept>
<code value="8281/0"/>
<display value="Mixed acidophil-basophil adenoma"/>
</concept>
<concept>
<code value="8281/3"/>
<display value="Mixed acidophil-basophil carcinoma"/>
</concept>
<concept>
<code value="8290/0"/>
<display value="Oxyphilic adenoma"/>
</concept>
<concept>
<code value="8290/3"/>
<display value="Oxyphilic adenocarcinoma"/>
</concept>
<concept>
<code value="8300/0"/>
<display value="Basophil adenoma"/>
</concept>
<concept>
<code value="8300/3"/>
<display value="Basophil carcinoma"/>
</concept>
<concept>
<code value="8310/0"/>
<display value="Clear cell adenoma"/>
</concept>
<concept>
<code value="8310/3"/>
<display value="Clear cell adenocarcinoma, NOS"/>
</concept>
<concept>
<code value="8311/1"/>
<display value="Hypernephroid tumour"/>
</concept>
<concept>
<code value="8311/3"/>
<display
value="Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome-associated renal cell carcinoma"/>
</concept>
<concept>
<code value="8312/3"/>
<display value="Renal cell carcinoma, NOS"/>
</concept>
<concept>
<code value="8313/0"/>
<display value="Clear cell adenofibroma"/>
</concept>
<concept>
<code value="8313/1"/>
<display value="Clear cell borderline tumour"/>
</concept>
<concept>
<code value="8313/3"/>
<display value="Clear cell adenocarcinofibroma"/>
</concept>
<concept>
<code value="8314/3"/>
<display value="Lipid-rich carcinoma"/>
</concept>
<concept>
<code value="8315/3"/>
<display value="Glycogen-rich carcinoma"/>
</concept>
<concept>
<code value="8316/1"/>
<display
value="Multilocular cystic renal neoplasm of low malignant potential"/>
</concept>
<concept>
<code value="8316/3"/>
<display value="Cyst-associated renal cell carcinoma"/>
</concept>
<concept>
<code value="8317/3"/>
<display value="Renal cell carcinoma, chromophobe type"/>
</concept>
<concept>
<code value="8318/3"/>
<display value="Renal cell carcinoma, sarcomatoid"/>
</concept>
<concept>
<code value="8319/3"/>
<display value="Collecting duct carcinoma"/>
</concept>
<concept>
<code value="8320/3"/>
<display value="Granular cell carcinoma"/>
</concept>
<concept>
<code value="8321/0"/>
<display value="Chief cell adenoma"/>
</concept>
<concept>
<code value="8322/0"/>
<display value="Water-clear cell adenoma"/>
</concept>
<concept>
<code value="8322/3"/>
<display value="Water-clear cell adenocarcinoma"/>
</concept>
<concept>
<code value="8323/0"/>
<display value="Mixed cell adenoma"/>
</concept>
<concept>
<code value="8323/1"/>
<display value="Clear cell papillary renal cell carcinoma"/>
</concept>
<concept>
<code value="8323/3"/>
<display value="Mixed cell adenocarcinoma"/>
</concept>
<concept>
<code value="8324/0"/>
<display value="Lipoadenoma"/>
</concept>
<concept>
<code value="8325/0"/>
<display value="Metanephric adenoma"/>
</concept>
<concept>
<code value="8330/0"/>
<display value="Follicular adenoma"/>
</concept>
<concept>
<code value="8330/1"/>
<display value="Atypical follicular adenoma"/>
</concept>
<concept>
<code value="8330/3"/>
<display value="Follicular carcinoma, NOS"/>
</concept>
<concept>
<code value="8331/3"/>
<display value="Follicular adenocarcinoma, well differentiated"/>
</concept>
<concept>
<code value="8332/3"/>
<display value="Follicular adenocarcinoma, trabecular"/>
</concept>
<concept>
<code value="8333/0"/>
<display value="Microfollicular adenoma, NOS"/>
</concept>
<concept>
<code value="8333/3"/>
<display value="Fetal adenocarcinoma"/>
</concept>
<concept>
<code value="8334/0"/>
<display value="Macrofollicular adenoma"/>
</concept>
<concept>
<code value="8335/1"/>
<display value="Follicular tumour of uncertain malignant potential"/>
</concept>
<concept>
<code value="8335/3"/>
<display value="Follicular carcinoma, minimally invasive"/>
</concept>
<concept>
<code value="8336/1"/>
<display value="Hyalinizing trabecular tumour"/>
</concept>
<concept>
<code value="8337/3"/>
<display value="Poorly differentiated thyroid carcinoma"/>
</concept>
<concept>
<code value="8339/3"/>
<display value="Follicular carcinoma, encapsulated, angioinvasive"/>
</concept>
<concept>
<code value="8340/3"/>
<display value="Papillary carcinoma, follicular variant"/>
</concept>
<concept>
<code value="8341/3"/>
<display value="Papillary microcarcinoma"/>
</concept>
<concept>
<code value="8342/3"/>
<display value="Papillary carcinoma, oncocytic variant"/>
</concept>
<concept>
<code value="8343/3"/>
<display value="Papillary carcinoma, encapsulated, of thyroid"/>
</concept>
<concept>
<code value="8344/3"/>
<display value="Papillary carcinoma, columnar cell"/>
</concept>
<concept>
<code value="8345/3"/>
<display value="Medullary thyroid carcinoma"/>
</concept>
<concept>
<code value="8346/3"/>
<display value="Mixed medullary-follicular carcinoma"/>
</concept>
<concept>
<code value="8347/3"/>
<display value="Mixed medullary-papillary carcinoma"/>
</concept>
<concept>
<code value="8348/1"/>
<display
value="Well differentiated tumour of uncertain malignant potential"/>
</concept>
<concept>
<code value="8349/1"/>
<display
value="Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)"/>
</concept>
<concept>
<code value="8350/3"/>
<display value="Nonencapsulated sclerosing carcinoma"/>
</concept>
<concept>
<code value="8360/1"/>
<display value="Multiple endocrine adenomas"/>
</concept>
<concept>
<code value="8361/0"/>
<display value="Juxtaglomerular tumour"/>
</concept>
<concept>
<code value="8370/0"/>
<display value="Adrenal cortical adenoma, NOS"/>
</concept>
<concept>
<code value="8370/3"/>
<display value="Adrenal cortical carcinoma"/>
</concept>
<concept>
<code value="8371/0"/>
<display value="Adrenal cortical adenoma, compact cell"/>
</concept>
<concept>
<code value="8372/0"/>
<display value="Adrenal cortical adenoma, pigmented"/>
</concept>
<concept>
<code value="8373/0"/>
<display value="Adrenal cortical adenoma, clear cell"/>
</concept>
<concept>
<code value="8374/0"/>
<display value="Adrenal cortical adenoma, glomerulosa cell"/>
</concept>
<concept>
<code value="8375/0"/>
<display value="Adrenal cortical adenoma, mixed cell"/>
</concept>
<concept>
<code value="8380/0"/>
<display value="Endometrioid adenoma, NOS"/>
</concept>
<concept>
<code value="8380/1"/>
<display value="Endometrioid adenoma, borderline malignancy"/>
</concept>
<concept>
<code value="8380/2"/>
<display value="Endometrioid intraepithelial neoplasia"/>
</concept>
<concept>
<code value="8380/3"/>
<display value="Endometrioid adenocarcinoma, NOS"/>
</concept>
<concept>
<code value="8381/0"/>
<display value="Endometrioid adenofibroma, NOS"/>
</concept>
<concept>
<code value="8381/1"/>
<display value="Endometrioid adenofibroma, borderline malignancy"/>
</concept>
<concept>
<code value="8381/3"/>
<display value="Endometrioid adenofibroma, malignant"/>
</concept>
<concept>
<code value="8382/3"/>
<display value="Endometrioid adenocarcinoma, secretory variant"/>
</concept>
<concept>
<code value="8383/3"/>
<display value="Endometrioid adenocarcinoma, ciliated cell variant"/>
</concept>
<concept>
<code value="8384/3"/>
<display value="Adenocarcinoma, endocervical type"/>
</concept>
<concept>
<code value="8390/0"/>
<display value="Skin appendage adenoma"/>
</concept>
<concept>
<code value="8390/3"/>
<display value="Adnexal adenocarcinoma, NOS"/>
</concept>
<concept>
<code value="8391/0"/>
<display value="Follicular fibroma"/>
</concept>
<concept>
<code value="8392/0"/>
<display value="Syringofibroadenoma"/>
</concept>
<concept>
<code value="8400/0"/>
<display value="Sweat gland adenoma"/>
</concept>
<concept>
<code value="8400/1"/>
<display value="Sweat gland tumour, NOS"/>
</concept>
<concept>
<code value="8400/3"/>
<display value="Sweat gland adenocarcinoma"/>
</concept>
<concept>
<code value="8401/0"/>
<display value="Apocrine adenoma"/>
</concept>
<concept>
<code value="8401/3"/>
<display value="Apocrine adenocarcinoma"/>
</concept>
<concept>
<code value="8402/0"/>
<display value="Hidradenoma, NOS"/>
</concept>
<concept>
<code value="8402/3"/>
<display value="Hidradenocarcinoma"/>
</concept>
<concept>
<code value="8403/0"/>
<display value="Spiradenoma, NOS"/>
</concept>
<concept>
<code value="8403/3"/>
<display value="Malignant eccrine spiradenoma"/>
</concept>
<concept>
<code value="8404/0"/>
<display value="Hidrocystoma"/>
</concept>
<concept>
<code value="8405/0"/>
<display value="Papillary hidradenoma"/>
</concept>
<concept>
<code value="8406/0"/>
<display value="Syringocystadenoma papilliferum"/>
</concept>
<concept>
<code value="8406/3"/>
<display value="Syringocystadenocarcinoma papilliferum"/>
</concept>
<concept>
<code value="8407/0"/>
<display value="Syringoma, NOS"/>
</concept>
<concept>
<code value="8407/3"/>
<display value="Microcystic adnexal carcinoma"/>
</concept>
<concept>
<code value="8408/0"/>
<display value="Eccrine papillary adenoma"/>
</concept>
<concept>
<code value="8409/0"/>
<display value="Poroma, NOS"/>
</concept>
<concept>
<code value="8409/2"/>
<display value="Porocarcinoma in situ"/>
</concept>
<concept>
<code value="8409/3"/>
<display value="Porocarcinoma, NOS"/>
</concept>
<concept>
<code value="8410/0"/>
<display value="Sebaceoma"/>
</concept>
<concept>
<code value="8410/3"/>
<display value="Sebaceous carcinoma"/>
</concept>
<concept>
<code value="8413/3"/>
<display value="Eccrine adenocarcinoma"/>
</concept>
<concept>
<code value="8420/0"/>
<display value="Ceruminous adenoma"/>
</concept>
<concept>
<code value="8420/3"/>
<display value="Ceruminous adenocarcinoma"/>
</concept>
<concept>
<code value="8430/1"/>
<display value="Mucoepidermoid tumour"/>
</concept>
<concept>
<code value="8430/3"/>
<display value="Mucoepidermoid carcinoma"/>
</concept>
<concept>
<code value="8440/0"/>
<display value="Cystadenoma, NOS"/>
</concept>
<concept>
<code value="8440/3"/>
<display value="Cystadenocarcinoma, NOS"/>
</concept>
<concept>
<code value="8441/0"/>
<display value="Serous cystadenoma, NOS"/>
</concept>
<concept>
<code value="8441/2"/>
<display value="Serous intraepithelial carcinoma"/>
</concept>
<concept>
<code value="8441/3"/>
<display value="Serous carcinoma, NOS"/>
</concept>
<concept>
<code value="8443/0"/>
<display value="Clear cell cystadenoma"/>
</concept>
<concept>
<code value="8450/0"/>
<display value="Papillary cystadenoma, NOS"/>
</concept>
<concept>
<code value="8450/3"/>
<display value="Papillary cystadenocarcinoma, NOS"/>
</concept>
<concept>
<code value="8451/1"/>
<display value="Papillary cystadenoma, borderline malignancy"/>
</concept>
<concept>
<code value="8452/1"/>
<display value="Solid pseudopapillary tumour of ovary"/>
</concept>
<concept>
<code value="8452/3"/>
<display value="Solid pseudopapillary neoplasm of pancreas"/>
</concept>
<concept>
<code value="8453/0"/>
<display value="Intraductal papillary-mucinous adenoma"/>
</concept>
<concept>
<code value="8453/2"/>
<display
value="Intraductal papillary mucinous neoplasm with high grade dysplasia"/>
</concept>
<concept>
<code value="8453/3"/>
<display
value="Intraductal papillary mucinous neoplasm with an associated invasive carcinoma"/>
</concept>
<concept>
<code value="8454/0"/>
<display value="Cystic tumour of atrio-ventricular node"/>
</concept>
<concept>
<code value="8460/2"/>
<display value="Serous borderline tumour, micropapillary variant"/>
</concept>
<concept>
<code value="8460/3"/>
<display value="Low grade serous carcinoma"/>
</concept>
<concept>
<code value="8461/0"/>
<display value="Serous surface papilloma"/>
</concept>
<concept>
<code value="8461/3"/>
<display value="High grade serous carcinoma"/>
</concept>
<concept>
<code value="8470/0"/>
<display value="Mucinous cystadenoma, NOS"/>
</concept>
<concept>
<code value="8470/2"/>
<display value="Mucinous cystic neoplasm with high-grade dysplasia"/>
</concept>
<concept>
<code value="8470/3"/>
<display value="Mucinous cystadenocarcinoma, NOS"/>
</concept>
<concept>
<code value="8472/1"/>
<display value="Mucinous cystic tumour of borderline malignancy"/>
</concept>
<concept>
<code value="8474/0"/>
<display value="Seromucinous cystadenoma"/>
</concept>
<concept>
<code value="8474/1"/>
<display value="Seromucinous borderline tumour"/>
</concept>
<concept>
<code value="8474/3"/>
<display value="Seromucinous carcinoma"/>
</concept>
<concept>
<code value="8480/0"/>
<display value="Mucinous adenoma"/>
</concept>
<concept>
<code value="8480/1"/>
<display value="Low grade appendiceal mucinous neoplasm"/>
</concept>
<concept>
<code value="8480/3"/>
<display value="Mucinous adenocarcinoma"/>
</concept>
<concept>
<code value="8480/6"/>
<display value="Pseudomyxoma peritonei"/>
</concept>
<concept>
<code value="8481/3"/>
<display value="Mucin-producing adenocarcinoma"/>
</concept>
<concept>
<code value="8482/3"/>
<display value="Mucinous carcinoma, gastric type"/>
</concept>
<concept>
<code value="8490/3"/>
<display value="Signet ring cell carcinoma"/>
</concept>
<concept>
<code value="8490/6"/>
<display value="Metastatic signet ring cell carcinoma"/>
</concept>
<concept>
<code value="8500/2"/>
<display value="Intraductal carcinoma, noninfiltrating, NOS"/>
</concept>
<concept>
<code value="8500/3"/>
<display value="Infiltrating duct carcinoma, NOS"/>
</concept>
<concept>
<code value="8501/2"/>
<display value="Comedocarcinoma, noninfiltrating"/>
</concept>
<concept>
<code value="8501/3"/>
<display value="Comedocarcinoma, NOS"/>
</concept>
<concept>
<code value="8502/3"/>
<display value="Secretory carcinoma"/>
</concept>
<concept>
<code value="8503/0"/>
<display value="Intraductal papilloma"/>
</concept>
<concept>
<code value="8503/2"/>
<display
value="Noninfiltrating intraductal papillary adenocarcinoma"/>
</concept>
<concept>
<code value="8503/3"/>
<display value="Intraductal papillary adenocarcinoma with invasion"/>
</concept>
<concept>
<code value="8504/0"/>
<display value="Intracystic papillary adenoma"/>
</concept>
<concept>
<code value="8504/2"/>
<display value="Noninfiltrating intracystic carcinoma"/>
</concept>
<concept>
<code value="8504/3"/>
<display value="Encapsulated papillary carcinoma with invasion"/>
</concept>
<concept>
<code value="8505/0"/>
<display value="Intraductal papillomatosis, NOS"/>
</concept>
<concept>
<code value="8506/0"/>
<display value="Adenoma of nipple"/>
</concept>
<concept>
<code value="8507/2"/>
<display value="Intraductal micropapillary carcinoma"/>
</concept>
<concept>
<code value="8507/3"/>
<display value="Invasive micropapillary carcinoma of breast"/>
</concept>
<concept>
<code value="8508/3"/>
<display value="Cystic hypersecretory carcinoma"/>
</concept>
<concept>
<code value="8509/2"/>
<display value="Solid papillary carcinoma in situ"/>
</concept>
<concept>
<code value="8509/3"/>
<display value="Solid papillary carcinoma with invasion"/>
</concept>
<concept>
<code value="8510/3"/>
<display value="Medullary carcinoma, NOS"/>
</concept>
<concept>
<code value="8512/3"/>
<display value="Medullary carcinoma with lymphoid stroma"/>
</concept>
<concept>
<code value="8513/3"/>
<display value="Atypical medullary carcinoma"/>
</concept>
<concept>
<code value="8514/3"/>
<display value="Duct carcinoma, desmoplastic type"/>
</concept>
<concept>
<code value="8519/2"/>
<display value="Lobular carcinoma in situ, pleomorphic"/>
</concept>
<concept>
<code value="8520/2"/>
<display value="Lobular carcinoma in situ, NOS"/>
</concept>
<concept>
<code value="8520/3"/>
<display value="Lobular carcinoma, NOS"/>
</concept>
<concept>
<code value="8521/3"/>
<display value="Infiltrating ductular carcinoma"/>
</concept>
<concept>
<code value="8522/2"/>
<display value="Intraductal carcinoma and lobular carcinoma in situ"/>
</concept>
<concept>
<code value="8522/3"/>
<display value="Infiltrating duct and lobular carcinoma"/>
</concept>
<concept>
<code value="8523/3"/>
<display
value="Infiltrating duct mixed with other types of carcinoma"/>
</concept>
<concept>
<code value="8524/3"/>
<display
value="Infiltrating lobular mixed with other types of carcinoma"/>
</concept>
<concept>
<code value="8525/3"/>
<display value="Polymorphous adenocarcinoma"/>
</concept>
<concept>
<code value="8530/3"/>
<display value="Inflammatory carcinoma"/>
</concept>
<concept>
<code value="8540/3"/>
<display value="Paget disease, mammary"/>
</concept>
<concept>
<code value="8541/3"/>
<display
value="Paget disease and infiltrating duct carcinoma of breast"/>
</concept>
<concept>
<code value="8542/3"/>
<display value="Paget disease, extramammary"/>
</concept>
<concept>
<code value="8543/3"/>
<display value="Paget disease and intraductal carcinoma of breast"/>
</concept>
<concept>
<code value="8550/0"/>
<display value="Acinar cell adenoma"/>
</concept>
<concept>
<code value="8550/1"/>
<display value="Acinar cell tumour"/>
</concept>
<concept>
<code value="8550/3"/>
<display value="Acinar cell carcinoma"/>
</concept>
<concept>
<code value="8551/3"/>
<display value="Acinar cell cystadenocarcinoma"/>
</concept>
<concept>
<code value="8552/3"/>
<display value="Mixed acinar-ductal carcinoma"/>
</concept>
<concept>
<code value="8560/0"/>
<display value="Mixed squamous cell and glandular papilloma"/>
</concept>
<concept>
<code value="8560/3"/>
<display value="Adenosquamous carcinoma"/>
</concept>
<concept>
<code value="8561/0"/>
<display value="Adenolymphoma"/>
</concept>
<concept>
<code value="8562/3"/>
<display value="Epithelial-myoepithelial carcinoma"/>
</concept>
<concept>
<code value="8563/0"/>
<display value="Lymphadenoma"/>
</concept>
<concept>
<code value="8570/3"/>
<display value="Adenocarcinoma with squamous metaplasia"/>
</concept>
<concept>
<code value="8571/3"/>
<display
value="Adenocarcinoma with cartilaginous and osseous metaplasia"/>
</concept>
<concept>
<code value="8572/3"/>
<display value="Adenocarcinoma with spindle cell metaplasia"/>
</concept>
<concept>
<code value="8573/3"/>
<display value="Adenocarcinoma with apocrine metaplasia"/>
</concept>
<concept>
<code value="8574/3"/>
<display value="Adenocarcinoma with neuroendocrine differentiation"/>
</concept>
<concept>
<code value="8575/3"/>
<display value="Metaplastic carcinoma, NOS"/>
</concept>
<concept>
<code value="8576/3"/>
<display value="Hepatoid adenocarcinoma"/>
</concept>
<concept>
<code value="8580/0"/>
<display value="Microscopic thymoma"/>
</concept>
<concept>
<code value="8580/1"/>
<display value="Micronodular thymoma with lymphoid stroma"/>
</concept>
<concept>
<code value="8580/3"/>
<display value="Thymoma, NOS"/>
</concept>
<concept>
<code value="8581/3"/>
<display value="Thymoma, type A"/>
</concept>
<concept>
<code value="8582/3"/>
<display value="Thymoma, type AB"/>
</concept>
<concept>
<code value="8583/3"/>
<display value="Thymoma, type B1"/>
</concept>
<concept>
<code value="8584/3"/>
<display value="Thymoma, type B2"/>
</concept>
<concept>
<code value="8585/3"/>
<display value="Thymoma, type B3"/>
</concept>
<concept>
<code value="8586/3"/>
<display value="Thymic carcinoma, NOS"/>
</concept>
<concept>
<code value="8587/0"/>
<display value="Ectopic hamartomatous thymoma"/>
</concept>
<concept>
<code value="8588/3"/>
<display value="Spindle epithelial tumour with thymus-like element"/>
</concept>
<concept>
<code value="8589/3"/>
<display value="Intrathyroid thymic carcinoma"/>
</concept>
<concept>
<code value="8590/0"/>
<display value="Sex cord-stromal tumour, benign"/>
</concept>
<concept>
<code value="8590/1"/>
<display value="Sex cord-gonadal stromal tumour, NOS"/>
</concept>
<concept>
<code value="8591/1"/>
<display
value="Sex cord-gonadal stromal tumour, incompletely differentiated"/>
</concept>
<concept>
<code value="8592/1"/>
<display value="Sex cord-gonadal stromal tumour, mixed forms"/>
</concept>
<concept>
<code value="8593/1"/>
<display value="Stromal tumour with minor sex cord elements"/>
</concept>
<concept>
<code value="8594/1"/>
<display value="Mixed germ cell-sex cord-stromal tumour, NOS"/>
</concept>
<concept>
<code value="8600/0"/>
<display value="Thecoma, NOS"/>
</concept>
<concept>
<code value="8600/3"/>
<display value="Thecoma, malignant"/>
</concept>
<concept>
<code value="8601/0"/>
<display value="Thecoma, luteinized"/>
</concept>
<concept>
<code value="8602/0"/>
<display value="Sclerosing stromal tumour"/>
</concept>
<concept>
<code value="8610/0"/>
<display value="Luteoma, NOS"/>
</concept>
<concept>
<code value="8620/1"/>
<display value="Adult granulosa cell tumour of testis"/>
</concept>
<concept>
<code value="8620/3"/>
<display value="Adult granulosa cell tumour of ovary"/>
</concept>
<concept>
<code value="8621/1"/>
<display value="Granulosa cell-theca cell tumour"/>
</concept>
<concept>
<code value="8622/0"/>
<display value="Granulosa cell tumour of the testis, juvenile"/>
</concept>
<concept>
<code value="8622/1"/>
<display value="Granulosa cell tumour, juvenile"/>
</concept>
<concept>
<code value="8623/1"/>
<display value="Sex cord tumour with annular tubules"/>
</concept>
<concept>
<code value="8630/0"/>
<display value="Androblastoma, benign"/>
</concept>
<concept>
<code value="8630/1"/>
<display value="Androblastoma, NOS"/>
</concept>
<concept>
<code value="8630/3"/>
<display value="Androblastoma, malignant"/>
</concept>
<concept>
<code value="8631/0"/>
<display value="Sertoli-Leydig cell tumour, well differentiated"/>
</concept>
<concept>
<code value="8631/1"/>
<display
value="Sertoli-Leydig cell tumour of intermediate differentiation"/>
</concept>
<concept>
<code value="8631/3"/>
<display value="Sertoli-Leydig cell tumour, poorly differentiated"/>
</concept>
<concept>
<code value="8632/1"/>
<display value="Gynandroblastoma"/>
</concept>
<concept>
<code value="8633/1"/>
<display value="Sertoli-Leydig cell tumour, retiform"/>
</concept>
<concept>
<code value="8634/1"/>
<display
value="Sertoli-Leydig cell tumour, intermediate differentiation, with heterologous elements"/>
</concept>
<concept>
<code value="8634/3"/>
<display
value="Sertoli-Leydig cell tumour, poorly differentiated, with heterologous elements"/>
</concept>
<concept>
<code value="8640/1"/>
<display value="Sertoli cell tumour, NOS"/>
</concept>
<concept>
<code value="8640/3"/>
<display value="Sertoli cell carcinoma"/>
</concept>
<concept>
<code value="8641/0"/>
<display value="Sertoli cell tumour with lipid storage"/>
</concept>
<concept>
<code value="8642/1"/>
<display value="Large cell calcifying Sertoli cell tumour"/>
</concept>
<concept>
<code value="8643/1"/>
<display
value="Intratubular large cell hyalinizing Sertoli cell neoplasia"/>
</concept>
<concept>
<code value="8650/0"/>
<display value="Leydig cell tumour of the ovary, NOS"/>
</concept>
<concept>
<code value="8650/1"/>
<display value="Leydig cell tumour of the testis, NOS"/>
</concept>
<concept>
<code value="8650/3"/>
<display value="Leydig cell tumour, malignant"/>
</concept>
<concept>
<code value="8660/0"/>
<display value="Hilus cell tumour"/>
</concept>
<concept>
<code value="8670/0"/>
<display value="Lipid cell tumour of ovary"/>
</concept>
<concept>
<code value="8670/3"/>
<display value="Steroid cell tumour, malignant"/>
</concept>
<concept>
<code value="8671/0"/>
<display value="Adrenal rest tumour"/>
</concept>
<concept>
<code value="8680/3"/>
<display value="Paraganglioma, NOS"/>
</concept>
<concept>
<code value="8681/3"/>
<display value="Sympathetic paraganglioma"/>
</concept>
<concept>
<code value="8682/3"/>
<display value="Parasympathetic paraganglioma"/>
</concept>
<concept>
<code value="8683/0"/>
<display value="Gangliocytic paraganglioma"/>
</concept>
<concept>
<code value="8690/3"/>
<display value="Middle ear paraganglioma"/>
</concept>
<concept>
<code value="8691/3"/>
<display value="Aortic body tumour"/>
</concept>
<concept>
<code value="8692/3"/>
<display value="Carotid body paraganglioma"/>
</concept>
<concept>
<code value="8693/3"/>
<display value="Extra-adrenal paraganglioma"/>
</concept>
<concept>
<code value="8700/3"/>
<display value="Pheochromocytoma, NOS"/>
</concept>
<concept>
<code value="8710/3"/>
<display value="Glomangiosarcoma"/>
</concept>
<concept>
<code value="8711/0"/>
<display value="Glomus tumour, NOS"/>
</concept>
<concept>
<code value="8711/1"/>
<display value="Glomangiomatosis"/>
</concept>
<concept>
<code value="8711/3"/>
<display value="Glomus tumour, malignant"/>
</concept>
<concept>
<code value="8712/0"/>
<display value="Glomangioma"/>
</concept>
<concept>
<code value="8713/0"/>
<display value="Glomangiomyoma"/>
</concept>
<concept>
<code value="8714/0"/>
<display value="Perivascular epithelioid tumour, benign"/>
</concept>
<concept>
<code value="8714/3"/>
<display value="Perivascular epithelioid tumour, malignant"/>
</concept>
<concept>
<code value="8720/0"/>
<display value="Pigmented naevus, NOS"/>
</concept>
<concept>
<code value="8720/2"/>
<display value="Melanoma in situ"/>
</concept>
<concept>
<code value="8720/3"/>
<display value="Malignant melanoma, NOS"/>
</concept>
<concept>
<code value="8721/3"/>
<display value="Nodular melanoma"/>
</concept>
<concept>
<code value="8722/0"/>
<display value="Balloon cell naevus"/>
</concept>
<concept>
<code value="8722/3"/>
<display value="Balloon cell melanoma"/>
</concept>
<concept>
<code value="8723/0"/>
<display value="Halo naevus"/>
</concept>
<concept>
<code value="8723/3"/>
<display value="Malignant melanoma, regressing"/>
</concept>
<concept>
<code value="8725/0"/>
<display value="Neuronevus"/>
</concept>
<concept>
<code value="8726/0"/>
<display value="Magnocellular naevus"/>
</concept>
<concept>
<code value="8727/0"/>
<display value="Dysplastic naevus"/>
</concept>
<concept>
<code value="8728/0"/>
<display value="Meningeal melanocytosis"/>
</concept>
<concept>
<code value="8728/1"/>
<display value="Meningeal melanocytoma"/>
</concept>
<concept>
<code value="8728/3"/>
<display value="Meningeal melanomatosis"/>
</concept>
<concept>
<code value="8730/0"/>
<display value="Nonpigmented naevus"/>
</concept>
<concept>
<code value="8730/3"/>
<display value="Amelanotic melanoma"/>
</concept>
<concept>
<code value="8740/0"/>
<display value="Junctional naevus, NOS"/>
</concept>
<concept>
<code value="8740/3"/>
<display value="Malignant melanoma in junctional naevus"/>
</concept>
<concept>
<code value="8741/2"/>
<display value="Precancerous melanosis, NOS"/>
</concept>
<concept>
<code value="8741/3"/>
<display value="Malignant melanoma in precancerous melanosis"/>
</concept>
<concept>
<code value="8742/0"/>
<display value="Lentiginous melanocytic naevus"/>
</concept>
<concept>
<code value="8742/2"/>
<display value="Lentigo maligna"/>
</concept>
<concept>
<code value="8742/3"/>
<display value="Lentigo maligna melanoma"/>
</concept>
<concept>
<code value="8743/3"/>
<display value="Low cumulative sun damage melanoma"/>
</concept>
<concept>
<code value="8744/0"/>
<display value="Acral naevus"/>
</concept>
<concept>
<code value="8744/3"/>
<display value="Acral melanoma"/>
</concept>
<concept>
<code value="8745/3"/>
<display value="Desmoplastic melanoma, NOS"/>
</concept>
<concept>
<code value="8746/3"/>
<display value="Mucosal lentiginous melanoma"/>
</concept>
<concept>
<code value="8750/0"/>
<display value="Dermal naevus"/>
</concept>
<concept>
<code value="8760/0"/>
<display value="Compound naevus"/>
</concept>
<concept>
<code value="8761/0"/>
<display value="Congenital melanocytic naevus, NOS"/>
</concept>
<concept>
<code value="8761/1"/>
<display value="Giant pigmented naevus, NOS"/>
</concept>
<concept>
<code value="8761/3"/>
<display
value="Malignant melanoma arising in giant congenital naevus"/>
</concept>
<concept>
<code value="8762/1"/>
<display value="Proliferative dermal lesion in congenital naevus"/>
</concept>
<concept>
<code value="8770/0"/>
<display value="Epithelioid and spindle cell naevus"/>
</concept>
<concept>
<code value="8770/3"/>
<display value="Malignant Spitz tumour"/>
</concept>
<concept>
<code value="8771/0"/>
<display value="Epithelioid cell naevus"/>
</concept>
<concept>
<code value="8771/3"/>
<display value="Epithelioid cell melanoma"/>
</concept>
<concept>
<code value="8772/0"/>
<display value="Spindle cell naevus, NOS"/>
</concept>
<concept>
<code value="8772/3"/>
<display value="Spindle cell melanoma, NOS"/>
</concept>
<concept>
<code value="8773/3"/>
<display value="Spindle cell melanoma, type A"/>
</concept>
<concept>
<code value="8774/3"/>
<display value="Spindle cell melanoma, type B"/>
</concept>
<concept>
<code value="8780/0"/>
<display value="Blue nevus, NOS"/>
</concept>
<concept>
<code value="8780/1"/>
<display value="Pigmented epithelioid melanocytoma"/>
</concept>
<concept>
<code value="8780/3"/>
<display value="Blue naevus, malignant"/>
</concept>
<concept>
<code value="8790/0"/>
<display value="Cellular blue naevus"/>
</concept>
<concept>
<code value="8800/0"/>
<display value="Soft tissue tumour, benign"/>
</concept>
<concept>
<code value="8800/3"/>
<display value="Sarcoma, NOS"/>
</concept>
<concept>
<code value="8800/9"/>
<display value="Sarcomatosis, NOS"/>
</concept>
<concept>
<code value="8801/3"/>
<display value="Spindle cell sarcoma"/>
</concept>
<concept>
<code value="8802/1"/>
<display value="Pleomorphic hyalinizing angiectatic tumour"/>
</concept>
<concept>
<code value="8802/3"/>
<display value="Giant cell sarcoma"/>
</concept>
<concept>
<code value="8803/3"/>
<display value="Small cell sarcoma"/>
</concept>
<concept>
<code value="8804/3"/>
<display value="Epithelioid sarcoma"/>
</concept>
<concept>
<code value="8805/3"/>
<display value="Undifferentiated sarcoma"/>
</concept>
<concept>
<code value="8806/3"/>
<display value="Desmoplastic small round cell tumour"/>
</concept>
<concept>
<code value="8810/0"/>
<display value="Fibroma, NOS"/>
</concept>
<concept>
<code value="8810/1"/>
<display value="Cellular fibroma"/>
</concept>
<concept>
<code value="8810/3"/>
<display value="Fibrosarcoma, NOS"/>
</concept>
<concept>
<code value="8811/0"/>
<display value="Fibromyxoma"/>
</concept>
<concept>
<code value="8811/1"/>
<display value="Myxoinflammatory fibroblastic sarcoma"/>
</concept>
<concept>
<code value="8811/3"/>
<display value="Myxofibrosarcoma"/>
</concept>
<concept>
<code value="8812/0"/>
<display value="Periosteal fibroma"/>
</concept>
<concept>
<code value="8812/3"/>
<display value="Periosteal fibrosarcoma"/>
</concept>
<concept>
<code value="8813/0"/>
<display value="Fibroma of tendon sheath"/>
</concept>
<concept>
<code value="8813/1"/>
<display value="Palmar/plantar type fibromatosis"/>
</concept>
<concept>
<code value="8813/3"/>
<display value="Fascial fibrosarcoma"/>
</concept>
<concept>
<code value="8814/3"/>
<display value="Infantile fibrosarcoma"/>
</concept>
<concept>
<code value="8815/0"/>
<display
value="Solitary fibrous tumour/Haemangiopericytoma, grade 1"/>
</concept>
<concept>
<code value="8815/1"/>
<display value="Solitary fibrous tumour, NOS"/>
</concept>
<concept>
<code value="8815/3"/>
<display value="Solitary fibrous tumour, malignant"/>
</concept>
<concept>
<code value="8816/0"/>
<display value="Calcifying aponeurotic fibroma"/>
</concept>
<concept>
<code value="8817/0"/>
<display value="Calcifying fibrous tumour"/>
</concept>
<concept>
<code value="8818/0"/>
<display value="Fibrous dysplasia"/>
</concept>
<concept>
<code value="8820/0"/>
<display value="Elastofibroma"/>
</concept>
<concept>
<code value="8821/1"/>
<display value="Aggressive fibromatosis"/>
</concept>
<concept>
<code value="8822/1"/>
<display value="Abdominal fibromatosis"/>
</concept>
<concept>
<code value="8823/0"/>
<display value="Sclerotic fibroma"/>
</concept>
<concept>
<code value="8823/1"/>
<display value="Desmoplastic fibroma"/>
</concept>
<concept>
<code value="8824/0"/>
<display value="Myofibroma"/>
</concept>
<concept>
<code value="8824/1"/>
<display value="Myofibromatosis"/>
</concept>
<concept>
<code value="8825/0"/>
<display value="Myofibroblastoma"/>
</concept>
<concept>
<code value="8825/1"/>
<display value="Myofibroblastic tumour, NOS"/>
</concept>
<concept>
<code value="8825/3"/>
<display value="Myofibroblastic sarcoma"/>
</concept>
<concept>
<code value="8826/0"/>
<display value="Angiomyofibroblastoma"/>
</concept>
<concept>
<code value="8827/1"/>
<display value="Myofibroblastic tumour, peribronchial"/>
</concept>
<concept>
<code value="8828/0"/>
<display value="Nodular fasciitis"/>
</concept>
<concept>
<code value="8830/0"/>
<display value="Benign fibrous histiocytoma"/>
</concept>
<concept>
<code value="8830/1"/>
<display value="Atypical fibrous histiocytoma"/>
</concept>
<concept>
<code value="8830/3"/>
<display value="Malignant fibrous histiocytoma"/>
</concept>
<concept>
<code value="8831/0"/>
<display value="Histiocytoma, NOS"/>
</concept>
<concept>
<code value="8832/0"/>
<display value="Dermatofibroma, NOS"/>
</concept>
<concept>
<code value="8832/1"/>
<display value="Dermatofibrosarcoma protuberans, NOS"/>
</concept>
<concept>
<code value="8832/3"/>
<display value="Dermatofibrosarcoma protuberans, fibrosarcomatous"/>
</concept>
<concept>
<code value="8833/1"/>
<display value="Pigmented dermatofibrosarcoma protuberans"/>
</concept>
<concept>
<code value="8834/1"/>
<display value="Giant cell fibroblastoma"/>
</concept>
<concept>
<code value="8835/1"/>
<display value="Plexiform fibrohistiocytic tumour"/>
</concept>
<concept>
<code value="8836/1"/>
<display value="Angiomatoid fibrous histiocytoma"/>
</concept>
<concept>
<code value="8840/0"/>
<display value="Myxoma, NOS"/>
</concept>
<concept>
<code value="8840/3"/>
<display value="Myxosarcoma"/>
</concept>
<concept>
<code value="8841/0"/>
<display value="Angiomyxoma"/>
</concept>
<concept>
<code value="8842/0"/>
<display value="Ossifying fibromyxoid tumour"/>
</concept>
<concept>
<code value="8842/3"/>
<display value="Ossifying fibromyxoid tumour, malignant"/>
</concept>
<concept>
<code value="8850/0"/>
<display value="Lipoma, NOS"/>
</concept>
<concept>
<code value="8850/1"/>
<display value="Atypical lipomatous tumour"/>
</concept>
<concept>
<code value="8850/3"/>
<display value="Liposarcoma, NOS"/>
</concept>
<concept>
<code value="8851/0"/>
<display value="Fibrolipoma"/>
</concept>
<concept>
<code value="8851/1"/>
<display value="Lipofibromatosis"/>
</concept>
<concept>
<code value="8851/3"/>
<display value="Liposarcoma, well differentiated"/>
</concept>
<concept>
<code value="8852/0"/>
<display value="Fibromyxolipoma"/>
</concept>
<concept>
<code value="8852/3"/>
<display value="Myxoid liposarcoma"/>
</concept>
<concept>
<code value="8854/0"/>
<display value="Pleomorphic lipoma"/>
</concept>
<concept>
<code value="8854/3"/>
<display value="Pleomorphic liposarcoma"/>
</concept>
<concept>
<code value="8855/3"/>
<display value="Mixed liposarcoma"/>
</concept>
<concept>
<code value="8856/0"/>
<display value="Intramuscular lipoma"/>
</concept>
<concept>
<code value="8857/0"/>
<display value="Spindle cell lipoma"/>
</concept>
<concept>
<code value="8857/3"/>
<display value="Fibroblastic liposarcoma"/>
</concept>
<concept>
<code value="8858/3"/>
<display value="Dedifferentiated liposarcoma"/>
</concept>
<concept>
<code value="8860/0"/>
<display value="Angiomyolipoma"/>
</concept>
<concept>
<code value="8860/1"/>
<display value="Angiomyolipoma, Epithelioid"/>
</concept>
<concept>
<code value="8861/0"/>
<display value="Angiolipoma, NOS"/>
</concept>
<concept>
<code value="8862/0"/>
<display value="Chondroid lipoma"/>
</concept>
<concept>
<code value="8870/0"/>
<display value="Myelolipoma"/>
</concept>
<concept>
<code value="8880/0"/>
<display value="Hibernoma"/>
</concept>
<concept>
<code value="8881/0"/>
<display value="Lipoblastomatosis"/>
</concept>
<concept>
<code value="8890/0"/>
<display value="Leiomyoma, NOS"/>
</concept>
<concept>
<code value="8890/1"/>
<display value="Leiomyomatosis, NOS"/>
</concept>
<concept>
<code value="8890/3"/>
<display value="Leiomyosarcoma, NOS"/>
</concept>
<concept>
<code value="8891/0"/>
<display value="Epithelioid leiomyoma"/>
</concept>
<concept>
<code value="8891/3"/>
<display value="Epithelioid leiomyosarcoma"/>
</concept>
<concept>
<code value="8892/0"/>
<display value="Cellular leiomyoma"/>
</concept>
<concept>
<code value="8893/0"/>
<display value="Bizarre leiomyoma"/>
</concept>
<concept>
<code value="8894/0"/>
<display value="Angiomyoma"/>
</concept>
<concept>
<code value="8894/3"/>
<display value="Angiomyosarcoma"/>
</concept>
<concept>
<code value="8895/0"/>
<display value="Myoma"/>
</concept>
<concept>
<code value="8895/3"/>
<display value="Myosarcoma"/>
</concept>
<concept>
<code value="8896/0"/>
<display value="Myxoid leiomyoma"/>
</concept>
<concept>
<code value="8896/3"/>
<display value="Myxoid leiomyosarcoma"/>
</concept>
<concept>
<code value="8897/1"/>
<display
value="Smooth muscle tumour of uncertain malignant potential"/>
</concept>
<concept>
<code value="8898/1"/>
<display value="Metastasizing leiomyoma"/>
</concept>
<concept>
<code value="8900/0"/>
<display value="Rhabdomyoma, NOS"/>
</concept>
<concept>
<code value="8900/3"/>
<display value="Rhabdomyosarcoma, NOS"/>
</concept>
<concept>
<code value="8901/3"/>
<display value="Pleomorphic rhabdomyosarcoma, adult type"/>
</concept>
<concept>
<code value="8902/3"/>
<display value="Mixed type rhabdomyosarcoma"/>
</concept>
<concept>
<code value="8903/0"/>
<display value="Fetal rhabdomyoma"/>
</concept>
<concept>
<code value="8904/0"/>
<display value="Adult cellular rhabdomyoma"/>
</concept>
<concept>
<code value="8905/0"/>
<display value="Genital rhabdomyoma"/>
</concept>
<concept>
<code value="8910/3"/>
<display value="Embryonal rhabdomyosarcoma, NOS"/>
</concept>
<concept>
<code value="8912/3"/>
<display value="Spindle cell rhabdomyosarcoma"/>
</concept>
<concept>
<code value="8920/3"/>
<display value="Alveolar rhabdomyosarcoma"/>
</concept>
<concept>
<code value="8921/3"/>
<display value="Ectomesenchymoma"/>
</concept>
<concept>
<code value="8930/0"/>
<display value="Endometrial stromal nodule"/>
</concept>
<concept>
<code value="8930/3"/>
<display value="Endometrial stromal sarcoma, NOS"/>
</concept>
<concept>
<code value="8931/3"/>
<display value="Endometrial stromal sarcoma, low grade"/>
</concept>
<concept>
<code value="8932/0"/>
<display value="Adenomyoma"/>
</concept>
<concept>
<code value="8933/3"/>
<display value="Adenosarcoma"/>
</concept>
<concept>
<code value="8934/3"/>
<display value="Carcinofibroma"/>
</concept>
<concept>
<code value="8935/0"/>
<display value="Stromal tumour, benign"/>
</concept>
<concept>
<code value="8935/1"/>
<display value="Stromal tumour, NOS"/>
</concept>
<concept>
<code value="8935/3"/>
<display value="Stromal sarcoma, NOS"/>
</concept>
<concept>
<code value="8936/3"/>
<display value="Gastrointestinal stromal tumour"/>
</concept>
<concept>
<code value="8940/0"/>
<display value="Pleomorphic adenoma"/>
</concept>
<concept>
<code value="8940/3"/>
<display value="Mixed tumour, malignant, NOS"/>
</concept>
<concept>
<code value="8941/3"/>
<display value="Carcinoma ex pleomorphic adenoma"/>
</concept>
<concept>
<code value="8950/3"/>
<display value="Mullerian mixed tumour"/>
</concept>
<concept>
<code value="8951/3"/>
<display value="Mesodermal mixed tumour"/>
</concept>
<concept>
<code value="8959/0"/>
<display value="Benign cystic nephroma"/>
</concept>
<concept>
<code value="8959/1"/>
<display value="Cystic partially differentiated nephroblastoma"/>
</concept>
<concept>
<code value="8959/3"/>
<display value="Malignant cystic nephroma"/>
</concept>
<concept>
<code value="8960/1"/>
<display value="Mesoblastic nephroma"/>
</concept>
<concept>
<code value="8960/3"/>
<display value="Nephroblastoma, NOS"/>
</concept>
<concept>
<code value="8963/3"/>
<display value="Rhabdoid tumour, NOS"/>
</concept>
<concept>
<code value="8964/3"/>
<display value="Clear cell sarcoma of kidney"/>
</concept>
<concept>
<code value="8966/0"/>
<display value="Renomedullary interstitial cell tumour"/>
</concept>
<concept>
<code value="8967/0"/>
<display value="Ossifying renal tumour"/>
</concept>
<concept>
<code value="8970/3"/>
<display value="Hepatoblastoma"/>
</concept>
<concept>
<code value="8971/3"/>
<display value="Pancreatoblastoma"/>
</concept>
<concept>
<code value="8972/3"/>
<display value="Pulmonary blastoma"/>
</concept>
<concept>
<code value="8973/3"/>
<display value="Pleuropulmonary blastoma"/>
</concept>
<concept>
<code value="8974/1"/>
<display value="Sialoblastoma"/>
</concept>
<concept>
<code value="8975/1"/>
<display value="Calcifying nested stromal-epithelial tumour"/>
</concept>
<concept>
<code value="8980/3"/>
<display value="Carcinosarcoma, NOS"/>
</concept>
<concept>
<code value="8981/3"/>
<display value="Carcinosarcoma, embryonal"/>
</concept>
<concept>
<code value="8982/0"/>
<display value="Myoepithelioma"/>
</concept>
<concept>
<code value="8982/3"/>
<display value="Myoepithelial carcinoma"/>
</concept>
<concept>
<code value="8983/0"/>
<display value="Adenomyoepithelioma, NOS"/>
</concept>
<concept>
<code value="8983/3"/>
<display value="Adenomyoepithelioma with carcinoma"/>
</concept>
<concept>
<code value="8990/0"/>
<display value="Mesenchymoma, benign"/>
</concept>
<concept>
<code value="8990/1"/>
<display value="Mesenchymoma, NOS"/>
</concept>
<concept>
<code value="8990/3"/>
<display value="Mesenchymoma, malignant"/>
</concept>
<concept>
<code value="8991/3"/>
<display value="Embryonal sarcoma"/>
</concept>
<concept>
<code value="8992/0"/>
<display value="Pulmonary hamartoma"/>
</concept>
<concept>
<code value="9000/0"/>
<display value="Brenner tumour, NOS"/>
</concept>
<concept>
<code value="9000/1"/>
<display value="Brenner tumour, borderline malignancy"/>
</concept>
<concept>
<code value="9000/3"/>
<display value="Brenner tumour, malignant"/>
</concept>
<concept>
<code value="9010/0"/>
<display value="Fibroadenoma, NOS"/>
</concept>
<concept>
<code value="9011/0"/>
<display value="Intracanalicular fibroadenoma"/>
</concept>
<concept>
<code value="9012/0"/>
<display value="Pericanalicular fibroadenoma"/>
</concept>
<concept>
<code value="9013/0"/>
<display value="Adenofibroma, NOS"/>
</concept>
<concept>
<code value="9014/0"/>
<display value="Serous adenofibroma, NOS"/>
</concept>
<concept>
<code value="9014/1"/>
<display value="Serous adenofibroma of borderline malignancy"/>
</concept>
<concept>
<code value="9014/3"/>
<display value="Serous adenocarcinofibroma"/>
</concept>
<concept>
<code value="9015/0"/>
<display value="Mucinous adenofibroma, NOS"/>
</concept>
<concept>
<code value="9015/1"/>
<display value="Mucinous adenofibroma of borderline malignancy"/>
</concept>
<concept>
<code value="9015/3"/>
<display value="Mucinous adenocarcinofibroma"/>
</concept>
<concept>
<code value="9016/0"/>
<display value="Giant fibroadenoma"/>
</concept>
<concept>
<code value="9020/0"/>
<display value="Phyllodes tumour, benign"/>
</concept>
<concept>
<code value="9020/1"/>
<display value="Phyllodes tumour, borderline"/>
</concept>
<concept>
<code value="9020/3"/>
<display value="Phyllodes tumour, malignant"/>
</concept>
<concept>
<code value="9030/0"/>
<display value="Juvenile fibroadenoma"/>
</concept>
<concept>
<code value="9040/0"/>
<display value="Synovioma, benign"/>
</concept>
<concept>
<code value="9040/3"/>
<display value="Synovial sarcoma, NOS"/>
</concept>
<concept>
<code value="9041/3"/>
<display value="Synovial sarcoma, spindle cell"/>
</concept>
<concept>
<code value="9042/3"/>
<display value="Synovial sarcoma, epithelioid cell"/>
</concept>
<concept>
<code value="9043/3"/>
<display value="Synovial sarcoma, biphasic"/>
</concept>
<concept>
<code value="9044/3"/>
<display value="Clear cell sarcoma, NOS"/>
</concept>
<concept>
<code value="9045/3"/>
<display value="Biphenotypic sinonasal sarcoma"/>
</concept>
<concept>
<code value="9050/0"/>
<display value="Mesothelioma, benign"/>
</concept>
<concept>
<code value="9050/3"/>
<display value="Mesothelioma, malignant"/>
</concept>
<concept>
<code value="9051/0"/>
<display value="Fibrous mesothelioma, benign"/>
</concept>
<concept>
<code value="9051/3"/>
<display value="Fibrous mesothelioma, malignant"/>
</concept>
<concept>
<code value="9052/0"/>
<display value="Epithelioid mesothelioma, benign"/>
</concept>
<concept>
<code value="9052/1"/>
<display
value="Well differentiated papillary mesothelioma of the pleura"/>
</concept>
<concept>
<code value="9052/3"/>
<display value="Epithelioid mesothelioma, malignant"/>
</concept>
<concept>
<code value="9053/3"/>
<display value="Mesothelioma, biphasic, malignant"/>
</concept>
<concept>
<code value="9054/0"/>
<display value="Adenomatoid tumour, NOS"/>
</concept>
<concept>
<code value="9055/0"/>
<display value="Peritoneal inclusion cysts"/>
</concept>
<concept>
<code value="9060/3"/>
<display value="Dysgerminoma"/>
</concept>
<concept>
<code value="9061/3"/>
<display value="Seminoma, NOS"/>
</concept>
<concept>
<code value="9062/3"/>
<display value="Seminoma, anaplastic"/>
</concept>
<concept>
<code value="9063/3"/>
<display value="Spermatocytic seminoma"/>
</concept>
<concept>
<code value="9064/2"/>
<display value="Intratubular malignant germ cells"/>
</concept>
<concept>
<code value="9064/3"/>
<display value="Germinoma"/>
</concept>
<concept>
<code value="9065/3"/>
<display value="Germ cell tumour, nonseminomatous"/>
</concept>
<concept>
<code value="9070/3"/>
<display value="Embryonal carcinoma, NOS"/>
</concept>
<concept>
<code value="9071/3"/>
<display value="Yolk sac tumour"/>
</concept>
<concept>
<code value="9072/3"/>
<display value="Polyembryoma"/>
</concept>
<concept>
<code value="9073/1"/>
<display value="Gonadoblastoma"/>
</concept>
<concept>
<code value="9080/0"/>
<display value="Teratoma, benign"/>
</concept>
<concept>
<code value="9080/1"/>
<display value="Teratoma, NOS"/>
</concept>
<concept>
<code value="9080/3"/>
<display value="Teratoma, malignant, NOS"/>
</concept>
<concept>
<code value="9081/3"/>
<display value="Teratocarcinoma"/>
</concept>
<concept>
<code value="9082/3"/>
<display value="Malignant teratoma, undifferentiated"/>
</concept>
<concept>
<code value="9083/3"/>
<display value="Malignant teratoma, intermediate"/>
</concept>
<concept>
<code value="9084/0"/>
<display value="Dermoid cyst, NOS"/>
</concept>
<concept>
<code value="9084/3"/>
<display value="Teratoma with malignant transformation"/>
</concept>
<concept>
<code value="9085/3"/>
<display value="Mixed germ cell tumour"/>
</concept>
<concept>
<code value="9086/3"/>
<display
value="Germ cell tumour with associated haematological malignancy"/>
</concept>
<concept>
<code value="9090/0"/>
<display value="Struma ovarii, NOS"/>
</concept>
<concept>
<code value="9090/3"/>
<display value="Struma ovarii, malignant"/>
</concept>
<concept>
<code value="9091/1"/>
<display value="Strumal carcinoid"/>
</concept>
<concept>
<code value="9100/0"/>
<display value="Hydatidiform mole, NOS"/>
</concept>
<concept>
<code value="9100/1"/>
<display value="Invasive hydatidiform mole"/>
</concept>
<concept>
<code value="9100/3"/>
<display value="Choriocarcinoma, NOS"/>
</concept>
<concept>
<code value="9101/3"/>
<display
value="Choriocarcinoma combined with other germ cell elements"/>
</concept>
<concept>
<code value="9102/3"/>
<display value="Malignant teratoma, trophoblastic"/>
</concept>
<concept>
<code value="9103/0"/>
<display value="Partial hydatidiform mole"/>
</concept>
<concept>
<code value="9104/1"/>
<display value="Placental site trophoblastic tumour"/>
</concept>
<concept>
<code value="9105/3"/>
<display value="Trophoblastic tumour, epithelioid"/>
</concept>
<concept>
<code value="9110/0"/>
<display value="Adenoma of rete ovarii"/>
</concept>
<concept>
<code value="9110/1"/>
<display value="Wolffian tumour"/>
</concept>
<concept>
<code value="9110/3"/>
<display value="Mesonephroma, malignant"/>
</concept>
<concept>
<code value="9120/0"/>
<display value="Haemangioma, NOS"/>
</concept>
<concept>
<code value="9120/3"/>
<display value="Hemangiosarcoma"/>
</concept>
<concept>
<code value="9121/0"/>
<display value="Cavernous haemangioma"/>
</concept>
<concept>
<code value="9122/0"/>
<display value="Venous haemangioma"/>
</concept>
<concept>
<code value="9123/0"/>
<display value="Racemose haemangioma"/>
</concept>
<concept>
<code value="9124/3"/>
<display value="Kupffer cell sarcoma"/>
</concept>
<concept>
<code value="9125/0"/>
<display value="Epithelioid haemangioma"/>
</concept>
<concept>
<code value="9126/0"/>
<display value="Atypical vascular lesion"/>
</concept>
<concept>
<code value="9130/0"/>
<display value="Haemangioendothelioma, benign"/>
</concept>
<concept>
<code value="9130/1"/>
<display value="Haemangioendothelioma, NOS"/>
</concept>
<concept>
<code value="9130/3"/>
<display value="Haemangioendothelioma, malignant"/>
</concept>
<concept>
<code value="9131/0"/>
<display value="Capillary haemangioma"/>
</concept>
<concept>
<code value="9132/0"/>
<display value="Intramuscular haemangioma"/>
</concept>
<concept>
<code value="9133/3"/>
<display value="Epithelioid haemangioendothelioma, NOS"/>
</concept>
<concept>
<code value="9135/1"/>
<display value="Papillary intralymphatic angioendothelioma"/>
</concept>
<concept>
<code value="9136/1"/>
<display value="Spindle cell haemangioendothelioma"/>
</concept>
<concept>
<code value="9137/0"/>
<display value="Myointimoma"/>
</concept>
<concept>
<code value="9137/3"/>
<display value="Intimal sarcoma"/>
</concept>
<concept>
<code value="9138/1"/>
<display
value="Pseudomyogenic (epithelioid sarcoma-like) haemangioendothelioma"/>
</concept>
<concept>
<code value="9140/3"/>
<display value="Kaposi sarcoma"/>
</concept>
<concept>
<code value="9141/0"/>
<display value="Angiokeratoma"/>
</concept>
<concept>
<code value="9142/0"/>
<display value="Verrucous keratotic haemangioma"/>
</concept>
<concept>
<code value="9160/0"/>
<display value="Angiofibroma, NOS"/>
</concept>
<concept>
<code value="9161/0"/>
<display value="Acquired tufted haemangioma"/>
</concept>
<concept>
<code value="9161/1"/>
<display value="Haemangioblastoma"/>
</concept>
<concept>
<code value="9170/0"/>
<display value="Lymphangioma, NOS"/>
</concept>
<concept>
<code value="9170/3"/>
<display value="Lymphangiosarcoma"/>
</concept>
<concept>
<code value="9171/0"/>
<display value="Capillary lymphangioma"/>
</concept>
<concept>
<code value="9172/0"/>
<display value="Cavernous lymphangioma"/>
</concept>
<concept>
<code value="9173/0"/>
<display value="Cystic lymphangioma"/>
</concept>
<concept>
<code value="9174/0"/>
<display value="Lymphangiomyoma"/>
</concept>
<concept>
<code value="9174/1"/>
<display value="Lymphangiomyomatosis"/>
</concept>
<concept>
<code value="9175/0"/>
<display value="Haemolymphangioma"/>
</concept>
<concept>
<code value="9180/0"/>
<display value="Osteoma, NOS"/>
</concept>
<concept>
<code value="9180/3"/>
<display value="Osteosarcoma, NOS"/>
</concept>
<concept>
<code value="9181/3"/>
<display value="Chondroblastic osteosarcoma"/>
</concept>
<concept>
<code value="9182/3"/>
<display value="Fibroblastic osteosarcoma"/>
</concept>
<concept>
<code value="9183/3"/>
<display value="Telangiectatic osteosarcoma"/>
</concept>
<concept>
<code value="9184/3"/>
<display value="Osteosarcoma in Paget disease of bone"/>
</concept>
<concept>
<code value="9185/3"/>
<display value="Small cell osteosarcoma"/>
</concept>
<concept>
<code value="9186/3"/>
<display value="Central osteosarcoma"/>
</concept>
<concept>
<code value="9187/3"/>
<display value="Low grade central osteosarcoma"/>
</concept>
<concept>
<code value="9191/0"/>
<display value="Osteoid osteoma, NOS"/>
</concept>
<concept>
<code value="9192/3"/>
<display value="Parosteal osteosarcoma"/>
</concept>
<concept>
<code value="9193/3"/>
<display value="Periosteal osteosarcoma"/>
</concept>
<concept>
<code value="9194/3"/>
<display value="High grade surface osteosarcoma"/>
</concept>
<concept>
<code value="9195/3"/>
<display value="Intracortical osteosarcoma"/>
</concept>
<concept>
<code value="9200/0"/>
<display value="Osteoblastoma, NOS"/>
</concept>
<concept>
<code value="9200/1"/>
<display value="Aggressive osteoblastoma"/>
</concept>
<concept>
<code value="9210/0"/>
<display value="Osteochondroma"/>
</concept>
<concept>
<code value="9210/1"/>
<display value="Osteochondromatosis, NOS"/>
</concept>
<concept>
<code value="9211/0"/>
<display value="Osteochondromyxoma"/>
</concept>
<concept>
<code value="9212/0"/>
<display value="Bizarre parosteal osteochondromatous proliferation"/>
</concept>
<concept>
<code value="9213/0"/>
<display value="Subungual exostosis"/>
</concept>
<concept>
<code value="9220/0"/>
<display value="Chondroma, NOS"/>
</concept>
<concept>
<code value="9220/1"/>
<display value="Chondromatosis, NOS"/>
</concept>
<concept>
<code value="9220/3"/>
<display value="Chondrosarcoma, NOS"/>
</concept>
<concept>
<code value="9221/0"/>
<display value="Periosteal chondroma"/>
</concept>
<concept>
<code value="9221/3"/>
<display value="Periosteal chondrosarcoma"/>
</concept>
<concept>
<code value="9222/1"/>
<display value="Atypical cartilaginous tumour"/>
</concept>
<concept>
<code value="9230/1"/>
<display value="Chondroblastoma, NOS"/>
</concept>
<concept>
<code value="9230/3"/>
<display value="Chondroblastoma, malignant"/>
</concept>
<concept>
<code value="9231/3"/>
<display value="Myxoid chondrosarcoma"/>
</concept>
<concept>
<code value="9240/3"/>
<display value="Mesenchymal chondrosarcoma"/>
</concept>
<concept>
<code value="9241/0"/>
<display value="Chondromyxoid fibroma"/>
</concept>
<concept>
<code value="9242/3"/>
<display value="Clear cell chondrosarcoma"/>
</concept>
<concept>
<code value="9243/3"/>
<display value="Dedifferentiated chondrosarcoma"/>
</concept>
<concept>
<code value="9250/1"/>
<display value="Giant cell tumour of bone, NOS"/>
</concept>
<concept>
<code value="9250/3"/>
<display value="Giant cell tumour of bone, malignant"/>
</concept>
<concept>
<code value="9251/1"/>
<display value="Giant cell tumour of soft parts, NOS"/>
</concept>
<concept>
<code value="9251/3"/>
<display value="Malignant giant cell tumour of soft parts"/>
</concept>
<concept>
<code value="9252/0"/>
<display value="Tenosynovial giant cell tumour, NOS"/>
</concept>
<concept>
<code value="9252/1"/>
<display value="Tenosynovial giant cell tumour, diffuse"/>
</concept>
<concept>
<code value="9252/3"/>
<display value="Malignant tenosynovial giant cell tumour"/>
</concept>
<concept>
<code value="9260/0"/>
<display value="Aneurysmal bone cyst"/>
</concept>
<concept>
<code value="9261/3"/>
<display value="Adamantinoma of long bones"/>
</concept>
<concept>
<code value="9262/0"/>
<display value="Ossifying fibroma"/>
</concept>
<concept>
<code value="9270/0"/>
<display value="Odontogenic tumour, benign"/>
</concept>
<concept>
<code value="9270/1"/>
<display value="Odontogenic tumour, NOS"/>
</concept>
<concept>
<code value="9270/3"/>
<display value="Odontogenic tumour, malignant"/>
</concept>
<concept>
<code value="9271/0"/>
<display value="Ameloblastic fibrodentinoma"/>
</concept>
<concept>
<code value="9272/0"/>
<display value="Cementoma, NOS"/>
</concept>
<concept>
<code value="9273/0"/>
<display value="Cementoblastoma, benign"/>
</concept>
<concept>
<code value="9274/0"/>
<display value="Cemento-ossifying fibroma"/>
</concept>
<concept>
<code value="9275/0"/>
<display value="Gigantiform cementoma"/>
</concept>
<concept>
<code value="9280/0"/>
<display value="Odontoma, NOS"/>
</concept>
<concept>
<code value="9281/0"/>
<display value="Compound odontoma"/>
</concept>
<concept>
<code value="9282/0"/>
<display value="Complex odontoma"/>
</concept>
<concept>
<code value="9290/0"/>
<display value="Ameloblastic fibro-odontoma"/>
</concept>
<concept>
<code value="9290/3"/>
<display value="Ameloblastic odontosarcoma"/>
</concept>
<concept>
<code value="9300/0"/>
<display value="Adenomatoid odontogenic tumour"/>
</concept>
<concept>
<code value="9301/0"/>
<display value="Calcifying odontogenic cyst"/>
</concept>
<concept>
<code value="9302/0"/>
<display value="Dentinogenic ghost cell tumour"/>
</concept>
<concept>
<code value="9302/3"/>
<display value="Ghost cell odontogenic carcinoma"/>
</concept>
<concept>
<code value="9310/0"/>
<display value="Ameloblastoma, NOS"/>
</concept>
<concept>
<code value="9310/3"/>
<display value="Ameloblastoma, metastasizing"/>
</concept>
<concept>
<code value="9311/0"/>
<display value="Odontoameloblastoma"/>
</concept>
<concept>
<code value="9312/0"/>
<display value="Squamous odontogenic tumour"/>
</concept>
<concept>
<code value="9320/0"/>
<display value="Odontogenic myxoma"/>
</concept>
<concept>
<code value="9321/0"/>
<display value="Odontogenic fibroma, NOS"/>
</concept>
<concept>
<code value="9322/0"/>
<display value="Peripheral odontogenic fibroma"/>
</concept>
<concept>
<code value="9330/0"/>
<display value="Ameloblastic fibroma"/>
</concept>
<concept>
<code value="9330/3"/>
<display value="Ameloblastic fibrosarcoma"/>
</concept>
<concept>
<code value="9340/0"/>
<display value="Calcifying epithelial odontogenic tumour"/>
</concept>
<concept>
<code value="9341/3"/>
<display value="Clear cell odontogenic carcinoma"/>
</concept>
<concept>
<code value="9342/3"/>
<display value="Odontogenic carcinosarcoma"/>
</concept>
<concept>
<code value="9350/1"/>
<display value="Craniopharyngioma"/>
</concept>
<concept>
<code value="9351/1"/>
<display value="Craniopharyngioma, adamantinomatous"/>
</concept>
<concept>
<code value="9352/1"/>
<display value="Craniopharyngioma, papillary"/>
</concept>
<concept>
<code value="9360/1"/>
<display value="Pinealoma"/>
</concept>
<concept>
<code value="9361/1"/>
<display value="Pineocytoma"/>
</concept>
<concept>
<code value="9362/3"/>
<display value="Pineoblastoma"/>
</concept>
<concept>
<code value="9363/0"/>
<display value="Melanotic neuroectodermal tumour"/>
</concept>
<concept>
<code value="9364/3"/>
<display value="Ewing sarcoma"/>
</concept>
<concept>
<code value="9365/3"/>
<display value="Askin tumour"/>
</concept>
<concept>
<code value="9370/0"/>
<display value="Benign notochordal cell tumour"/>
</concept>
<concept>
<code value="9370/3"/>
<display value="Chordoma, NOS"/>
</concept>
<concept>
<code value="9371/3"/>
<display value="Chondroid chordoma"/>
</concept>
<concept>
<code value="9372/3"/>
<display value="Dedifferentiated chordoma"/>
</concept>
<concept>
<code value="9373/0"/>
<display value="Parachordoma"/>
</concept>
<concept>
<code value="9380/3"/>
<display value="Glioma, malignant"/>
</concept>
<concept>
<code value="9381/3"/>
<display value="Gliomatosis cerebri"/>
</concept>
<concept>
<code value="9382/3"/>
<display value="Oligoastrocytoma, NOS"/>
</concept>
<concept>
<code value="9383/1"/>
<display value="Subependymoma"/>
</concept>
<concept>
<code value="9384/1"/>
<display value="Subependymal giant cell astrocytoma"/>
</concept>
<concept>
<code value="9385/3"/>
<display value="Diffuse midline glioma, H3 K27M-mutant"/>
</concept>
<concept>
<code value="9390/0"/>
<display value="Choroid plexus papilloma, NOS"/>
</concept>
<concept>
<code value="9390/1"/>
<display value="Atypical choroid plexus papilloma"/>
</concept>
<concept>
<code value="9390/3"/>
<display value="Choroid plexus carcinoma"/>
</concept>
<concept>
<code value="9391/1"/>
<display value="Sellar ependymoma"/>
</concept>
<concept>
<code value="9391/3"/>
<display value="Ependymoma, NOS"/>
</concept>
<concept>
<code value="9392/3"/>
<display value="Ependymoma, anaplastic"/>
</concept>
<concept>
<code value="9393/3"/>
<display value="Papillary ependymoma"/>
</concept>
<concept>
<code value="9394/1"/>
<display value="Myxopapillary ependymoma"/>
</concept>
<concept>
<code value="9395/3"/>
<display value="Papillary tumour of the pineal region"/>
</concept>
<concept>
<code value="9396/3"/>
<display value="Ependymoma, RELA fusion-positive"/>
</concept>
<concept>
<code value="9400/3"/>
<display value="Astrocytoma, NOS"/>
</concept>
<concept>
<code value="9401/3"/>
<display value="Astrocytoma, anaplastic"/>
</concept>
<concept>
<code value="9410/3"/>
<display value="Protoplasmic astrocytoma"/>
</concept>
<concept>
<code value="9411/3"/>
<display value="Gemistocytic astrocytoma"/>
</concept>
<concept>
<code value="9412/1"/>
<display value="Desmoplastic infantile astrocytoma"/>
</concept>
<concept>
<code value="9413/0"/>
<display value="Dysembryoplastic neuroepithelial tumour"/>
</concept>
<concept>
<code value="9420/3"/>
<display value="Fibrillary astrocytoma"/>
</concept>
<concept>
<code value="9421/1"/>
<display value="Pilocytic astrocytoma"/>
</concept>
<concept>
<code value="9423/3"/>
<display value="Polar spongioblastoma"/>
</concept>
<concept>
<code value="9424/3"/>
<display value="Pleomorphic xanthoastrocytoma"/>
</concept>
<concept>
<code value="9425/3"/>
<display value="Pilomyxoid astrocytoma"/>
</concept>
<concept>
<code value="9430/3"/>
<display value="Astroblastoma"/>
</concept>
<concept>
<code value="9431/1"/>
<display value="Angiocentric glioma"/>
</concept>
<concept>
<code value="9432/1"/>
<display value="Pituicytoma"/>
</concept>
<concept>
<code value="9440/3"/>
<display value="Glioblastoma, NOS"/>
</concept>
<concept>
<code value="9441/3"/>
<display value="Giant cell glioblastoma"/>
</concept>
<concept>
<code value="9442/1"/>
<display value="Gliofibroma"/>
</concept>
<concept>
<code value="9442/3"/>
<display value="Gliosarcoma"/>
</concept>
<concept>
<code value="9444/1"/>
<display value="Chordoid glioma"/>
</concept>
<concept>
<code value="9445/3"/>
<display value="Glioblastoma, IDH mutant"/>
</concept>
<concept>
<code value="9450/3"/>
<display value="Oligodendroglioma, NOS"/>
</concept>
<concept>
<code value="9451/3"/>
<display value="Oligodendroglioma, anaplastic"/>
</concept>
<concept>
<code value="9460/3"/>
<display value="Oligodendroblastoma"/>
</concept>
<concept>
<code value="9470/3"/>
<display value="Medulloblastoma, NOS"/>
</concept>
<concept>
<code value="9471/3"/>
<display value="Desmoplastic nodular medulloblastoma"/>
</concept>
<concept>
<code value="9472/3"/>
<display value="Medullomyoblastoma"/>
</concept>
<concept>
<code value="9473/3"/>
<display value="CNS embryonal tumour, NOS"/>
</concept>
<concept>
<code value="9474/3"/>
<display value="Large cell medulloblastoma"/>
</concept>
<concept>
<code value="9475/3"/>
<display value="Medulloblastoma, WNT-activated, NOS"/>
</concept>
<concept>
<code value="9476/3"/>
<display value="Medulloblastoma, SHH-activated and TP53-mutant"/>
</concept>
<concept>
<code value="9477/3"/>
<display value="Medulloblastoma, non-WNT/non-SHH"/>
</concept>
<concept>
<code value="9478/3"/>
<display
value="Embryonal tumours with multilayered rosettes with C19MC alteration"/>
</concept>
<concept>
<code value="9480/3"/>
<display value="Cerebellar sarcoma, NOS"/>
</concept>
<concept>
<code value="9490/0"/>
<display value="Ganglioneuroma"/>
</concept>
<concept>
<code value="9490/3"/>
<display value="Ganglioneuroblastoma"/>
</concept>
<concept>
<code value="9491/0"/>
<display value="Ganglioneuromatosis"/>
</concept>
<concept>
<code value="9492/0"/>
<display value="Gangliocytoma"/>
</concept>
<concept>
<code value="9493/0"/>
<display
value="Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos)"/>
</concept>
<concept>
<code value="9500/3"/>
<display value="Neuroblastoma, NOS"/>
</concept>
<concept>
<code value="9501/0"/>
<display value="Medulloepithelioma, benign"/>
</concept>
<concept>
<code value="9501/3"/>
<display value="Medulloepithelioma, NOS"/>
</concept>
<concept>
<code value="9502/0"/>
<display value="Teratoid medulloepithelioma, benign"/>
</concept>
<concept>
<code value="9502/3"/>
<display value="Teratoid medulloepithelioma"/>
</concept>
<concept>
<code value="9503/3"/>
<display value="Neuroepithelioma, NOS"/>
</concept>
<concept>
<code value="9504/3"/>
<display value="Spongioneuroblastoma"/>
</concept>
<concept>
<code value="9505/1"/>
<display value="Ganglioglioma, NOS"/>
</concept>
<concept>
<code value="9505/3"/>
<display value="Ganglioglioma, anaplastic"/>
</concept>
<concept>
<code value="9506/1"/>
<display value="Central neurocytoma"/>
</concept>
<concept>
<code value="9507/0"/>
<display value="Pacinian tumour"/>
</concept>
<concept>
<code value="9508/3"/>
<display value="Atypical teratoid/rhabdoid tumour"/>
</concept>
<concept>
<code value="9509/1"/>
<display value="Papillary glioneuronal tumour"/>
</concept>
<concept>
<code value="9510/0"/>
<display value="Retinocytoma"/>
</concept>
<concept>
<code value="9510/3"/>
<display value="Retinoblastoma, NOS"/>
</concept>
<concept>
<code value="9511/3"/>
<display value="Retinoblastoma, differentiated"/>
</concept>
<concept>
<code value="9512/3"/>
<display value="Retinoblastoma, undifferentiated"/>
</concept>
<concept>
<code value="9513/3"/>
<display value="Retinoblastoma, diffuse"/>
</concept>
<concept>
<code value="9514/1"/>
<display value="Retinoblastoma, spontaneously regressed"/>
</concept>
<concept>
<code value="9520/3"/>
<display value="Olfactory neurogenic tumour"/>
</concept>
<concept>
<code value="9521/3"/>
<display value="Olfactory neurocytoma"/>
</concept>
<concept>
<code value="9522/3"/>
<display value="Olfactory neuroblastoma"/>
</concept>
<concept>
<code value="9523/3"/>
<display value="Olfactory neuroepithelioma"/>
</concept>
<concept>
<code value="9530/0"/>
<display value="Meningioma, NOS"/>
</concept>
<concept>
<code value="9530/3"/>
<display value="Meningioma, malignant"/>
</concept>
<concept>
<code value="9531/0"/>
<display value="Meningothelial meningioma"/>
</concept>
<concept>
<code value="9532/0"/>
<display value="Fibrous meningioma"/>
</concept>
<concept>
<code value="9533/0"/>
<display value="Psammomatous meningioma"/>
</concept>
<concept>
<code value="9534/0"/>
<display value="Angiomatous meningioma"/>
</concept>
<concept>
<code value="9535/0"/>
<display value="Haemangioblastic meningioma"/>
</concept>
<concept>
<code value="9537/0"/>
<display value="Transitional meningioma"/>
</concept>
<concept>
<code value="9538/1"/>
<display value="Clear cell meningioma"/>
</concept>
<concept>
<code value="9538/3"/>
<display value="Papillary meningioma"/>
</concept>
<concept>
<code value="9539/1"/>
<display value="Atypical meningioma"/>
</concept>
<concept>
<code value="9539/3"/>
<display value="Meningeal sarcomatosis"/>
</concept>
<concept>
<code value="9540/0"/>
<display value="Neurofibroma, NOS"/>
</concept>
<concept>
<code value="9540/3"/>
<display value="Malignant peripheral nerve sheath tumour"/>
</concept>
<concept>
<code value="9541/0"/>
<display value="Melanotic neurofibroma"/>
</concept>
<concept>
<code value="9542/3"/>
<display
value="Malignant peripheral nerve sheath tumour, epithelioid"/>
</concept>
<concept>
<code value="9550/0"/>
<display value="Plexiform neurofibroma"/>
</concept>
<concept>
<code value="9560/0"/>
<display value="Schwannoma, NOS"/>
</concept>
<concept>
<code value="9560/1"/>
<display value="Melanotic schwannoma"/>
</concept>
<concept>
<code value="9560/3"/>
<display value="Neurilemoma, malignant"/>
</concept>
<concept>
<code value="9561/3"/>
<display
value="Malignant peripheral nerve sheath tumour with rhabdomyoblastic differentiation"/>
</concept>
<concept>
<code value="9562/0"/>
<display value="Nerve sheath myxoma"/>
</concept>
<concept>
<code value="9563/0"/>
<display value="Nerve sheath tumour, NOS"/>
</concept>
<concept>
<code value="9570/0"/>
<display value="Neuroma, NOS"/>
</concept>
<concept>
<code value="9571/0"/>
<display value="Perineurioma, NOS"/>
</concept>
<concept>
<code value="9571/3"/>
<display value="Perineurioma, malignant"/>
</concept>
<concept>
<code value="9580/0"/>
<display value="Granular cell tumour, NOS"/>
</concept>
<concept>
<code value="9580/3"/>
<display value="Granular cell tumour, malignant"/>
</concept>
<concept>
<code value="9581/3"/>
<display value="Alveolar soft part sarcoma"/>
</concept>
<concept>
<code value="9582/0"/>
<display value="Granular cell tumour of the sellar region"/>
</concept>
<concept>
<code value="9590/3"/>
<display value="Malignant lymphoma, NOS"/>
</concept>
<concept>
<code value="9591/1"/>
<display value="Monoclonal B-cell lymphocytosis, NOS"/>
</concept>
<concept>
<code value="9591/3"/>
<display value="Malignant lymphoma, non-Hodgkin, NOS"/>
</concept>
<concept>
<code value="9596/3"/>
<display value="Composite Hodgkin and non-Hodgkin lymphoma"/>
</concept>
<concept>
<code value="9597/3"/>
<display value="Primary cutaneous follicle centre lymphoma"/>
</concept>
<concept>
<code value="9650/3"/>
<display value="Hodgkin lymphoma, NOS"/>
</concept>
<concept>
<code value="9651/3"/>
<display value="Hodgkin lymphoma, lymphocyte-rich"/>
</concept>
<concept>
<code value="9652/3"/>
<display value="Hodgkin lymphoma, mixed cellularity, NOS"/>
</concept>
<concept>
<code value="9653/3"/>
<display value="Hodgkin lymphoma, lymphocyte depletion, NOS"/>
</concept>
<concept>
<code value="9654/3"/>
<display
value="Hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis"/>
</concept>
<concept>
<code value="9655/3"/>
<display value="Hodgkin lymphoma, lymphocyte depletion, reticular"/>
</concept>
<concept>
<code value="9659/3"/>
<display value="Hodgkin lymphoma, nodular lymphocyte predominant"/>
</concept>
<concept>
<code value="9661/3"/>
<display value="Hodgkin granuloma"/>
</concept>
<concept>
<code value="9662/3"/>
<display value="Hodgkin sarcoma"/>
</concept>
<concept>
<code value="9663/3"/>
<display value="Hodgkin lymphoma, nodular sclerosis, NOS"/>
</concept>
<concept>
<code value="9664/3"/>
<display value="Hodgkin lymphoma, nodular sclerosis, cellular phase"/>
</concept>
<concept>
<code value="9665/3"/>
<display value="Hodgkin lymphoma, nodular sclerosis, grade 1"/>
</concept>
<concept>
<code value="9667/3"/>
<display value="Hodgkin lymphoma, nodular sclerosis, grade 2"/>
</concept>
<concept>
<code value="9671/3"/>
<display value="Lymphoplasmacytic lymphoma"/>
</concept>
<concept>
<code value="9673/1"/>
<display value="In situ mantle cell neoplasia"/>
</concept>
<concept>
<code value="9673/3"/>
<display value="Mantle cell lymphoma"/>
</concept>
<concept>
<code value="9675/3"/>
<display
value="Malignant lymphoma, mixed small and large cell, diffuse"/>
</concept>
<concept>
<code value="9678/3"/>
<display value="Primary effusion lymphoma"/>
</concept>
<concept>
<code value="9679/3"/>
<display value="Mediastinal large B-cell lymphoma"/>
</concept>
<concept>
<code value="9680/1"/>
<display value="EBV positive mucocutaneous ulcer"/>
</concept>
<concept>
<code value="9680/3"/>
<display value="Diffuse large B-cell lymphoma, NOS"/>
</concept>
<concept>
<code value="9684/3"/>
<display
value="Malignant lymphoma, large B-cell, diffuse, immunoblastic, NOS"/>
</concept>
<concept>
<code value="9687/3"/>
<display value="Burkitt lymphoma, NOS"/>
</concept>
<concept>
<code value="9688/3"/>
<display value="T-cell/histiocyte rich large B-cell lymphoma"/>
</concept>
<concept>
<code value="9689/3"/>
<display value="Splenic marginal zone B-cell lymphoma"/>
</concept>
<concept>
<code value="9690/3"/>
<display value="Follicular lymphoma, NOS"/>
</concept>
<concept>
<code value="9691/3"/>
<display value="Follicular lymphoma, grade 2"/>
</concept>
<concept>
<code value="9695/1"/>
<display value="In situ follicular neoplasia"/>
</concept>
<concept>
<code value="9695/3"/>
<display value="Follicular lymphoma, grade 1"/>
</concept>
<concept>
<code value="9698/3"/>
<display value="Follicular lymphoma, grade 3"/>
</concept>
<concept>
<code value="9699/3"/>
<display value="Marginal zone B-cell lymphoma, NOS"/>
</concept>
<concept>
<code value="9700/3"/>
<display value="Mycosis fungoides"/>
</concept>
<concept>
<code value="9701/3"/>
<display value="Sezary syndrome"/>
</concept>
<concept>
<code value="9702/1"/>
<display
value="Indolent T-cell lymphoproliferative disorder of gastrointestinal tract"/>
</concept>
<concept>
<code value="9702/3"/>
<display value="Mature T-cell lymphoma, NOS"/>
</concept>
<concept>
<code value="9705/3"/>
<display value="Angioimmunoblastic T-cell lymphoma"/>
</concept>
<concept>
<code value="9708/3"/>
<display value="Subcutaneous panniculitis-like T-cell lymphoma"/>
</concept>
<concept>
<code value="9709/1"/>
<display
value="Primary cutaneous CD4 positive small/medium T-cell lymphoproliferative disorder"/>
</concept>
<concept>
<code value="9709/3"/>
<display value="Cutaneous T-cell lymphoma, NOS"/>
</concept>
<concept>
<code value="9712/3"/>
<display value="Intravascular large B-cell lymphoma"/>
</concept>
<concept>
<code value="9714/3"/>
<display
value="Anaplastic large cell lymphoma, T cell and Null cell type"/>
</concept>
<concept>
<code value="9715/3"/>
<display value="Anaplastic large cell lymphoma, ALK negative"/>
</concept>
<concept>
<code value="9716/3"/>
<display value="Hepatosplenic T-cell lymphoma"/>
</concept>
<concept>
<code value="9717/3"/>
<display value="Intestinal T-cell lymphoma"/>
</concept>
<concept>
<code value="9718/1"/>
<display
value="Primary cutaneous CD30+ T-cell lymphoproliferative disorder"/>
</concept>
<concept>
<code value="9718/3"/>
<display value="Primary cutaneous anaplastic large cell lymphoma"/>
</concept>
<concept>
<code value="9719/3"/>
<display value="NK/T-cell lymphoma, nasal and nasal-type"/>
</concept>
<concept>
<code value="9724/3"/>
<display
value="Systemic EBV positive T-cell lymphoproliferative disease of childhood"/>
</concept>
<concept>
<code value="9725/1"/>
<display
value="Hydroa vacciniforme-like lymphoproliferative disorder"/>
</concept>
<concept>
<code value="9726/3"/>
<display value="Primary cutaneous gamma/delta T-cell lymphoma"/>
</concept>
<concept>
<code value="9727/3"/>
<display value="Precursor cell lymphoblastic lymphoma, NOS"/>
</concept>
<concept>
<code value="9731/3"/>
<display value="Plasmacytoma, NOS"/>
</concept>
<concept>
<code value="9732/3"/>
<display value="Plasma cell myeloma"/>
</concept>
<concept>
<code value="9733/3"/>
<display value="Plasma cell leukaemia"/>
</concept>
<concept>
<code value="9734/3"/>
<display value="Plasmacytoma, extramedullary"/>
</concept>
<concept>
<code value="9735/3"/>
<display value="Plasmablastic lymphoma"/>
</concept>
<concept>
<code value="9737/3"/>
<display value="ALK positive large B-cell lymphoma"/>
</concept>
<concept>
<code value="9738/3"/>
<display
value="Large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease"/>
</concept>
<concept>
<code value="9740/1"/>
<display value="Mastocytoma, NOS"/>
</concept>
<concept>
<code value="9740/3"/>
<display value="Mast cell sarcoma"/>
</concept>
<concept>
<code value="9741/1"/>
<display value="Indolent systemic mastocytosis"/>
</concept>
<concept>
<code value="9741/3"/>
<display value="Malignant mastocytosis"/>
</concept>
<concept>
<code value="9742/3"/>
<display value="Mast cell leukaemia"/>
</concept>
<concept>
<code value="9749/3"/>
<display value="Erdheim-Chester disease"/>
</concept>
<concept>
<code value="9750/3"/>
<display value="Malignant histiocytosis"/>
</concept>
<concept>
<code value="9751/1"/>
<display value="Langerhans cell histiocytosis"/>
</concept>
<concept>
<code value="9751/3"/>
<display value="Langerhans cell histiocytosis, disseminated"/>
</concept>
<concept>
<code value="9755/3"/>
<display value="Histiocytic sarcoma"/>
</concept>
<concept>
<code value="9756/3"/>
<display value="Langerhans cell sarcoma"/>
</concept>
<concept>
<code value="9757/3"/>
<display value="Interdigitating dendritic cell sarcoma"/>
</concept>
<concept>
<code value="9758/3"/>
<display value="Follicular dendritic cell sarcoma"/>
</concept>
<concept>
<code value="9759/3"/>
<display value="Fibroblastic reticular cell tumour"/>
</concept>
<concept>
<code value="9760/3"/>
<display value="Immunoproliferative disease, NOS"/>
</concept>
<concept>
<code value="9761/1"/>
<display
value="IgM monoclonal gammopathy of undetermined significance"/>
</concept>
<concept>
<code value="9761/3"/>
<display value="Waldenstrom macroglobulinemia"/>
</concept>
<concept>
<code value="9762/3"/>
<display value="Heavy chain disease, NOS"/>
</concept>
<concept>
<code value="9764/3"/>
<display value="Immunoproliferative small intestinal disease"/>
</concept>
<concept>
<code value="9765/1"/>
<display value="Monoclonal gammopathy of undetermined significance"/>
</concept>
<concept>
<code value="9766/1"/>
<display value="Angiocentric immunoproliferative lesion"/>
</concept>
<concept>
<code value="9766/3"/>
<display value="Lymphomatoid granulomatosis, grade 3"/>
</concept>
<concept>
<code value="9767/1"/>
<display value="Angioimmunoblastic lymphadenopathy (AIL)"/>
</concept>
<concept>
<code value="9768/1"/>
<display value="T-gamma lymphoproliferative disease"/>
</concept>
<concept>
<code value="9769/1"/>
<display value="Immunoglobulin deposition disease"/>
</concept>
<concept>
<code value="9800/3"/>
<display value="Leukaemia, NOS"/>
</concept>
<concept>
<code value="9801/3"/>
<display value="Acute leukaemia, NOS"/>
</concept>
<concept>
<code value="9805/3"/>
<display value="Acute biphenotypic leukaemia"/>
</concept>
<concept>
<code value="9806/3"/>
<display
value="Mixed phenotype acute leukaemia with t(9;22)(q34;q11.2); BCR-ABL1"/>
</concept>
<concept>
<code value="9807/3"/>
<display
value="Mixed phenotype acute leukaemia with t(v;11q23); MLL rearranged"/>
</concept>
<concept>
<code value="9808/3"/>
<display value="Mixed phenotype acute leukaemia, B/myeloid, NOS"/>
</concept>
<concept>
<code value="9809/3"/>
<display value="Mixed phenotype acute leukaemia, T/myeloid, NOS"/>
</concept>
<concept>
<code value="9811/3"/>
<display value="B lymphoblastic leukaemia/lymphoma, NOS"/>
</concept>
<concept>
<code value="9812/3"/>
<display
value="B lymphoblastic leukaemia/lymphoma with t(9;22)(q34;q11.2); BCR-ABL1"/>
</concept>
<concept>
<code value="9813/3"/>
<display
value="B lymphoblastic leukaemia/lymphoma with t(v;11q23); MLL rearranged"/>
</concept>
<concept>
<code value="9814/3"/>
<display
value="B lymphoblastic leukaemia/lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)"/>
</concept>
<concept>
<code value="9815/3"/>
<display
value="B lymphoblastic leukaemia/lymphoma with hyperdiploidy"/>
</concept>
<concept>
<code value="9816/3"/>
<display
value="B lymphoblastic leukaemia/lymphoma with hypodiploidy (Hypodiploid ALL)"/>
</concept>
<concept>
<code value="9817/3"/>
<display
value="B lymphoblastic leukaemia/lymphoma with t(5;14)(q31;q32); IL3-IGH"/>
</concept>
<concept>
<code value="9818/3"/>
<display
value="B lymphoblastic leukaemia/lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)"/>
</concept>
<concept>
<code value="9819/3"/>
<display value="B lymphoblastic leukemia/lymphoma, BCR-ABL1-like"/>
</concept>
<concept>
<code value="9820/3"/>
<display value="Lymphoid leukaemia, NOS"/>
</concept>
<concept>
<code value="9823/1"/>
<display value="Monoclonal B-cell lymphocytosis, CLL type"/>
</concept>
<concept>
<code value="9823/3"/>
<display
value="B-cell chronic lymphocytic leukaemia/small lymphocytic lymphoma"/>
</concept>
<concept>
<code value="9827/3"/>
<display value="Adult T-cell leukaemia/lymphoma (HTLV-1 positive)"/>
</concept>
<concept>
<code value="9831/3"/>
<display value="T-cell large granular lymphocytic leukaemia"/>
</concept>
<concept>
<code value="9832/3"/>
<display value="Prolymphocytic leukaemia, NOS"/>
</concept>
<concept>
<code value="9833/3"/>
<display value="Prolymphocytic leukaemia, B-cell type"/>
</concept>
<concept>
<code value="9834/3"/>
<display value="Prolymphocytic leukaemia, T-cell type"/>
</concept>
<concept>
<code value="9835/3"/>
<display value="Precursor cell lymphoblastic leukaemia, NOS"/>
</concept>
<concept>
<code value="9837/3"/>
<display value="Precursor T-cell lymphoblastic leukaemia"/>
</concept>
<concept>
<code value="9840/3"/>
<display value="Acute erythroid leukemia"/>
</concept>
<concept>
<code value="9860/3"/>
<display value="Myeloid leukaemia, NOS"/>
</concept>
<concept>
<code value="9861/3"/>
<display value="Acute myeloid leukaemia, NOS"/>
</concept>
<concept>
<code value="9863/3"/>
<display value="Chronic myeloid leukaemia, NOS"/>
</concept>
<concept>
<code value="9865/3"/>
<display
value="Acute myeloid leukaemia with t(6;9)(p23;q34); DEK-NUP214"/>
</concept>
<concept>
<code value="9866/3"/>
<display value="Acute promyelocytic leukaemia, t(15;17)(q22;q11-12)"/>
</concept>
<concept>
<code value="9867/3"/>
<display value="Acute myelomonocytic leukaemia"/>
</concept>
<concept>
<code value="9869/3"/>
<display
value="Acute myeloid leukaemia with inv(3)(q21;q26.2) or t(3.3)(q21;q26.2); RPN1-EVI1"/>
</concept>
<concept>
<code value="9870/3"/>
<display value="Acute basophilic leukaemia"/>
</concept>
<concept>
<code value="9871/3"/>
<display
value="Acute myeloid leukaemia with abnormal marrow eosinophils"/>
</concept>
<concept>
<code value="9872/3"/>
<display value="Acute myeloid leukaemia, minimal differentiation"/>
</concept>
<concept>
<code value="9873/3"/>
<display value="Acute myeloid leukaemia without maturation"/>
</concept>
<concept>
<code value="9874/3"/>
<display value="Acute myeloid leukaemia with maturation"/>
</concept>
<concept>
<code value="9875/3"/>
<display value="Chronic myelogenous leukaemia, BCR/ABL positive"/>
</concept>
<concept>
<code value="9876/3"/>
<display
value="Atypical chronic myeloid leukaemia, BCR/ABL negative"/>
</concept>
<concept>
<code value="9877/3"/>
<display value="Acute myeloid leukaemia with mutated NPM1"/>
</concept>
<concept>
<code value="9878/3"/>
<display
value="Acute myeloid leukemia with biallelic mutation of CEBPA"/>
</concept>
<concept>
<code value="9879/3"/>
<display value="Acute myeloid leukemia with mutated RUNX1"/>
</concept>
<concept>
<code value="9891/3"/>
<display value="Acute monocytic leukaemia"/>
</concept>
<concept>
<code value="9895/3"/>
<display
value="Acute myeloid leukaemia with myelodysplasia-related changes"/>
</concept>
<concept>
<code value="9896/3"/>
<display value="Acute myeloid leukaemia, t(8;21)(q22;q22)"/>
</concept>
<concept>
<code value="9897/3"/>
<display value="Acute myeloid leukaemia, 11q23 abnormalities"/>
</concept>
<concept>
<code value="9898/1"/>
<display value="Transient abnormal myelopoiesis"/>
</concept>
<concept>
<code value="9898/3"/>
<display value="Myeloid leukaemia associated with Down Syndrome"/>
</concept>
<concept>
<code value="9910/3"/>
<display value="Acute megakaryoblastic leukaemia"/>
</concept>
<concept>
<code value="9911/3"/>
<display
value="Acute myeloid leukaemia (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1"/>
</concept>
<concept>
<code value="9912/3"/>
<display value="Acute myeloid leukemia with BCR-ABL1"/>
</concept>
<concept>
<code value="9920/3"/>
<display value="Therapy related myeloid neoplasm"/>
</concept>
<concept>
<code value="9930/3"/>
<display value="Myeloid sarcoma"/>
</concept>
<concept>
<code value="9931/3"/>
<display value="Acute panmyelosis with myelofibrosis"/>
</concept>
<concept>
<code value="9940/3"/>
<display value="Hairy cell leukaemia"/>
</concept>
<concept>
<code value="9945/3"/>
<display value="Chronic myelomonocytic leukaemia, NOS"/>
</concept>
<concept>
<code value="9946/3"/>
<display value="Juvenile myelomonocytic leukaemia"/>
</concept>
<concept>
<code value="9948/3"/>
<display value="Aggressive NK-cell leukaemia"/>
</concept>
<concept>
<code value="9950/3"/>
<display value="Polycythaemia vera"/>
</concept>
<concept>
<code value="9960/3"/>
<display value="Myeloproliferative neoplasm, NOS"/>
</concept>
<concept>
<code value="9961/3"/>
<display value="Primary myelofibrosis"/>
</concept>
<concept>
<code value="9962/3"/>
<display value="Essential thrombocythemia"/>
</concept>
<concept>
<code value="9963/3"/>
<display value="Chronic neutrophilic leukaemia"/>
</concept>
<concept>
<code value="9964/3"/>
<display value="Chronic eosinophilic leukaemia"/>
</concept>
<concept>
<code value="9965/3"/>
<display
value="Myeloid and lymphoid neoplasms with PDGFRA rearrangement"/>
</concept>
<concept>
<code value="9966/3"/>
<display value="Myeloid neoplasms with PDGFRB rearrangement"/>
</concept>
<concept>
<code value="9967/3"/>
<display
value="Myeloid and lymphoid neoplasms with FGFR1 abnormalities"/>
</concept>
<concept>
<code value="9968/3"/>
<display value="Myeloid or lymphoid neoplasm with PCM1-JAK2"/>
</concept>
<concept>
<code value="9970/1"/>
<display value="Lymphoproliferative disorder, NOS"/>
</concept>
<concept>
<code value="9971/1"/>
<display value="Post transplant lymphoproliferative disorder, NOS"/>
</concept>
<concept>
<code value="9975/3"/>
<display value="Myeloproliferative neoplasm, unclassifiable"/>
</concept>
<concept>
<code value="9982/3"/>
<display
value="Myelodysplastic syndrome with ring sideroblasts and single lineage dysplasia"/>
</concept>
<concept>
<code value="9983/3"/>
<display value="Myelodysplastic syndrome with excess blasts"/>
</concept>
<concept>
<code value="9984/3"/>
<display
value="Refractory anaemia with excess blasts in transformation"/>
</concept>
<concept>
<code value="9985/3"/>
<display
value="Myelodysplastic syndrome with multilineage dysplasia"/>
</concept>
<concept>
<code value="9986/3"/>
<display value="Myelodysplastic syndrome with isolated del (5q)"/>
</concept>
<concept>
<code value="9987/3"/>
<display value="Therapy-related myelodysplastic syndrome, NOS"/>
</concept>
<concept>
<code value="9989/3"/>
<display value="Myelodysplastic syndrome, NOS"/>
</concept>
<concept>
<code value="9993/3"/>
<display
value="Myelodysplastic syndrome with ring sideroblasts and multilineage dysplasia"/>
</concept>
<concept>
<code value="8408/3"/>
<display value="Digital papillary adenocarcinoma"/>
</concept>
<concept>
<code value="8442/1"/>
<display value="Serous borderline tumour, NOS"/>
</concept>
<concept>
<code value="9980/3"/>
<display
value="Myelodysplastic syndrome with single lineage dysplasia"/>
</concept>
</include>
</compose>
</ValueSet>
IG © 2025+ MyHealth@Eu. Package myhealth.eu.fhir.idr#0.0.1 based on FHIR 4.0.1. Generated 2025-06-06
